https://www.oncozine.com/cancer-mortality-may-increase-for-successive-generations-of-latino-immigrants/ 2018-11-07T02:30:24+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_20736088_Subscription_Monthly_M.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2018/11/V.-Wendy-Setiawan-PhD.jpg https://www.oncozine.com/study-shows-promise-in-preventing-heart-disease-in-cancer-survivors/ 2018-11-07T03:35:03+00:00 https://www.oncozine.com/wp-content/uploads/2016/07/Fotolia_94619649_Subscription_Monthly_M-e1490845631347.jpg https://www.oncozine.com/wp-content/uploads/2018/11/ZhaokangCheng_PengXia_inLab_fullsize.jpg https://www.oncozine.com/new-type-of-molecule-shows-early-promise-against-prostate-cancer/ 2018-11-07T04:23:54+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Lower_Manhattan_from_Jersey_City_November_2014_panorama_3.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Susan-K.-Logan_NYU.jpg https://www.oncozine.com/study-shows-zoledronic-acid-improves-disease-free-survival-in-premenopausal-hr-early-breast-cancer/ 2018-11-07T05:31:29+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/ESMO-2018_3435.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/981-esmo_logo_medium-300x120.jpg https://www.oncozine.com/addition-of-pelvic-lymph-node-radiation-may-significant-improve-prostate-cancer-treatment/ 2018-11-07T06:20:03+00:00 https://www.oncozine.com/wp-content/uploads/2007/04/Fotolia_101834621_Subscription_Monthly_M.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/558-ASTRO_logi-300x103.jpg https://www.oncozine.com/wp-content/uploads/2018/11/ASTRO_2018_pollack.jpg https://www.oncozine.com/immunotherapy-chemotherapy-combination-improves-treatment-of-aggressive-breast-cancer/ 2018-11-07T15:29:17+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/ESMO2018-456_o.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Leisha-Emens-University-of-Pittsburgh.jpg https://www.oncozine.com/new-partnership-attacks-disparities-in-cancer-outcomes/ 2018-11-07T16:19:33+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_135301177_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Diana-Chow-UH-College-of-Pharmacy-.jpg https://www.oncozine.com/pancreatic-cancer-risk-in-adulthood-affected-by-weight-during-adolescence/ 2018-11-12T07:03:46+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_180537644_Subscription_Monthly_M.jpg https://www.oncozine.com/investigational-compound-from-chinese-tree-bark-shows-potential-as-treatment-for-pancreatic-cancer/ 2018-11-08T04:56:58+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/Pancreatic-cancer-cells.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Camptothecin.png https://www.oncozine.com/wp-content/uploads/2018/11/Li-Fengzhi.jpg https://www.oncozine.com/lower-burden-and-better-mental-health-outcomes-reported-by-african-american-caregivers/ 2018-11-08T05:58:19+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_55720641_Subscription_Monthly_M.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/phase-ii-trial-evaluating-lurbinectedin-shows-notable-efficacy-in-brca-1-and-2/ 2018-11-09T01:45:43+00:00 https://www.oncozine.com/wp-content/uploads/2017/12/Fotolia_169706202_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Balmana_Judith.2018.jpg https://www.oncozine.com/are-new-and-innovative-drugs-expensive-the-economic-impact-of-new-drug-therapies/ 2018-11-09T20:35:35+00:00 https://www.oncozine.com/wp-content/uploads/2016/06/Fotolia_118711423_Subscription_Monthly_M.jpg https://www.oncozine.com/photodynamic-therapy-shows-efficacy-in-head-and-neck-cancers/ 2018-11-09T23:43:07+00:00 https://www.oncozine.com/wp-content/uploads/2001/11/Fotolia_94210549_Subscription_Monthly_M.jpg https://www.oncozine.com/new-immunotherapeutic-agent-for-the-treatment-of-5t4-positive-solid-tumors-s-shows-promise/ 2018-11-10T01:06:19+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Supermoon_in_Washington_D.C.jpg https://www.oncozine.com/brentuximab-vedotin-included-in-new-supplemental-bla-for-peripheral-t-cell-lymphoma/ 2018-11-10T04:49:55+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_201606393_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Echelon_2.png https://www.oncozine.com/study-links-higher-rates-of-hodgkin-lymphoma-relapse-in-pediatric-patients-to-cancer-drug-shortage/ 2018-11-10T04:57:08+00:00 https://www.oncozine.com/wp-content/uploads/2018/02/Fotolia_159740245_Subscription_Monthly_M.jpg https://www.oncozine.com/european-medicines-agency-validates-and-grants-accelerated-assessment-for-quizartinib-in-aml/ 2018-11-10T06:13:04+00:00 https://www.oncozine.com/wp-content/uploads/2018/05/Fotolia_201313207_Subscription_Monthly_M-1.jpg https://www.oncozine.com/safety-efficacy-data-phase-study-ds-3201-shows-benefit-patients-relapsed-refractory-non-hodgkin-lymphoma/ 2018-11-10T06:19:41+00:00 https://www.oncozine.com/wp-content/uploads/2017/12/ASH2017.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/wp-content/uploads/2017/12/DA-1-e1513227426692.jpg https://www.oncozine.com/wp-content/uploads/2017/12/DS_2-e1513227454202.jpg https://www.oncozine.com/brigatinib-reduces-risk-of-progression-by-73-in-nsclc-patients-with-brain-metastases/ 2018-11-10T21:17:18+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/ESMO2018-4549.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/979-esmo_logo_medium.jpg https://www.oncozine.com/isofol-initiates-pivotal-phase-iii-clinical-trial-of-arfolitixorin-for-metastatic-colorectal-cancer/ 2018-11-17T00:17:51+00:00 https://www.oncozine.com/wp-content/uploads/2016/07/Fotolia_84467109_Subscription_Monthly_M.jpg https://www.oncozine.com/scientists-physicians-and-patients-collaborate-to-improve-treatment-of-egfr-positive-lung-cancer/ 2018-11-17T03:46:45+00:00 https://www.oncozine.com/wp-content/uploads/2018/09/Fotolia_169430449_Subscription_Monthly_M.jpg https://www.oncozine.com/otis-brawley-discusses-life-after-leaving-the-american-cancer-society/ 2018-11-17T05:06:43+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/AACR_2012-Otis-Brawley.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Otis-Brawley_5x7-Portrait.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/05/PRX-Logo-Small.png https://www.oncozine.com/interim-phase-ii-results-of-dnx-2401-pembrolizumab-for-glioblastoma-shows-remarkable-results/ 2018-11-18T21:26:51+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/Fotolia_110761091_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/11/DNX.png https://www.oncozine.com/australian-kazia-therapeutics-presents-trial-in-progress-data-for-glioblastoma-study/ 2018-11-19T13:40:16+00:00 https://www.oncozine.com/wp-content/uploads/2017/12/Fotolia_83157922_Subscription_Monthly_M.jpg https://www.oncozine.com/battling-obesity-and-cancer-an-integrated-teams-approach/ 2018-11-19T19:35:04+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_98354359_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Cancer-and-Obesity-infographic.jpg https://www.oncozine.com/survey-shows-public-to-be-embarrassingly-ignorant-about-lung-cancer/ 2018-11-19T23:35:31+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_120339977_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Dusty-headshot.jpg https://www.oncozine.com/how-a-florida-man-maintains-a-sunny-disposition-throughout-his-battle-with-a-rare-brain-tumor/ 2018-11-20T16:37:35+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_125743946_Subscription_Monthly_M.jpg https://www.oncozine.com/fixing-our-flawed-drug-development-pipeline-by-applying-one-fundamental-tech-principle/ 2018-11-20T20:51:38+00:00 https://www.oncozine.com/wp-content/uploads/2018/08/Fotolia_143302996_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/11/InCrowd-Diane-Hayes-high-res-03-25-16.jpg https://www.oncozine.com/grandfathers-approach-to-sci-fi-cancer-therapy-i-have-nothing-to-lose-and-everything-to-gain/ 2018-11-20T21:08:20+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_96495538_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/11/BrianandSusan.jpeg https://www.oncozine.com/professional-societies-disclose-their-disclosure-policies-but-why-wont-some-discuss-them/ 2018-11-21T23:51:14+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_175808859_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/11/18ASCO_Cliff-A.-Hudis-MD.jpg https://www.oncozine.com/wp-content/uploads/2018/11/brenda-nevidjon.jpg https://www.oncozine.com/su2c-and-lustgarten-award-u-s-7-million-grants-to-pancreatic-cancer-research/ 2018-11-23T06:00:22+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/SU2C-Katie-900x0.jpg https://www.oncozine.com/wp-content/uploads/2018/09/DSC_5320-e1537645129779.jpg https://www.oncozine.com/su2c-grant-helps-uc-san-diego-to-test-drugs-ability-to-block-signals-driving-treatment-resistance/ 2018-11-23T06:36:47+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Andrew-Lowy-MD-110314-0019_sml.jpg.jpeg https://www.oncozine.com/wp-content/uploads/2018/11/Reya_PA0A0417.jpg.jpeg https://www.oncozine.com/aggressive-tobacco-control-programs-reduces-california-lung-cancer-deaths-by-28/ 2018-11-23T16:04:16+00:00 https://www.oncozine.com/wp-content/uploads/2014/05/Fotolia_28377833_Subscription_Monthly_M.jpg https://www.oncozine.com/breast-cancers-recruit-cells-from-bone-marrow-to-enhance-their-growth/ 2018-11-23T18:03:59+00:00 https://www.oncozine.com/wp-content/uploads/2017/11/Fotolia_169706158_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Neta-Erez-170.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Raz-et-al.2018.jpg https://www.oncozine.com/dna-origami-how-a-tailored-dna-nanoplatform-carries-to-multidrug-resistant-tumors/ 2018-11-23T19:32:33+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_131471922_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Professor-Baoquan-Ding.jpg https://www.oncozine.com/colorectal-cancer-screening-helps-avoids-intense-treatments-in-men/ 2018-11-24T00:54:11+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/kuva_1184_1.jpg https://www.oncozine.com/adding-negative-social-cues-on-tobacco-packaging-may-help-denormalize-smoking/ 2018-11-24T01:31:41+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_69579283_Subscription_Monthly_M.jpg https://www.oncozine.com/researchers-identify-protein-that-makes-skin-cancer-cells-more-invasive/ 2018-11-24T03:15:18+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_85674751_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/11/TRIM29-knockdown_1.jpg https://www.oncozine.com/wp-content/uploads/2018/11/TRIM29-knockdown_2.jpg https://www.oncozine.com/optimal-pain-control-hampered-by-misconceptions-about-opioids/ 2018-11-24T12:15:36+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/ESMO-ASIA-1-2018.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Misconceptions-Opioids-Survey_2018.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Sumitra-Thongprasert-MD-232x300.jpg https://www.oncozine.com/wp-content/uploads/2018/10/Josep-Tabernero_ESMO_2018-e1540062259250.jpg https://www.oncozine.com/esmo-launches-partnership-designed-to-promote-asian-european-collaboration-in-rare-cancers-research/ 2018-11-24T12:05:18+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/ESMO-ASIA-2-2018.jpg https://www.oncozine.com/wp-content/uploads/2018/11/casali-paolo_medium_portrait.jpg https://www.oncozine.com/fda-approval-of-emapalumab-marks-significant-improvement-in-primary-hlh-induction-therapy/ 2018-11-24T19:10:09+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Hemophagocytic_syndrome_-_cropped_-_very_high_mag.jpg https://www.oncozine.com/wp-content/uploads/2018/11/jordan-B-michael.jpg https://www.oncozine.com/european-commission-approves-pegfilgrastim-biosimilar-pelmeg/ 2018-11-24T20:40:30+00:00 https://www.oncozine.com/wp-content/uploads/2015/11/Fotolia_204907344_Subscription_Monthly_M.jpg https://www.oncozine.com/fda-grants-accelerated-approval-for-venetoclax-in-newly-diagnosed-acute-myeloid-leukemia-patients/ 2018-11-24T21:52:35+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_205060840_Subscription_Monthly_M.jpg https://www.oncozine.com/glasdegib-approved-in-newly-diagnosed-aml-patients-for-whom-intensive-chemotherapy-is-not-an-option/ 2018-11-25T00:11:45+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_84467129.jpg https://www.oncozine.com/increased-popularity-of-e-cigarettes-results-in-alarming-rise-of-young-smokers/ 2018-11-25T05:13:52+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_116471973_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Alex_Azar_official_portrait.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Scott_FDA.jpg https://www.oncozine.com/wp-content/uploads/2018/04/Roy-S-Herbst-2018-April-1.png https://www.oncozine.com/patients-diagnosed-with-adenomas-may-not-receive-colonoscopies-in-recommended-time-frame/ 2018-11-25T06:10:54+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_219643525_Subscription_Monthly_M.jpg https://www.oncozine.com/immunotherapys-promise-for-lung-cancer-treatment/ 2018-11-25T22:10:29+00:00 https://www.oncozine.com/wp-content/uploads/2018/04/Fotolia_43349819_Subscription_Monthly_M-e1523928869263-1.jpg https://www.oncozine.com/wp-content/uploads/2018/04/Roy-Herbst-Yale-2018-1.jpg https://www.oncozine.com/disease-activity-in-circulating-tumor-dna-predicts-melanoma-progression/ 2018-11-27T22:54:14+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_53156547_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/11/ctDNA_Johns_Hopkins_b.jpg https://www.oncozine.com/changing-behaviors-cigarette-smoking-declines-as-vaping-increases-in-popularity/ 2018-11-28T17:58:22+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_121043144_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/11/2018_Youth_Tobacco.jpg https://www.oncozine.com/fda-approves-larotrectinib-the-first-tumor-agnostic-cancer-treatment/ 2018-11-29T03:42:38+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Bayer_Vitrakvi_Product_Shot.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Scott_FDA.jpg https://www.oncozine.com/proof-of-concept-study-of-live-tumor-cell-biomarker-test-in-prostate-cancer/ 2018-11-30T15:48:14+00:00 https://www.oncozine.com/wp-content/uploads/2018/09/Fotolia_88682252_Subscription_Monthly_M.jpg https://www.oncozine.com/neoadjuvant-ipilimumab-nivolumab-offers-potential-to-change-standard-of-care-in-colon-cancer/ 2018-12-02T15:44:08+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/ESMO_2018_65.jpg https://www.oncozine.com/wp-content/uploads/2018/10/Major-response-to-immunotherapy-in-early-stage-mismatch-repair-deficient-colon-cancer.jpg https://www.oncozine.com/wp-content/uploads/2018/10/chalaby-miriam_medium.jpg https://www.oncozine.com/katherine-trial-trastuzumab-emtansine-reduces-risk-of-invasive-recurrence-of-breast-cancer-by-50/ 2018-12-07T18:29:04+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/18SABCS-001.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Geyer_Charles-SABC2018.jpg https://www.oncozine.com/no-significant-improvement-in-early-stage-tnbc-patients-treated-with-adjuvant-capecitabine/ 2018-12-08T03:51:31+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/18SABCS_TB_00298a.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Martin_Miguel.jpg https://www.oncozine.com/gilteritinib-available-for-prescription-in-the-united-states-for-adults-with-acute-myeloid-leukemia/ 2018-12-11T21:23:07+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_200359299_Subscription_Monthly_M-e1626644890152.jpg https://www.oncozine.com/type-of-surgery-may-affect-health-related-quality-of-life-for-young-breast-cancer-survivors/ 2018-12-11T23:18:32+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_193186103_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Dominici_Laura.jpg https://www.oncozine.com/exercise-may-improve-cardiovascular-function-during-adjuvant-breast-cancer-treatment/ 2018-12-12T01:55:00+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_195721386_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Inger-Thune-120x171.jpg https://www.oncozine.com/oxybutynin-improved-quality-of-life-for-breast-cancer-survivors/ 2018-12-12T02:56:33+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_104076196_Subscription_Monthly_M.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Roberto-A.-Leon-Ferre-M.D.png https://www.oncozine.com/lifestyle-intervention-associated-with-higher-disease-free-survival-rates-in-breast-cancer/ 2018-12-12T04:07:16+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/18SABCS_00261.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Janni_Wolfgang.jpg https://www.oncozine.com/study-shows-low-dose-tamoxifen-to-be-safe-and-effective-in-reducing-recurrence-new-breast-disease/ 2018-12-12T06:18:19+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/18SABCS_TB_a.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2018/12/De-Censi_Andrea.jpg https://www.oncozine.com/study-shows-accelerated-partial-breast-irradiation-not-equivalent-to-whole-breast-irradiation/ 2018-12-13T05:10:16+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/18SABCS_TB_00648.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Frank_A_Vicini.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Julia-White.jpg https://www.oncozine.com/lymph-node-surgery-and-axillary-radiotherapy-yield-comparable-10-year-outcome-in-breast-cancer/ 2018-12-13T14:19:16+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/18SABCS_SM_32.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Rutgers_Emiel.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Donker_Mila.jpg https://www.oncozine.com/circulating-tumor-cell-count-may-help-in-treatment-selection-for-metastatic-breast-cancer/ 2018-12-13T23:44:22+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/18SABCS_TB_01771.jpg https://www.oncozine.com/wp-content/uploads/2018/12/FRANCOIS-CLEMENT-BIDARD.jpg https://www.oncozine.com/despite-receiving-similar-treatment-as-white-women-black-women-have-worse-breast-cancer-outcomes/ 2018-12-17T03:19:25+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/18SABCS_TB_01708.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Albain_Kathy.jpg https://www.oncozine.com/phase-iii-agent-trial-enrolls-first-metastatic-colorectal-cancer-patient/ 2018-12-20T01:46:21+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/Fotolia_178119603_Subscription_Monthly_M-960x290.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Isofol-Personal_1013-7349.jpg.jpeg https://www.oncozine.com/wp-content/uploads/2018/12/Isofol-Karin_1013-7186.jpg.jpeg https://www.oncozine.com/jose-baselga-resigns-as-co-editor-in-chief-of-cancer-discovery/ 2018-12-20T21:41:09+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/14AACR_Balsega-X4.jpg https://www.oncozine.com/childhood-lymphoma-survivors-have-elevated-risk-of-solid-cancers/ 2018-12-20T21:43:32+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_235928524_Subscription_Monthly_M.jpg https://www.oncozine.com/phase-iii-arches-trial-shows-positive-results-for-enzalutamide-in-prostate-cancer/ 2018-12-21T00:27:48+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_167331259_Subscription_Monthly_M-1.jpg https://www.oncozine.com/wp-content/uploads/2018/12/m.rothenberg_013.jpg.jpeg https://www.oncozine.com/wp-content/uploads/2018/12/Benner_Steve_02f.jpg.jpeg https://www.oncozine.com/rakuten-aspyrian-raises-us-284-million-series-c-financing-develops-photoimmunotherapy-platform/ 2018-12-21T04:22:55+00:00 https://www.oncozine.com/wp-content/uploads/2016/05/Fotolia_67648589_Micrsocope.jpg https://www.oncozine.com/inmune-bio-receives-phase-i-clinical-trial-authorization-for-lead-product-in-ovarian-cancer/ 2018-12-21T05:27:53+00:00 https://www.oncozine.com/wp-content/uploads/2018/03/Fotolia_131807156_Subscription_Monthly_M-2.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/1126-immun_dev.jpg https://www.oncozine.com/supreme-court-justice-ruth-bader-ginsburg-has-malignant-lung-nodules-removed/ 2018-12-21T22:17:03+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Screen-Shot-2018-12-21-at-2.53.33-PM.png https://www.oncozine.com/wp-content/uploads/2018/12/1024px-Ruth_Bader_Ginsburg_2016_portrait.jpg https://www.oncozine.com/daiichi-sankyo-out-licenses-investigational-agent-ds-6051-to-anheart-therapeutics/ 2018-12-24T03:15:39+00:00 https://www.oncozine.com/wp-content/uploads/2017/12/DS_3.jpg https://www.oncozine.com/focused-ultrasound-assisted-treatment-helps-drugs-cross-blood-brain-barrier/ 2018-12-25T23:19:28+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/brain_cancer.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Costas-D.-Arvanitis.png https://www.oncozine.com/specific-class-of-biomarkers-may-help-take-uncertainty-out-of-cancer-prognosis/ 2019-01-03T02:48:35+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_201606393_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/01/ColdSpringH-001.jpg https://www.oncozine.com/drug-cocktail-inhibits-tumor-growth/ 2019-01-03T03:07:03+00:00 https://www.oncozine.com/wp-content/uploads/2018/03/Fotolia_96700621_Subscription_Monthly_M-1.jpg https://www.oncozine.com/wp-content/uploads/2019/01/Syrosingopine-CFN98542.jpg https://www.oncozine.com/medical-imaging-modalities-for-prostate-cancer-diagnosis/ 2019-01-03T04:14:27+00:00 https://www.oncozine.com/wp-content/uploads/2018/09/A_Prostate.jpg https://www.oncozine.com/wp-content/uploads/2019/01/AR-1.jpg https://www.oncozine.com/a-compound-being-developed-to-treat-an-eye-disease-may-also-kill-leukemia-cells/ 2019-01-03T05:54:21+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_200359299_Subscription_Monthly_M-e1626644890152.jpg https://www.oncozine.com/wp-content/uploads/2019/01/Bates_9.jpg https://www.oncozine.com/daiichi-sankyo-initiates-phase-i-study-to-evaluate-the-combination-quizartinib-and-milademetand/ 2019-01-04T16:51:21+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_201606393_Subscription_Monthly_M.jpg https://www.oncozine.com/bristol-myers-squibb-and-celgene-merge/ 2019-01-05T03:38:45+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/Celgene-2Onc.jpg https://www.oncozine.com/wp-content/uploads/2019/01/Screen-Shot-2019-01-04-at-5.50.17-PM.png https://www.oncozine.com/anti-bcma-car-t-therapy-jcarh125-in-relapsed-refractory-multiple-myeloma-shows-promise/ 2019-01-05T04:03:59+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/ASH-2018-conference-center.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/tailoring-treatment-to-men-or-women-with-glioblastoma-may-improve-survival/ 2019-01-05T19:08:47+00:00 https://www.oncozine.com/wp-content/uploads/2017/07/Glioblastoma_with_extreme_nuclear_enlargement_-_very_high_mag.jpg https://www.oncozine.com/study-confirms-complication-rates-and-costs-for-drugs-and-diagnostics-higher-in-lung-cancer/ 2019-01-15T22:40:17+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/A_Lung-Cancer_1.jpg https://www.oncozine.com/wp-content/uploads/2019/01/Tina-Shih-MD-Anderson.jpg https://www.oncozine.com/comparison-of-state-by-state-data-shows-melanoma-survival-varies-regionally/ 2019-01-16T04:45:47+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/melanoma.jpg https://www.oncozine.com/wp-content/uploads/2019/01/melanoma-syrvival-1.jpg https://www.oncozine.com/financial-toxicity-privately-insured-cancer-survivors-carry-greater-medical-debt/ 2019-01-21T18:19:04+00:00 https://www.oncozine.com/wp-content/uploads/2018/09/Fotolia_166323409_Subscription_Monthly_M.jpg https://www.oncozine.com/fda-accepts-sbla-for-atezolizumab-abraxane-and-carboplatin-for-metastatic-non-squamous-nsclc/ 2019-01-18T04:40:52+00:00 https://www.oncozine.com/wp-content/uploads/2018/09/Fotolia_169430449_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/01/Sandra_Horning.jpg https://www.oncozine.com/trifluridine-tipiracil-significantly-improved-overall-survival-versus-placebo-in-gastric-cancer/ 2019-01-18T06:09:59+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/Fotolia_195507244_Subscription_Monthly_M.jpg https://www.oncozine.com/amid-controversy-astrazeneca-appoints-jose-baselga-to-head-rd-for-oncology/ 2019-01-19T05:36:47+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/Jose?_Baselga.jpg https://www.oncozine.com/increased-risk-of-heart-attack-stroke-in-patients-with-late-stage-cancer-lung-colon-cancers/ 2019-01-22T05:26:11+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/Fotolia_211674813_Subscription_Monthly_M.jpg https://www.oncozine.com/fda-approves-samsung-bioepis-first-oncology-biosimilar-trastuzumab-dttb/ 2019-01-22T16:36:47+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/Fotolia_110656635_Subscription_Monthly_M.jpg https://www.oncozine.com/study-shows-how-molecular-profiling-may-help-catch-lung-cancer-early-leading-to-new-treatments/ 2019-01-22T19:43:46+00:00 https://www.oncozine.com/wp-content/uploads/2018/08/Fotolia_197447531_Subscription_Monthly_M.jpg https://www.oncozine.com/minimally-invasive-endoscopy-tool-may-change-treatment-for-pancreatic-cancer-patients/ 2019-01-31T06:21:29+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/Fotolia_170048078_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/01/hanks-electrode.jpg https://www.oncozine.com/scientists-discover-possible-way-to-make-resistant-melanomas-susceptible-to-immunotherapy/ 2019-01-31T16:14:05+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/Fotolia_112737156_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/01/Ping-Chih-Ho-Ludwig-Lausanne.jpg https://www.oncozine.com/killing-cancer-cells-by-shining-a-light-on-a-rare-metal/ 2019-02-04T17:59:07+00:00 https://www.oncozine.com/wp-content/uploads/2019/02/Fotolia_184218989_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/01/Cinzia_Imberti2.jpg https://www.oncozine.com/electromagnetic-navigation-bronchoscopy-shows-positive-response-in-lung-cancer-study-e/ 2019-02-01T01:10:14+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/Fotolia_192797337_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/01/Medtronics-001.jpg https://www.oncozine.com/studies-on-origins-of-colon-cancer-may-lead-to-new-and-more-effective-therapies/ 2019-02-01T02:58:04+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/900K_grant_will_advance_stem_cell_research_at_the_Helen_F._Graham_Cancer_Center___Research_Institute.jpg https://www.oncozine.com/wp-content/uploads/2019/01/B_900K_grant_will_advance_stem_cell_research_at_the_Helen_F._Graham_Cancer_Center___Research_Institute.jpg https://www.oncozine.com/after-the-cancer-diagnosis-six-steps-for-moving-from-fear-to-action/ 2019-02-18T05:41:48+00:00 https://www.oncozine.com/wp-content/uploads/2019/02/Fotolia_96842386_Subscription_Monthly_M.jpg https://www.oncozine.com/diet-and-cancer-whats-the-connection/ 2019-02-22T05:33:00+00:00 https://www.oncozine.com/wp-content/uploads/2019/02/Fotolia_9415959_Subscription_Diet.jpg https://www.oncozine.com/two-studies-confirm-liquid-biopsies-to-accurately-track-treatment-response-to-cancer/ 2019-02-28T04:58:00+00:00 https://www.oncozine.com/wp-content/uploads/2019/02/2-13-2019-Larry-Cover-Art-CAN181127-800_a.jpg https://www.oncozine.com/pembrolizumab-as-1st-line-therapy-for-merkel-cell-carcinoma-shows-improved-survival/ 2019-03-01T05:39:00+00:00 https://www.oncozine.com/wp-content/uploads/2019/02/Merkel_cell_carcinoma_-_very_high_mag-e1551418261647.jpg https://www.oncozine.com/wp-content/uploads/2019/02/Mercle-Cell-_Kimmel-800.jpg https://www.oncozine.com/wp-content/uploads/2019/02/Adam_Riker-LSU.jpg https://www.oncozine.com/the-fear-insurance-will-not-cover/ 2019-03-06T00:25:36+00:00 https://www.oncozine.com/wp-content/uploads/2018/02/Fotolia_78447100_Subscription_Monthly_M.jpg https://www.oncozine.com/why-were-top-hhs-officials-interviews-thwarted-by-their-press-offices/ 2019-03-08T03:49:01+00:00 https://www.oncozine.com/wp-content/uploads/2019/03/NIH_Clinical_Research_Center_aerial.jpg https://www.oncozine.com/misdiagnosis-of-colorectal-cancer-may-be-common-in-people-younger-than-50-years-of-age/ 2019-03-08T03:53:14+00:00 https://www.oncozine.com/wp-content/uploads/2018/03/Fotolia_169254752_Subscription_Monthly_M-e1521442626744.jpg https://www.oncozine.com/debunking-the-7-most-common-misconceptions-of-colorectal-cancer/ 2019-03-20T06:01:31+00:00 https://www.oncozine.com/wp-content/uploads/2018/03/Fotolia_166189263_Subscription_Monthly_M-2.jpg https://www.oncozine.com/8211-2lonzas-cocoon-platform-brings-automated-cell-therapy-manufacturing-to-the-clinic/ 2019-03-21T05:39:05+00:00 https://www.oncozine.com/wp-content/uploads/2019/03/Lonza_12.jpg https://www.oncozine.com/lonza-and-takeda-bring-cancer-treatment-to-patients/ 2019-03-21T06:17:00+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/DSC_6199.jpg https://www.oncozine.com/can-cannabinoids-have-a-curative-impact-on-glioblastoma/ 2019-04-01T18:59:35+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Gioblastoma-Photo_1200x500px.jpg.jpeg https://www.oncozine.com/wp-content/uploads/2019/01/PRX-Logo-Horizontal-Color-NEW.png https://www.oncozine.com/new-test-instrumental-in-predicting-the-development-of-bloodstream-infections-in-high-risk-pediatric-cancer-patients/ 2019-04-05T00:43:19+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_225333132_Subscription_Monthly_M.jpg https://www.oncozine.com/anti-cd99-targeted-nanosphere-shows-potential-in-the-treatment-of-patients-with-ewings-sarcoma/ 2019-04-10T02:45:43+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/2824-AACR-2019-Annual-Meeting-033019-copy.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/three-recommendations-to-better-understand-hipaa-compliance/ 2019-04-10T03:13:14+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_99151528_Subscription_Monthly_M.jpg https://www.oncozine.com/cd166-expression-level-and-anti-cancer-activity-confirm-potential-for-combination-of-cx-2009-with-immunotherapy/ 2019-04-10T05:33:54+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/19AACR_TB_009612.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/high-risk-for-hiv-infection-linked-to-low-rates-of-vaccination-against-human-papillomavirus/ 2019-04-10T06:11:48+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/19AACR_TB_Pano1.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2019/04/Screen-Shot-2019-04-09-at-10.54.38-PM.png https://www.oncozine.com/bridging-the-gap-my-gene-counsel-and-ambry-genetics-join-forces-in-medical-grade-direct-to-consumer-testing/ 2019-04-11T01:56:38+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_137289643_Subscription_Monthly_M.jpg https://www.oncozine.com/natera-commercializes-tumor-whole-exome-sequencing-from-plasma/ 2019-04-11T04:47:38+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_201863659_Subscription_Monthly_M.jpg https://www.oncozine.com/study-show-targeted-drug-delivery-to-be-associated-with-a-reduction-in-healthcare-utilization-costs-for-patients-with-cancer-realted-pain/ 2019-04-11T15:06:33+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_233210219_Subscription_Monthly_M.jpg https://www.oncozine.com/new-approach-may-help-control-urinary-incontinence-following-prostate-cancer-surgery/ 2019-04-11T19:39:26+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_204073525_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/04/drpacey_medium.jpg https://www.oncozine.com/wp-content/uploads/2019/04/Pacey20cuff20Turbo.jpg https://www.oncozine.com/sun-pharma-launches-novel-premixed-ready-to-infuse-formulation-of-gemcitabine-in-the-united-states/ 2019-04-11T21:39:31+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_159799208_Subscription_Monthly_M.jpg https://www.oncozine.com/sanofis-oncology-targets-highlighted-at-annual-asco-meeting/ 2019-05-16T22:55:13+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Reed_Sanofi.jpg https://www.oncozine.com/marshalling-chemotherapy-radiotherapy-and-the-immune-system-to-fight-cancer/ 2019-05-17T20:40:26+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_125743946_Subscription_Monthly_M.jpg https://www.oncozine.com/fda-approves-venetoclax-as-a-chemotherapy-free-combination-in-previously-untreated-cll/ 2019-05-18T02:48:49+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_131807112_Subscription_Monthly_M.jpg https://www.oncozine.com/latest-data-of-oncoceutics-onc201-to-be-presented-at-fdas-pediatric-oncology-subcommittee/ 2019-05-20T23:58:00+00:00 https://www.oncozine.com/wp-content/uploads/2017/12/Fotolia_83157922_Subscription_Monthly_M.jpg https://www.oncozine.com/pfizer-to-showcase-data-from-innovative-science-at-2019-annual-asco-meeting/ 2019-05-21T05:34:20+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Pizer-1-1-1_NY.png http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/final-rule-maintains-protections-for-part-d-beneficiaries-with-cancer/ 2019-05-21T15:54:24+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_154437210_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/05/Monica.M.Bertagnolli_ASCO-1.jpg https://www.oncozine.com/study-shows-some-elderly-cancer-survivors-may-face-risk-of-brain-metastasis/ 2019-05-21T17:09:17+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_82833114_Subscription_Monthly_M.jpg https://www.oncozine.com/smoking-cessation-associated-with-lower-risk-of-bladder-cancer-in-postmenopausal-women/ 2019-05-21T17:29:59+00:00 https://www.oncozine.com/wp-content/uploads/2014/05/Fotolia_28377833_Subscription_Monthly_M.jpg https://www.oncozine.com/while-oncologists-pay-attention-to-patients-weight-management-and-diet-they-infrequently-refer-to-support-lifestyle-changes/ 2019-05-21T18:17:59+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_194728401_Subscription_Monthly_M.jpg https://www.oncozine.com/using-a-simple-blood-test-helps-detecting-cancer-earlier-than-ever-before/ 2019-05-21T22:15:19+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_202377709_Subscription_Monthly_M.jpg https://www.oncozine.com/how-anesthesiologists-are-fighting-the-opioid-crisis/ 2019-05-21T23:00:50+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_166135408_Subscription_Monthly_M.jpg https://www.oncozine.com/adding-bevacizumab-to-carboplatin-pemetrexed-may-result-in-modest-overall-survival-benefits-in-nsclc/ 2019-05-23T22:19:12+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/A_Lung-Cancer_1.jpg https://www.oncozine.com/findings-from-two-tapur-study-cohorts-to-be-presented-at-2019-annual-asco-meeting/ 2019-05-24T03:28:33+00:00 https://www.oncozine.com/wp-content/uploads/2018/03/Fotolia_166189806_Subscription_Monthly_M-1.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/entrectinib-benefits-children-and-adolescents-with-cns-and-other-cancers-that-have-specific-gene-fusions/ 2019-05-24T04:02:41+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_267016701_Subscription_Monthly_M.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/clinical-trial-finds-more-targetable-genetic-alterations-in-pediatric-cancers/ 2019-05-24T04:40:38+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/17ASCO_MH_000347.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/a-low-fat-diet-helps-reduce-risk-of-death-from-breast-cancer-in-postmenopausal-women/ 2019-05-24T05:12:55+00:00 https://www.oncozine.com/wp-content/uploads/2019/02/Fotolia_9415959_Subscription_Diet.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/stopping-triple-negative-breast-cancer-in-its-tracks/ 2019-05-24T16:26:23+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_138169498_Subscription_Monthly_M.jpg https://www.oncozine.com/ethicann-and-ilera-forms-partnership-to-develop-and-manufacture-of-botanical-thc-to-treat-chemotherapy-induced-nausea-and-vomiting/ 2019-05-24T19:10:54+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_193559789_Subscription_Monthly_M.jpg https://www.oncozine.com/united-states-patent-and-trademark-office-issues-patents-to-oncoceutics/ 2019-05-25T00:53:34+00:00 https://www.oncozine.com/wp-content/uploads/2017/07/Fotolia_113890287_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/05/ge_yubin_PhD.jpg https://www.oncozine.com/wp-content/uploads/2019/05/ONC213-Molecule-3.png https://www.oncozine.com/optimizing-chemotherapy-low-dose-regimen-effective-in-older-and-frail-gastroesophageal-cancer-patients/ 2019-05-25T00:59:40+00:00 https://www.oncozine.com/wp-content/uploads/2018/03/Fotolia_84467129_Subscription_Monthly_M-1.jpg https://www.oncozine.com/lenalidomide-significantly-reduces-the-risk-of-smoldering-multiple-myeloma-from-progressing/ 2019-05-25T06:39:33+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/ASCO17_SM_3597.jpg https://www.oncozine.com/alpelisib-approved-as-the-first-and-only-treatment-specifically-for-patients-with-a-pik3ca-mutation-in-hr-her2-advanced-breast-cancer/ 2019-05-26T23:46:00+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_193186103_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/05/PiqrayProduct_1556643948332-HR.jpg https://www.oncozine.com/wp-content/uploads/2019/05/Screen-Shot-2019-05-26-at-3.02.44-PM.png https://www.oncozine.com/arfolitixorin-receives-clinical-patent-approval-in-the-united-states/ 2019-05-27T17:04:07+00:00 https://www.oncozine.com/wp-content/uploads/2017/07/Fotolia_113890287_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Isofol-Personal_1013-7349.jpg.jpeg https://www.oncozine.com/european-union-accepts-new-marketing-application-for-biosimilar-formulation-trastuzumab-form-singapore-based-company/ 2019-05-30T00:48:57+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_177556962_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/05/Lisa-S.-Park-CEO-Prestige.-BioPharmajpg.jpg https://www.oncozine.com/study-shows-differences-in-the-prevalence-of-breast-cancer-genes-among-racial-and-ethnic-populations/ 2019-05-30T15:03:14+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/17ASCO_DRE_00521f.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/caris-life-sciences-and-debiopharm-collaborate-in-the-development-of-companion-diagnostic/ 2019-05-31T05:02:26+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_167331259_Subscription_Monthly_M-1.jpg https://www.oncozine.com/wp-content/uploads/2019/05/MWKorn_CARIS.jpg https://www.oncozine.com/phase-i-zuma-3-results-for-kte-x19-in-all-show-high-rates-of-response/ 2019-06-02T01:03:38+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/Fotolia_112622103_Subscription_Monthly_M.jpg https://www.oncozine.com/sub-population-analysis-shows-high-rates-of-durable-response-and-overall-survival-with-axicabtagene-ciloleucel-in-b-cell-lymphomas/ 2019-06-03T17:03:05+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/2017asco_dm_00089-X4.jpeg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/new-data-from-zuma-trials-offer-greater-understanding-of-car-t-cell-therapies/ 2019-05-31T19:16:40+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/ASCO17_SM_0073.jpg https://www.oncozine.com/growing-importance-of-community-oncologists-in-clinical-research-evidenced-by-large-number-of-presentations-at-asco-2019/ 2019-05-31T20:11:13+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/ASCO17_SM_0184.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/wp-content/uploads/2019/05/Debra-Patt.jpg https://www.oncozine.com/liquid-biopsy-platform-demonstrates-high-diagnostic-capabilities-in-early-stages-of-nasopharyngeal-carcinoma/ 2019-06-01T02:51:10+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/ASCO17_SM_0029.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/prioritizing-the-importance-of-the-immune-system/ 2019-06-01T06:19:30+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_83896595_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/05/Christian-Blank.jpg https://www.oncozine.com/wp-content/uploads/2019/05/Illustratie-neo-adjuvante-immuuntherapie-C-Jacqueline-Staring-ENGELS_kl.jpg.jpeg https://www.oncozine.com/wp-content/uploads/2019/05/Lisette_Rozeman.jpg https://www.oncozine.com/brentuximab-vedotin-continues-to-demonstrate-superior-clinical-activity/ 2019-06-05T06:12:56+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/IMG_0305.JPG.jpeg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/enfortumab-vedotin-produces-a-high-tumor-response-rate-in-patients-with-most-common-type-of-advanced-urothelial-cancer/ 2019-06-05T21:07:21+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/IMG_0308.JPG.jpeg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/wp-content/uploads/2019/06/IMG_0316.JPG.jpeg https://www.oncozine.com/laparoscopic-surgery-vs-open-surgery-in-patients-with-colorectal-cancer-with-liver-metastases-no-change-in-survival/ 2019-06-05T22:32:41+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/Fotolia_251737563_Subscription_Monthly_M.jpg https://www.oncozine.com/changing-clinical-trial-enrollment-criteria-dramatically-increases-participation-of-eligible-patients-with-lung-cancer/ 2019-06-06T02:52:41+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/19ASCO_KN_0071.jpg https://www.oncozine.com/majority-of-gynecologic-oncologists-have-experienced-sexual-harassment/ 2019-06-06T04:30:47+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/19ASCO_MSG_SAT_0010.jpg https://www.oncozine.com/rc48-adc-shows-clinically-meaningful-results-in-advanced-her2-urothelial-cancer/ 2019-06-08T06:15:33+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/19ASCO_LF_0602_0221.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/first-patient-enrolled-in-non-pharmaceutical-multi-center-triple-negative-breast-cancer-clinical-trial/ 2019-06-10T17:51:53+00:00 https://www.oncozine.com/wp-content/uploads/2008/12/Fotolia_95239759_Subscription_Monthly_M.jpg https://www.oncozine.com/even-with-growing-adoption-of-advanced-breast-cancer-screening-disparities-in-care-remain/ 2019-06-24T18:01:26+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/Fotolia_225653074_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/06/Richman-_-Yale.jpg https://www.oncozine.com/wp-content/uploads/2019/06/Cary-Gross-MD-Yale.jpg https://www.oncozine.com/improving-5-year-survival-in-glioblastoma-requires-more-aggressive-treatments/ 2019-06-20T17:52:25+00:00 https://www.oncozine.com/wp-content/uploads/2017/07/Glioblastoma_with_extreme_nuclear_enlargement_-_very_high_mag.jpg https://www.oncozine.com/wp-content/uploads/2019/06/Daniel-trifiletti-Mayo.jpg https://www.oncozine.com/children-with-birth-defects-may-have-elevated-risk-of-cancer/ 2019-06-20T19:16:14+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/Fotolia_177917205_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/06/Philip-J.-Lupo-Ph.D.jpeg https://www.oncozine.com/wp-content/uploads/2019/06/Jeremy-Schraw-Ph.D-baylor.jpeg https://www.oncozine.com/wp-content/uploads/2019/06/Sharon-E-Plon-M.D.-Ph.D.Baylor.jpeg https://www.oncozine.com/regorafenib-becomes-first-drug-used-in-clinical-trial-platform-to-investigate-new-brain-cancer-therapies/ 2019-06-20T19:57:00+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/Fotolia_140179381_Subscription_Monthly_M.jpg https://www.oncozine.com/chronic-pain-represents-major-unmet-medical-need-for-cancer-survivors-in-the-united-states/ 2019-06-21T17:00:48+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_233210219_Subscription_Monthly_M.jpg https://www.oncozine.com/new-ovarian-cancer-research-collaboration-launched/ 2019-06-21T18:10:40+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/Fotolia_237743640_Subscription_Monthly_M-e1600399749408.jpg https://www.oncozine.com/wp-content/uploads/2019/06/Audra-Moran_-Ovarian-Cancer.png https://www.oncozine.com/combination-of-targeted-therapies-survival-in-advanced-colorectal-cancers/ 2019-07-07T20:36:13+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/Fotolia_67470117_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/07/Kopetz_Scott.jpg https://www.oncozine.com/wp-content/uploads/2019/07/AndresCervantes_Valencia_Spain.jpg https://www.oncozine.com/combination-therapy-combating-cancer-from-multiple-flanks/ 2019-07-09T23:52:16+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Signing_the_national_cancer_act-e1641502609271.jpg https://www.oncozine.com/understanding-disparities-in-tnbc-may-help-to-better-inform-practice-and-policy/ 2019-07-10T17:19:58+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_55861092_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/07/Lia-Scott-979x1024.jpg https://www.oncozine.com/us-fda-to-review-isatuximab-as-a-potential-treatment-for-r-r-multiple-myeloma/ 2019-07-10T18:56:38+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/ASCO-2019-Sanofi-Booth.jpeg https://www.oncozine.com/sndx-5613-shows-strong-tumor-growth-inhibition-and-improved-survival-in-preclinical-models/ 2019-07-10T20:04:14+00:00 https://www.oncozine.com/wp-content/uploads/2017/08/Fotolia_100398270_Subscription_Monthly_M.jpg https://www.oncozine.com/fda-accepts-supplemental-biologics-license-applications-for-pembrolizumab/ 2019-07-10T20:26:50+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Merck_ASCO_2019_1.jpeg https://www.oncozine.com/japan-approves-olaparib-as-first-line-maintenance-therapy-in-brca-mutated-advanced-ovarian-cancer/ 2019-07-11T04:25:42+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/AstraZeneca_ASCO_2019.jpeg https://www.oncozine.com/durvalumab-shows-statistically-significant-benefit-in-aggressive-lung-cancer/ 2019-07-11T05:32:37+00:00 https://www.oncozine.com/wp-content/uploads/2018/04/Fotolia_43349819_Subscription_Monthly_M-e1523928869263-1.jpg https://www.oncozine.com/wp-content/uploads/2019/07/FDA-AZ_1280_720-e1562822248184.jpg https://www.oncozine.com/acalabrutinib-significantly-improves-progression-free-survival-in-chronic-lymphocytic-leukemia/ 2019-07-11T06:29:57+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/EHA_2019_1_n.jpg https://www.oncozine.com/wp-content/uploads/2017/03/657-ehalogo1.png https://www.oncozine.com/wp-content/uploads/2019/07/cq5dam.web_.1200.Kaplan-Meier-plot-for-PFS-ASCEND-6.15.png https://www.oncozine.com/wp-content/uploads/2019/06/cq5dam.web_.1200.calqdef.png https://www.oncozine.com/lung-cancer-among-the-most-likely-conditions-to-harm-patients-who-are-misdiagnosed/ 2019-07-12T21:50:03+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/vcsPRAsset_1153391_127990_a8f6547c-0f01-4faf-b8a8-113560fa10c9_0.jpg https://www.oncozine.com/wp-content/uploads/2019/07/NEWMAN-TOKER-david-001.jpg.jpeg https://www.oncozine.com/astellas-pharma-and-seattle-genetics-confirm-bla-submission-for-enfortumab-vedotin/ 2019-07-17T17:11:25+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/SeattleGen_ASCO2019.JPG.jpeg https://www.oncozine.com/erdafitinib-the-first-ever-targeted-therapy-for-bladder-cancer-receives-accelerated-fda-approval/ 2019-07-18T19:26:17+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_137289643_Subscription_Monthly_M.jpg https://www.oncozine.com/acquisition-of-mavupharma-helps-abbvie-to-enhances-early-stage-oncology-pipeline/ 2019-07-19T04:12:14+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/AbbVie001.JPG.jpeg https://www.oncozine.com/us-fda-lifts-partial-clinical-hold-on-phase-iii-study-of-venetoclax/ 2019-07-19T06:24:23+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/AbbVie_6647_low.jpg https://www.oncozine.com/results-of-liso-cel-in-patients-with-difficult-to-treat-blood-cancers-presented-at-asco-2019/ 2019-07-19T20:52:46+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/Celgene-2Onc.jpg https://www.oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/abbvies-acquisition-of-allergan-creates-transformative-pharmaceutical-powerhouse/ 2019-07-20T02:58:59+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/AbbVie_ASCO-1JPG.jpeg https://www.oncozine.com/wp-content/uploads/2019/06/AbbVie_CEO_Richard_A_Gonzalez_low.jpg https://www.oncozine.com/wp-content/uploads/2019/06/brent-saunders-Allergan-2018.jpg https://www.oncozine.com/american-college-of-surgeons-introduces-evidence-based-program-for-high-quality-surgical-care/ 2019-07-20T03:42:38+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/FACSExhibit.jpg https://www.oncozine.com/wp-content/uploads/2019/07/Screen-Shot-2019-07-19-at-11.33.05-PM.png https://www.oncozine.com/amgen-and-allergan-launch-biosimilar-products-in-the-united-states/ 2019-07-20T05:24:08+00:00 https://www.oncozine.com/wp-content/uploads/2018/03/Fotolia_84467129_Subscription_Monthly_M-1.jpg https://www.oncozine.com/new-drug-combination-for-difficult-to-treat-double-negative-prostate-cancer/ 2019-07-20T06:15:23+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_234893442_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/07/Filippo-Giancotti-M.D.-Ph.D.jpg https://www.oncozine.com/gene-prevents-immune-system-from-identifying-and-killing-cancer/ 2019-07-20T07:50:21+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/fred-hutch-cancer-research_campus.jpg https://www.oncozine.com/wp-content/uploads/2019/07/Robert-Bradley.-Fred-Hutch.jpeg https://www.oncozine.com/wp-content/uploads/2019/07/stephen-tapscott-Fred-Hutch.jpg https://www.oncozine.com/wp-content/uploads/2019/07/tapscott-and-Bradley-labs.jpeg https://www.oncozine.com/new-immunotherapy-strategy-offers-potential-for-liver-cancer-treatment-while-reducing-side-effects/ 2019-07-20T19:47:36+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_197669254_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/07/Li-Chuan-Chan-PhD.jpg https://www.oncozine.com/early-promise-for-pancreatic-cancer-patients-treated-with-immune-cell-therapy/ 2019-07-21T00:11:39+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_276080585_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2019/07/Brandon-G.-Smaglo-MD-FACP.jpeg https://www.oncozine.com/genmab-applies-for-extension-of-marketing-authorization-of-daratumumab/ 2019-07-21T02:06:24+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/genmab-research-facility.jpg https://www.oncozine.com/united-states-and-europe-reach-milestone-agreement-on-mutual-recognition-of-inspections/ 2019-07-21T03:36:01+00:00 https://www.oncozine.com/wp-content/uploads/2017/12/Precision-Cancer-Medicine-Call-to-Action-in-the-European-Parliament.jpg https://www.oncozine.com/johns-hopkins-creates-guidelines-that-meet-federal-regulations-for-providers-across-the-us/ 2019-07-21T04:32:12+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/PRAsset__0.jpg https://www.oncozine.com/women-with-hiv-have-higher-prevalence-of-anal-high-grade-squamous-intraepithelial-lesions-s/ 2019-07-22T05:38:01+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/hiv-photo.png https://www.oncozine.com/wp-content/uploads/2019/07/Elizabeth-Y.-Chiao.jpg https://www.oncozine.com/wp-content/uploads/2019/07/Elizabeth_Stier_MD.jpg https://www.oncozine.com/personalized-gene-edited-immune-cell-therapy-may-help-patients-with-solid-cancers/ 2019-07-22T17:46:45+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_185816154_Subscription_Monthly_M.jpg https://www.oncozine.com/common-myths-about-colorectal-cancer-surgery-dispelled/ 2019-07-22T20:39:35+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_181682820_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/07/Atif-Iqbal-M.D.-FACS-FACRS-.jpeg https://www.oncozine.com/novel-drug-offers-promise-for-patients-with-ovarian-or-pancreatic-cancers/ 2019-07-22T21:59:39+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_275426369_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/07/Wong_T_Stephen.jpg https://www.oncozine.com/wp-content/uploads/2019/07/wong_mfap5_release.jpg https://www.oncozine.com/liquid-biopsy-enables-widespread-screening-and-personalized-treatment/ 2019-07-23T18:26:44+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_224053342_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/07/cancerLab-chip.jpg https://www.oncozine.com/fda-approves-pfizers-biosimilar-rituximab-pvvr-for-certain-cancers-and-autoimmune-conditions/ 2019-07-29T18:49:22+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Pizer-1-1-1_NY.png https://www.oncozine.com/wp-content/uploads/2019/07/Jeff-Sharman.jpg https://www.oncozine.com/pembrolizumab-chemotherapy-meets-primary-endpoint-in-pivotal-phase-iii-trial-in-tnbc/ 2019-07-29T21:03:29+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Merck-_-ASCO-2019-2_JPG.jpeg https://www.oncozine.com/wp-content/uploads/2019/07/KEYTRUDA2.jpg https://www.oncozine.com/europe-adopts-pembrolizumab-axitinib-as-first-line-treatment-for-advanced-renal-cell-carcinoma/ 2019-07-29T22:02:22+00:00 https://www.oncozine.com/wp-content/uploads/2018/02/Fotolia_88982501_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/07/KEYTRUDA3.jpg https://www.oncozine.com/breakthrough-therapy-designation-for-pembrolizumab-lenvatinib-in-hepatocellular-carcinoma/ 2019-07-30T01:18:10+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Liver_Hepato.jpg https://www.oncozine.com/europe-adopts-positive-opinion-for-combination-therapy-of-atezolizumab-chemo-for-nsclc/ 2019-07-30T03:13:34+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Amsterdam-Rijksmuseum-Nikolai-Karaneschev.jpg https://www.oncozine.com/wp-content/uploads/2019/01/Sandra_Horning.jpg https://www.oncozine.com/histology-independent-treatment-for-solid-tumors-recommended-for-approval-in-the-eu/ 2019-07-30T05:17:00+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Bayer-2019-7734.jpg https://www.oncozine.com/scientists-find-novel-mechanism-of-action-for-natural-killer-cells-in-checkpoint-inhibitor-therapy/ 2019-08-01T15:59:22+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_90793182_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2017/03/1126-immun_dev-300x225.jpg https://www.oncozine.com/new-breast-cancer-drug-has-the-potential-to-be-a-novel-therapy-for-glioblastoma/ 2019-08-02T00:41:38+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/0154.jpg https://www.oncozine.com/a-call-to-action-addressing-healthcare-diversity-among-hispanic-latino-people-in-the-us/ 2019-08-02T00:50:33+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_21930765_Subscription_Monthly_M.jpg https://www.oncozine.com/no-rural-patient-left-behind-the-quest-to-democratize-access-to-cancer-care/ 2019-08-03T00:21:20+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_233831755_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/08/A-Noona_welcome.jpg.jpeg https://www.oncozine.com/wp-content/uploads/2019/08/A-patient_UI_mockup_BlueBkgrd.jpg.jpeg https://www.oncozine.com/wp-content/uploads/2019/08/A-Symptomreport_ipx.png https://www.oncozine.com/japan-approves-first-blood-based-ras-mutation-testing-for-colorectal-cancer/ 2019-08-07T01:10:00+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_202377709_Subscription_Monthly_M.jpg https://www.oncozine.com/some-but-not-all-breast-cancer-patients-could-benefit-from-aspirin/ 2019-08-12T13:01:38+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_169448515_Subscription_Monthly_M.jpg https://www.oncozine.com/neoleukin-2-15-neo-2-15-a-novel-immunotherapy-agent-designed-to-avoiding-common-side-effects/ 2019-08-08T22:11:27+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/new_protein.jpg https://www.oncozine.com/wp-content/uploads/2019/01/Neo2-15.jpg https://www.oncozine.com/aquinox-and-neoleukin-merger-to-create-next-generation-immunotherapies/ 2019-08-09T03:28:02+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_218198058_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/08/Jonathan_Drachman_Seattle_Genetics-731x1024.jpg https://www.oncozine.com/medicare-coverage-and-cancer-what-you-need-to-know/ 2019-08-12T21:34:32+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_219643525_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/08/Medicare-Coverage-and-cancer-info-for-OncoZine.com_.png https://www.oncozine.com/first-patient-enrolled-in-the-worlds-largest-brain-cancer-clinical-trial/ 2019-08-15T18:06:25+00:00 https://www.oncozine.com/wp-content/uploads/2017/07/Glioblastoma_with_extreme_nuclear_enlargement_-_very_high_mag.jpg https://www.oncozine.com/wp-content/uploads/2019/08/BeauBiden-DOJ2013.jpg https://www.oncozine.com/new-liquid-biopsy-helps-improves-breast-cancer-diagnostics-and-avoid-unnecessary-surgeries/ 2019-08-17T00:59:47+00:00 https://www.oncozine.com/wp-content/uploads/2016/06/Vials_Hospital_1.jpg https://www.oncozine.com/wp-content/uploads/2019/08/MM-TGen.png https://www.oncozine.com/research-shows-molecular-engine-that-drives-pancreatic-cancer-and-ways-to-turn-it-off/ 2019-08-22T19:00:25+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/Pancreatic-cancer-cells.jpg https://www.oncozine.com/johns-hopkins-study-links-blood-transfusions-with-dangerous-digestive-disease-in-preemies/ 2019-08-17T06:01:19+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_250596036_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/08/Laboratory-Mouse-0.jpg https://www.oncozine.com/aacc-2019-direct-to-consumer-genetic-testing-precision-medicine-and-breast-cancer-treatment/ 2019-08-20T00:24:13+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/AACC2019-ASM190804_AS_000136.jpg https://www.oncozine.com/wp-content/uploads/2019/08/AACC.png https://www.oncozine.com/wp-content/uploads/2019/08/CLSI.png https://www.oncozine.com/researchers-find-new-way-to-treat-aggressive-form-of-brain-tumor/ 2019-08-21T23:57:37+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_220350594_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/08/Stephen_Safe_400x320.jpg https://www.oncozine.com/researchers-convert-pro-tumor-macrophages-into-cancer-killers/ 2019-08-22T00:19:05+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_190278636_Subscription_Monthly_M.jpg https://www.oncozine.com/kissing-loops-in-rna-molecule-play-an-essential-role-in-tumor-suppression/ 2019-08-22T00:48:43+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_277320308_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/08/Kissing-Loops.jpg https://www.oncozine.com/exposure-to-antibiotics-linked-to-increased-risk-of-colon-cancer/ 2019-08-22T01:30:15+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/antibiotics_o.jpg https://www.oncozine.com/wp-content/uploads/2019/08/Antibiotic-use-diagram.jpg https://www.oncozine.com/nanovalent-receives-patent-for-novel-targeted-polymerized-nanoparticles/ 2019-08-22T03:08:55+00:00 https://www.oncozine.com/wp-content/uploads/2017/07/Fotolia_113890287_Subscription_Monthly_M.jpg https://www.oncozine.com/personalizing-cancer-treatment-why-adaptive-therapy-isnt-there-yet/ 2019-08-22T03:40:32+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_244694490_Subscription_Monthly_M.jpg https://www.oncozine.com/identifying-the-achilles-heel-of-cancer/ 2019-08-23T22:57:43+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_185816154_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/08/VanDang.png https://www.oncozine.com/belantamab-mafodotin-shows-positive-results-in-multiple-myeloma-study/ 2019-08-23T23:27:02+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_137289643_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/08/halbarron.jpg https://www.oncozine.com/u-s-food-and-drug-administration-fda-has-accepted-beigenes-new-drug-application-nda-for-zanubrutinibalso-known-as-bgb-3111-for-the-treatment-of-patients-with-mantle-cell-lymphoma-mcl/ 2019-08-24T00:25:21+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_131471922_Subscription_Monthly_M.jpg https://www.oncozine.com/fda-grants-priority-review-for-enzalutamide-in-metastatic-hormone-sensitive-prostate-cancer/ 2019-08-24T03:18:52+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_111509573_Subscription_Monthly_M.jpg https://www.oncozine.com/wclc-2019-updated-from-the-pembrolizumab-clinical-development-program/ 2019-08-26T17:01:46+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_82833114_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/08/WLCC2019.jpg https://www.oncozine.com/wp-content/uploads/2019/08/Jonathan-Cheng-MD-Merck-MSD-e1566838364608.jpg https://www.oncozine.com/modified-drug-combination-decreases-disease-recurrence-in-high-risk-her2-negative-breast-cancer/ 2019-08-26T19:39:22+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/Fotolia_87499980_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/08/Massey_Oncologists.jpg https://www.oncozine.com/increasing-pd-l1-expression-in-colorectal-cancer-cells-may-improve-effectiveness-of-chemotherapy/ 2019-08-26T20:12:55+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Mayo_MN.jpg https://www.oncozine.com/mental-health-comorbidities-linked-to-increased-opioid-use-in-women-with-breast-cancer/ 2019-08-26T20:57:18+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Emily-Couric-Clinical-Cancer-Center-.jpg https://www.oncozine.com/wp-content/uploads/2019/08/Rajesh-Balkrishnan-PhD-of-the-University-of-Virginia-School-of-Medicine.jpg https://www.oncozine.com/female-oncologists-and-hematologists-underrepresented-in-leadership-roles/ 2019-08-28T03:33:23+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_128056450_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/08/A_24994.jpg https://www.oncozine.com/wp-content/uploads/2019/08/Debra-Patt.jpg https://www.oncozine.com/researchers-describe-a-novel-mechanism-inducing-self-killing-of-cancer-cells/ 2019-08-28T21:53:17+00:00 https://www.oncozine.com/wp-content/uploads/2016/06/Fotolia_53968372_Subscription_Monthly_M-e1490931385956.jpg https://www.oncozine.com/wp-content/uploads/2019/08/Professor-Kim-and-lead-author-Lee.0.jpg https://www.oncozine.com/wp-content/uploads/2019/08/Korean_1.jpg https://www.oncozine.com/organ-on-chip-reveals-mechanism-by-which-pancreatic-cancer-drives-malignancy/ 2019-08-28T22:49:17+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/Fotolia_170048078_Subscription_Monthly_M.jpg https://www.oncozine.com/french-grape-seed-vx1-overcomes-chemoresistance-in-colorectal-cancer-cells/ 2019-08-28T23:21:10+00:00 https://www.oncozine.com/wp-content/uploads/2008/12/Fotolia_114252539_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/08/FGS.jpg https://www.oncozine.com/research-and-development-for-rovalpituzumab-tesirine-in-lung-cancer-discontinued/ 2019-08-30T03:28:09+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/DSC_6265.jpg https://www.oncozine.com/transparency-and-openness-a-must-in-the-murky-world-of-drug-pricing/ 2019-08-30T22:02:52+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_198929062_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/08/Chuck_Grassley_official_photo_2017.jpg https://www.oncozine.com/danish-biotech-develops-antibody-drug-conjugate-for-treatment-of-metastatic-soft-tissue-sarcoma/ 2019-08-31T01:09:05+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_95415268_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/08/ADCendi_team.jpg https://www.oncozine.com/study-shows-having-a-parent-sibling-or-child-with-blood-cancer-increases-ones-own-risk/ 2019-09-11T01:54:16+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/Fotolia_228548583_Subscription_Monthly_M.jpg https://www.oncozine.com/investigational-adc-is-well-tolerated-with-partial-dose-depended-response-in-nsclc/ 2019-09-11T22:22:20+00:00 https://www.oncozine.com/wp-content/uploads/2017/07/Fotolia_122277526_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/08/WLCC2019.jpg https://www.oncozine.com/biologics-license-application-and-priority-review-for-enfortumab-vedotin-in-urothelial-cancer/ 2019-09-17T19:44:55+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/SeattleGen_ASCO2019.JPG.jpeg https://www.oncozine.com/esmo-2019-seattle-genetics-to-present-latest-study-data-becomes-multi-product-oncology-company/ 2019-09-17T21:19:56+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/Fotolia_67470117_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2017/03/981-esmo_logo_medium-300x120.jpg https://www.oncozine.com/varians-adaptive-therapy-provides-opportunity-to-transform-radiation-oncology/ 2019-09-18T00:57:23+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/Chicago-Millenium-Park.jpg https://www.oncozine.com/wp-content/uploads/2019/09/astro.png https://www.oncozine.com/wp-content/uploads/2019/09/varian_Still_Cam_04.jpg https://www.oncozine.com/wclc-2019-daiichi-sankyo-to-present-results-from-first-in-class-her3-targeting-adcs/ 2019-09-18T15:13:10+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/DSC_6354.jpg https://www.oncozine.com/wp-content/uploads/2019/08/WLCC2019.jpg https://www.oncozine.com/wp-content/uploads/2019/08/DSC_6368.jpg https://www.oncozine.com/decreasing-breast-cancer-false-positives-with-nv-vpac1-pet-scan-technology/ 2019-09-25T20:22:54+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_193186103_Subscription_Monthly_M.jpg https://www.oncozine.com/esmo-2019-promising-development-in-treatment-of-colorectal-and-pancreatic-cancer/ 2019-09-28T02:31:25+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/ESMO_2019-Opening-1_o.jpg https://www.oncozine.com/wp-content/uploads/2017/03/981-esmo_logo_medium-300x120.jpg https://www.oncozine.com/wp-content/uploads/2019/09/Roger-Tell-MD-PhD.jpg https://www.oncozine.com/esmo-2019-are-novel-anti-cancer-drugs-worth-a-higher-price/ 2019-09-28T04:57:03+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/ESMO-2019-3_o.jpg https://www.oncozine.com/wp-content/uploads/2019/09/Marc-Rodwin-Law-School-Suffolk-University-Boston-USA.jpg https://www.oncozine.com/wp-content/uploads/2019/09/Prof-Kerstin-Vokinger-University-of-Zurich-Switzerland.jpg https://www.oncozine.com/wp-content/uploads/2019/09/Barbara_Kiesewetter.jpg https://www.oncozine.com/esmo-2019-advanced-hepatocellular-carcinoma-and-the-clinical-benefit-of-first-line-immunotherapy/ 2019-09-28T17:04:13+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/ESMO-2019-Opening-4_o.jpg https://www.oncozine.com/wp-content/uploads/2019/09/yau-thomas_medium.jpg https://www.oncozine.com/wp-content/uploads/2019/09/Angela_Lamarca.jpg https://www.oncozine.com/esmo-2019-positive-results-of-olaparib-bevacizumab-in-newly-diagnosed-advanced-ovarian-cancer/ 2019-09-28T20:54:28+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/ESMO-2019-General_1_o.jpg https://www.oncozine.com/wp-content/uploads/2019/09/Jose%CC%81_Baselga.jpg https://www.oncozine.com/wp-content/uploads/2019/09/ray-coquard-isabelle.jpg https://www.oncozine.com/wp-content/uploads/2019/09/Screen-Shot-2019-09-28-at-12.28.33-PM.png https://www.oncozine.com/wp-content/uploads/2019/09/Screen-Shot-2019-09-28-at-12.28.07-PM.png https://www.oncozine.com/esmo-2019-radiotherapy-after-surgery-could-be-omitted-or-delayed-in-some-prostate-cancer-patients/ 2019-09-29T03:29:08+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/ESMO-2019-General-4_o.jpg https://www.oncozine.com/wp-content/uploads/2019/09/parker-chris.jpg https://www.oncozine.com/wp-content/uploads/2019/09/vale-claire.jpg https://www.oncozine.com/esmo-2019-enfortumab-vedotin-pembrolizumab-as-bladder-cancer-results-in-high-orr/ 2019-09-29T20:46:36+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/ESMO-2019-General-7_o.jpg https://www.oncozine.com/wp-content/uploads/2017/03/969-esmo_logo_medium-300x120.jpg https://www.oncozine.com/wp-content/uploads/2019/09/Christopher-J-Hoimes-e1569736178944.jpg https://www.oncozine.com/new-blood-test-capable-of-accurately-detecting-and-localizing-more-than-20-types-of-cancer/ 2019-09-29T22:30:54+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/ESMO-2019-General-12_o.jpg https://www.oncozine.com/wp-content/uploads/2019/09/Geoffrey-Oxnard.jpg https://www.oncozine.com/esmo-2019-forward-i-study-evaluating-mirvetuximab-soravtansine-did-not-meet-pfs/ 2019-09-30T01:31:08+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/ESMO-2019-General-14_o.jpg https://www.oncozine.com/wp-content/uploads/2017/03/981-esmo_logo_medium-300x120.jpg https://www.oncozine.com/wp-content/uploads/2019/09/Kathleen-Moore-MD_-0.jpg https://www.oncozine.com/esmo-2019-target-engagement-in-phase-i-clinical-trial-with-first-in-class-tgf-beta-1-3-inhibitor/ 2019-09-30T04:44:49+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/ESMo-2019-General-16_o.jpg https://www.oncozine.com/wp-content/uploads/2017/03/981-esmo_logo_medium-300x120.jpg https://www.oncozine.com/esmo-2019-sacituzumab-govitecan-in-metastatic-urothelial-cancer-and-breast-cancer/ 2019-09-30T15:49:30+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/ESMO-2019-General-8_o.jpg https://www.oncozine.com/wp-content/uploads/2017/03/981-esmo_logo_medium-300x120.jpg https://www.oncozine.com/novel-nano-immunoconjugates-induces-local-immune-responses-in-glioblastoma-treatment/ 2019-10-02T00:29:34+00:00 https://www.oncozine.com/wp-content/uploads/2018/01/Fotolia_137025190_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/10/A-new-study-led-by-Julia-Ljubimova-MD-PhD-Cedars-Sinai-.jpg https://www.oncozine.com/esmo-2019-new-approach-in-treatment-of-cholangiocarcinoma-shows-clinical-benefit/ 2019-10-02T03:08:30+00:00 https://www.oncozine.com/wp-content/uploads/2019/10/ESMO-2019-General-36_o.jpg https://www.oncozine.com/wp-content/uploads/2019/10/Ghassan-K.-Abou-Alfa-Memorial-Sloan-Kettering.jpg https://www.oncozine.com/wp-content/uploads/2019/10/Chris-Verslype-University-Hospital-Leuven.jpg https://www.oncozine.com/wp-content/uploads/2019/09/Angela_Lamarca.jpg https://www.oncozine.com/cancer-type-and-incidence-among-american-indians-and-alaska-natives-varies-significantly-by-region/ 2019-10-02T16:06:51+00:00 https://www.oncozine.com/wp-content/uploads/2019/10/2007_National_Pow_Wow_Grass_Dancers.jpg https://www.oncozine.com/wp-content/uploads/2019/10/Melkonian_Stephanie.jpg https://www.oncozine.com/cellectis-lonza-sign-cgmp-manufacturing-service-agreement-for-allogeneic-ucart-product-candidates/ 2019-10-02T18:00:51+00:00 https://www.oncozine.com/wp-content/uploads/2019/03/Lonza_12.jpg https://www.oncozine.com/paired-rna-dna-tests-for-hereditary-cancer-identifies-more-patients-at-increased-risk-for-cancer/ 2019-10-03T00:21:55+00:00 https://www.oncozine.com/wp-content/uploads/2019/10/Ambry-Genetics-SuperLab.jpg.jpeg https://www.oncozine.com/wp-content/uploads/2019/10/aaron_elliot.jpg.jpeg https://www.oncozine.com/wp-content/uploads/2019/10/Huma_Rana_SOG_7263_16-Preferred.jpg.jpeg https://www.oncozine.com/zymeworks-awarded-best-adc-platform-technology-at-annual-event/ 2019-10-12T02:56:23+00:00 https://www.oncozine.com/wp-content/uploads/2019/10/Zymeworks_0930.jpeg https://www.oncozine.com/wp-content/uploads/2019/10/ADC-SD-logo-300x300.png https://www.oncozine.com/her2-targeted-bispecific-antibody-zw25-shows-durable-response/ 2019-10-12T04:27:03+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/ESMO-2018-2.jpg https://www.oncozine.com/wp-content/uploads/2017/03/981-esmo_logo_medium-300x120.jpg https://www.oncozine.com/wp-content/uploads/2019/10/Screen-Shot-2019-10-11-at-9.16.47-PM.png https://www.oncozine.com/nobel-prize-in-physiology-or-medicine-2019-how-do-cells-sense-and-adapt-to-availability-of-oxygen/ 2019-10-12T20:34:51+00:00 https://www.oncozine.com/wp-content/uploads/2019/10/Fotolia_268539503_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/10/medicine2019-1.jpg https://www.oncozine.com/wp-content/uploads/2019/10/medicine2019-2.jpg https://www.oncozine.com/federal-grant-helps-tgen-refine-cancer-detection-blood-tests-for-breast-cancer-patients/ 2019-10-16T00:54:14+00:00 https://www.oncozine.com/wp-content/uploads/2019/10/Dr-Muhammed-Murtaza-horizontal.JPG.jpeg https://www.oncozine.com/tucatinib-shows-positive-results-in-pivotal-trial-in-locally-advanced-her2-breast-cancer/ 2019-10-24T18:12:32+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/18SABCS_00261.jpg https://www.oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo-300x212.jpg https://www.oncozine.com/celyad-to-present-highlights-of-allogeneic-and-autologous-nkg2d-based-car-t-therapies-in-mcrc/ 2019-10-26T01:10:21+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_185816154_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/10/sitc_logo.png https://www.oncozine.com/trabectedin-shows-favorable-results-in-routine-real-life-clinical-practice-in-ovarian-cancer/ 2019-11-04T18:41:19+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/porch-of-the-caryatids.jpg https://www.oncozine.com/wp-content/uploads/2019/11/ESGO.jpg https://www.oncozine.com/wp-content/uploads/2019/11/maria-angeles-fores-MD_pharmamar.jpg https://www.oncozine.com/michigan-oncology-quality-consortium-selects-varian-to-support-transition-to-value-based-care/ 2019-11-07T03:48:45+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/A-Noona_welcome.jpg.jpeg https://www.oncozine.com/wp-content/uploads/2019/11/griggs-jennifer.jpg https://www.oncozine.com/study-shows-exposure-to-hematology-in-medical-school-and-mentorship-vital-to-future-of-the-field/ 2019-11-07T04:30:54+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_128056450_Subscription_Monthly_M.jpg https://www.oncozine.com/study-confirms-racial-disparities-in-treatment-of-multiple-myeloma-patients/ 2019-11-07T05:03:32+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_20736088_Subscription_Monthly_M.jpg https://www.oncozine.com/study-shows-oxygen-starved-cancer-cells-have-a-survival-advantage-promoting-cancer-spread/ 2019-11-07T16:53:09+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/Hypoxia-Jhmi-Yu-Jing-Shin.jpg https://www.oncozine.com/wp-content/uploads/2019/11/Daniele.Marie_.Gilkes.Ph_.D.jpg https://www.oncozine.com/medalist-trial-in-patients-with-myelodysplastic-syndromes-shows-statistical-benefit/ 2019-11-07T18:05:28+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/ASH-2018-conference-center.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Alan-F.-List-ASH-2018-1.jpg https://www.oncozine.com/the-future-of-medicine-is-bright-personalized-medicine-predictive-analytics-and-big-data/ 2019-11-07T18:26:44+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/ASH-2018-General-1.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Joseph-Mikhae-ASH-2018-1.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Aziz-Hazha-ASH-2018-1.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Amy-Burd_ASJ-2018-1.jpg https://www.oncozine.com/wp-content/uploads/2018/12/Jonathan-Peled-ASH-2018-1.jpg https://www.oncozine.com/how-cannabis-oil-works-to-kill-cancer/ 2019-11-10T19:25:07+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_233087215_Subscription_Monthly_M.jpg https://www.oncozine.com/moving-diagnostics-out-of-the-lab-electrochemical-sensor-for-a-wide-range-of-applications/ 2019-11-11T23:21:56+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/eRapid-9787.jpg https://www.oncozine.com/wp-content/uploads/2019/11/eRapid-Illustration.jpg https://www.oncozine.com/patients-receiving-integrative-multidisciplinary-treatment-show-improved-transplantation-outcomes/ 2019-11-15T14:35:44+00:00 https://www.oncozine.com/wp-content/uploads/2016/07/Fotolia_84467109.jpg https://www.oncozine.com/wp-content/uploads/2019/11/Andrew_Saul_Artz.jpg https://www.oncozine.com/modified-design-of-the-crispr-gene-editing-may-improve-therapy-for-hiv-and-sickle-cell-disease/ 2019-11-15T15:50:08+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/City_of_Hope_Duarte1024x682.jpg https://www.oncozine.com/phase-iii-hero-study-of-oral-relugolix-in-advanced-prostate-cancer-shows-high-response-rate/ 2019-11-20T00:55:43+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/Fotolia_234893442_Subscription_Monthly_M-e1748002293540.jpg https://www.oncozine.com/drug-loaded-nanoparticles-bound-to-circulating-red-blood-cells-inhibit-lung-cancer-metastasis/ 2019-11-20T03:44:06+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/ELECT-particles-on-RBCs-colored.jpeg https://www.oncozine.com/wp-content/uploads/2019/11/ELeCt-Fig-3F-composite.jpeg https://www.oncozine.com/wp-content/uploads/2019/11/ELeCt-Fig-2F-1.png https://www.oncozine.com/poor-patients-treated-outside-nci-centers-less-likely-to-receive-expensive-lung-cancer-drugs/ 2019-11-20T06:17:45+00:00 https://www.oncozine.com/wp-content/uploads/2018/09/Fotolia_166323409_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/11/Cathy-Bradley-PhD.jpg https://www.oncozine.com/wuxi-sta-and-impact-therapeutics-sign-strategic-partnership/ 2019-11-21T02:15:17+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/WuXi-STA-Nov-2019.jpg https://www.oncozine.com/belong-life-broadens-global-impact/ 2019-11-21T03:55:43+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/Belong.jpg-scaled.jpeg https://www.oncozine.com/wp-content/uploads/2019/11/Eliran-Malki-CEO-Belong.life_-e1574306298679.jpg https://www.oncozine.com/wp-content/uploads/2019/11/PEP.jpg https://www.oncozine.com/drug-combination-shows-promise-against-lethal-childhood-brain-cancers/ 2019-11-21T05:56:56+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/DIP.jpg https://www.oncozine.com/disparities-in-appalachian-breast-cancer-patients/ 2019-11-21T06:48:03+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/Fotolia_87499980_Subscription_Monthly_M.jpg https://www.oncozine.com/study-shows-subset-of-patients-benefit-from-advanced-melanoma-treatment-combination/ 2019-11-22T01:03:51+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/Fotolia_112737156_Subscription_Monthly_M-1.jpg https://www.oncozine.com/wp-content/uploads/2019/11/Antoni-Ribas.jpg https://www.oncozine.com/sex-related-differences-in-mortality-prediction-in-patients-with-early-stage-er-breast-cancer/ 2019-11-22T02:09:33+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_201863659_Subscription_Monthly_M.jpg https://www.oncozine.com/combination-of-atezolizumab-bevacizumab-improves-survival-in-hepatocellular-carcinoma/ 2019-11-24T07:36:26+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/ESMO-Asia-2019-002_o-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/11/ESMO-ASIA.png https://www.oncozine.com/wp-content/uploads/2019/11/C.jpg https://www.oncozine.com/wp-content/uploads/2019/09/Angela_Lamarca.jpg https://www.oncozine.com/trial-of-china-manufactured-trastuzumab-biosimilar-hlx02-meets-primary-endpoint-in-breast-cancer/ 2019-11-24T19:37:35+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/ESMO-Asia-2019_001_o-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/11/ESMO-ASIA.png https://www.oncozine.com/wp-content/uploads/2019/11/ESMO_Rosa_G.jpg https://www.oncozine.com/what-to-expect-5th-esmo-asia/ 2019-11-25T00:03:44+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/ESMO-Asia-2019-EW-keynote-lecture_o-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/11/ESMO-ASIA.png https://www.oncozine.com/wp-content/uploads/2019/11/Elisabete-Weiderpass_5th_ESMO-ASIA-_o-scaled.jpg https://www.oncozine.com/study-identifies-molecular-profiles-of-malignant-pleural-mesothelioma-with-clinical-impact/ 2019-11-25T03:21:14+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/Fotolia_39692538_Subscription_Monthly_M.jpg https://www.oncozine.com/tasadenoturev-pembrolizumab-shows-clinical-benefit-in-recurrent-glioblastoma/ 2019-11-25T05:44:18+00:00 https://www.oncozine.com/wp-content/uploads/2017/07/Glioblastoma_with_extreme_nuclear_enlargement_-_very_high_mag.jpg https://www.oncozine.com/wp-content/uploads/2019/11/Screen-Shot-2019-11-21-at-9.33.17-PM.png https://www.oncozine.com/wp-content/uploads/2019/11/Clark.C.Chen_-e1574658987836.jpg https://www.oncozine.com/wp-content/uploads/2019/11/DNX2401_moa.png https://www.oncozine.com/study-shows-more-children-being-diagnosed-with-neuroblastoma-but-survival-increases/ 2019-11-25T22:32:28+00:00 https://www.oncozine.com/wp-content/uploads/2018/06/Fotolia_117609459_Subscription_Monthly_M.jpg https://www.oncozine.com/health-canada-approves-supplemental-new-drug-submission-for-brentuximab-vedotin-in-ptcl/ 2019-11-26T01:30:00+00:00 https://www.oncozine.com/wp-content/uploads/2017/09/Fotolia_67740640_Subscription_Monthly_XXL.jpg https://www.oncozine.com/china-national-medical-products-administration-approves-enzalutamide/ 2019-11-26T18:26:53+00:00 https://www.oncozine.com/wp-content/uploads/2018/09/Fotolia_88682252_Subscription_Monthly_M.jpg https://www.oncozine.com/betting-on-antibody-drug-conjugates-zymeworks-regeneron-boehringer-ingelheim-pharma-and-others/ 2019-11-27T00:44:02+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/London-UK-Eye_of-Lodon_2014-08-11-scaled.jpg https://www.oncozine.com/wp-content/uploads/2019/11/IMXE-1200x800.jpg https://www.oncozine.com/study-identifies-cells-of-origin-of-high-grade-serous-ovarian-cancer/ 2019-11-27T18:35:21+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/Fotolia_237743640_Subscription_Monthly_M-e1600399749408.jpg https://www.oncozine.com/large-phase-ii-study-to-investigate-survaxm-in-glioblastoma-in-china-and-u-s/ 2019-11-28T00:34:05+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/Survaxm_Roswell_Park.jpg https://www.oncozine.com/wp-content/uploads/2019/11/fenstermakercieskielski2019_p1200167.jpg https://www.oncozine.com/wp-content/uploads/2019/11/Fosun_Mini.jpg https://www.oncozine.com/tetra-bio-pharma-to-resume-clinical-trial-in-advanced-cancer-patients-with-uncontrolled-pain/ 2019-11-28T06:11:37+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_233210219_Subscription_Monthly_M.jpg https://www.oncozine.com/us-fda-accepts-priority-review-of-nda-for-pemigatinib-in-cholangiocarcinoma/ 2019-11-29T18:16:35+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/Fotolia_100076616_Subscription_Monthly_M-e1496632156623.jpg https://www.oncozine.com/enfortumab-vedotin-pembrolizumab-to-be-evaluated-in-metastatic-bladder-cancer/ 2019-12-04T05:47:32+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/AdobeStock_76577781-scaled.jpeg https://www.oncozine.com/genetic-screening-guidelines-and-personalized-medicine-who-should-be-tested/ 2019-12-04T16:07:48+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_125743946_Subscription_Monthly_M.jpg https://www.oncozine.com/tivozanib-improved-pfs-and-was-better-tolerated-compared-with-sorafenib-in-patients-with-mrcc/ 2019-12-06T15:15:02+00:00 https://www.oncozine.com/wp-content/uploads/2018/02/Fotolia_88982501_Subscription_Monthly_M.jpg https://www.oncozine.com/new-initiative-highlights-importance-of-patient-reported-outcomes-in-sickle-cell-disease/ 2019-12-07T02:03:04+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_202377709_Subscription_Monthly_M.jpg https://www.oncozine.com/connecting-patients-to-clinical-trials-can-lead-to-new-and-better-treatments/ 2019-12-07T04:02:02+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_137289643_Subscription_Monthly_M.jpg https://www.oncozine.com/multiple-myeloma-research-foundation-to-present-30-abstracts-at-ash-annual-meeting/ 2019-12-07T05:40:06+00:00 https://www.oncozine.com/wp-content/uploads/2016/06/Vials_Hospital_1.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/combination-of-fimepinostat-venetoclax-generally-well-tolerated/ 2019-12-07T06:52:12+00:00 https://www.oncozine.com/wp-content/uploads/2017/09/Fotolia_67740640_Subscription_Monthly_XXL.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/new-protocols-for-older-adolescents-young-adults-with-all-what-are-the-implications-for-practice/ 2019-12-07T16:44:32+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_233831755_Subscription_Monthly_M.jpg https://www.oncozine.com/ash-2019-primo-study-evaluates-duvelisib-in-relapsed-or-refractory-peripheral-t-cell-lymphoma/ 2019-12-07T18:35:45+00:00 https://www.oncozine.com/wp-content/uploads/2017/12/ASH2017.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/wp-content/uploads/2019/12/horwitz-steven-110811-124-e1575662516362.png https://www.oncozine.com/wp-content/uploads/2019/12/ASH_121401_abstract_252843_0.png https://www.oncozine.com/wp-content/uploads/2019/12/Brian-Stuglik-CEO-Verastem-Oncology.jpg.jpeg https://www.oncozine.com/ash-2019-real-world-data-of-apixaban-in-venous-thromboembolism-patients-with-cancer/ 2019-12-08T06:12:14+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/ASH2019_002-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/wp-content/uploads/2019/12/Alexander_Cohen.jpg https://www.oncozine.com/ash-2019-second-gen-car-t-cell-therapy-overcome-resistance-reduce-toxicity-and-simplify-treatment/ 2019-12-09T04:23:04+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/ASH2019_001_o-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/ash-2019-brentuximab-vedotin-in-combination-with-nivolumab-in-frontline-and-r-r-hodgkin-lymphoma/ 2019-12-09T06:31:05+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/ASH2019_005-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/ash-2019-next-generation-sequencing-based-assay-shows-clinical-relevance-and-accurate-mrd-testing/ 2019-12-09T16:45:07+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/ASH2019_006-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/sabcs-2019-women-at-elevated-risk-of-breast-cancer-may-benefit-from-anti-inflammatory-drugs/ 2019-12-16T19:26:51+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/19SABCS_TB_014-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo-300x212.jpg https://www.oncozine.com/sabcs-2019-trastuzumab-deruxtecan-achieves-clinically-meaningful-and-durable-response/ 2019-12-17T00:05:41+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/19SABCS_TB_016-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo-300x212.jpg https://www.oncozine.com/wp-content/uploads/2019/12/19SABCS_Ian-Krop_03192-scaled.jpg https://www.oncozine.com/wp-content/uploads/2019/12/gang2.png https://www.oncozine.com/sabcs-2019-post-operative-drug-combination-improves-outcomes-in-luminal-breast-cancer/ 2019-12-17T03:45:37+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/19SABCS_TB_018-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo-300x212.jpg https://www.oncozine.com/ribociclib-letrozole-yields-similar-results-as-chemo-for-high-risk-luminal-b-breast-cancer/ 2019-12-17T05:34:47+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/19SABCS_TB_019-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/859-sabcslogo_2012.gif https://www.oncozine.com/wp-content/uploads/2019/12/19SABCS_TB_Joaquin-Gavila%CC%81-scaled.jpg https://www.oncozine.com/fda-approves-new-drug-for-advanced-bladder-cancer/ 2019-12-20T06:51:42+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/SeattleGen_ASCO2019.JPG.jpeg https://www.oncozine.com/wp-content/uploads/2019/12/PADCEV.jpg https://www.oncozine.com/fda-approves-novel-treatments-for-metastatic-urothelial-cancer-but-more-options-are-needed/ 2019-12-21T05:53:33+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_137289643_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/12/BCAN-Logo.png https://www.oncozine.com/trastuzumab-deruxtecan-approved-for-the-treatment-of-metastatic-her2-positive-breast-cancer/ 2019-12-22T01:00:16+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_177556962_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/12/Daiichi-Sankyo-ENHERTU-anchor-12.jpg https://www.oncozine.com/wp-content/uploads/2019/12/gang2.png https://www.oncozine.com/advances-bispecific-antibody-development-are-leading-to-an-evolution-anti-cancer-drugs/ 2019-12-22T03:02:20+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/IMG_9153.jpg https://www.oncozine.com/wp-content/uploads/2019/12/Screen-Shot-2019-12-21-at-7.25.53-PM.png https://www.oncozine.com/study-shows-circulating-tumor-dna-to-be-predictive-of-disease-progression-in-rectal-cancer/ 2019-12-22T06:13:23+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_202377709_Subscription_Monthly_M.jpg https://www.oncozine.com/sabcs-2019-circulating-tumor-dna-may-be-a-predictor-of-recurrence-of-triple-negative-breast-cancer/ 2019-12-22T22:47:43+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/IMG_1509-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo-300x212.jpg https://www.oncozine.com/wp-content/uploads/2019/12/19SABCS_Radovich-scaled.jpg https://www.oncozine.com/residual-cancer-burden-after-neoadjuvant-chemotherapy-can-be-a-predictor-of-breast-cancer-outcomes/ 2019-12-23T01:43:03+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/19SABCS_TB_Overview-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo-300x212.jpg https://www.oncozine.com/wp-content/uploads/2019/12/19SABCS_TB_Symmans-01-scaled.jpg https://www.oncozine.com/fda-grants-breakthrough-therapy-designation-for-tucatinib-in-metastatic-her2-positive-breast-cancer/ 2019-12-23T04:57:32+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/seattle-genetics.jpg https://www.oncozine.com/sabcs-2019-oral-paclitaxel-yields-superior-results-compared-to-intravenous-paclitaxel-in-mbc/ 2019-12-23T07:16:22+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/19ASH_TB_01041-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo-300x212.jpg https://www.oncozine.com/wp-content/uploads/2019/12/19SABCS_TB_UM-scaled.jpg https://www.oncozine.com/wp-content/uploads/2019/12/Screen-Shot-2019-12-22-at-10.10.10-PM.png https://www.oncozine.com/wp-content/uploads/2019/12/Screen-Shot-2019-12-22-at-10.09.43-PM.png https://www.oncozine.com/wp-content/uploads/2019/12/Screen-Shot-2019-12-23-at-12.05.38-AM.png https://www.oncozine.com/seattle-genetics-submits-new-drug-application-to-the-u-s-fda-for-tucatinib/ 2019-12-25T04:46:30+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/Fotolia_222115990_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/12/Rashmi_K_Murthy_MD-scaled.jpg https://www.oncozine.com/celebrate-being-a-holiday-hero-how-to-build-your-resilience-despite-working-holidays-in-oncology/ 2019-12-25T07:28:20+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/Fotolia_233831755_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/12/Thriving-1.jpg https://www.oncozine.com/wp-content/uploads/2019/12/Triving-Physician_-1.jpg https://www.oncozine.com/wp-content/uploads/2019/12/Building_.jpg https://www.oncozine.com/excessive-and-binge-drinking-surprisingly-common-among-cancer-survivors/ 2020-01-08T15:47:18+00:00 https://www.oncozine.com/wp-content/uploads/2020/01/alcohol-492871_1280.jpg https://www.oncozine.com/for-the-first-time-double-digit-survival-rates-reported-in-pancreatic-cancer/ 2020-01-08T21:22:59+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/Pancreatic-cancer-cells.jpg https://www.oncozine.com/immunotherapy-market-estimated-to-reach-u-s-115-billion-by-2023/ 2020-01-08T22:11:09+00:00 https://www.oncozine.com/wp-content/uploads/2018/08/Fotolia_127542566_Subscription_Monthly_M.jpg https://www.oncozine.com/scientists-discover-previous-unknown-role-of-immune-signal-in-p-pancreatic-cancer/ 2020-01-09T04:32:13+00:00 https://www.oncozine.com/wp-content/uploads/2020/01/pancreatic-cancer-cells_NYU.jpg https://www.oncozine.com/the-nuts-bolts-of-high-intensity-focal-ultrasound/ 2020-01-11T04:10:04+00:00 https://www.oncozine.com/wp-content/uploads/2016/07/Fotolia_78918767_Subscription_Monthly_M.jpg https://www.oncozine.com/first-targeted-therapy-approved-for-rare-mutation-of-gastrointestinal-stromal-tumors/ 2020-01-11T06:26:01+00:00 https://www.oncozine.com/wp-content/uploads/2020/01/AYVAK.jpg https://www.oncozine.com/wp-content/uploads/2020/01/AY.jpg https://www.oncozine.com/the-promise-of-car-t-cell-therapy/ 2020-01-15T06:23:37+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/AH-2018-App-o.jpg https://www.oncozine.com/european-commission-approves-polatuzumab-vedotin-in-r-r-diffuse-large-b-cell-lymphoma/ 2020-01-25T03:05:46+00:00 https://www.oncozine.com/wp-content/uploads/2020/01/Roche-307308-scaled.jpg https://www.oncozine.com/wp-content/uploads/2020/01/Screen-Shot-2020-01-24-at-5.38.36-PM.png https://www.oncozine.com/wp-content/uploads/2020/01/Screen-Shot-2020-01-24-at-7.28.03-PM.png https://www.oncozine.com/wp-content/uploads/2020/01/Screen-Shot-2020-01-24-at-7.28.18-PM.png https://www.oncozine.com/wp-content/uploads/2020/01/Screen-Shot-2020-01-24-at-7.28.31-PM.png https://www.oncozine.com/tapur-study-shows-benefit-of-various-molecularly-targeted-drugs-in-advanced-colorectal-cancer/ 2020-01-27T23:22:52+00:00 https://www.oncozine.com/wp-content/uploads/2020/01/GI20_TB_01174-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/study-shows-worse-overall-survival-and-a-higher-risk-of-death-of-some-young-adults-with-crc/ 2020-01-28T00:56:02+00:00 https://www.oncozine.com/wp-content/uploads/2020/01/GI20_TB_00878-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/wp-content/uploads/2020/01/salem-mohamed-1497882369-lab.png https://www.oncozine.com/blood-test-may-help-detect-hard-to-detect-gastrointestinal-cancers-in-asymptomatic-individuals/ 2020-01-28T06:08:06+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_202377709_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/01/brian_wolpin_MD.jpg https://www.oncozine.com/atezolizumab-bevacizumab-helps-patients-maintain-quality-of-life-in-colorectal-and-liver-cancers/ 2020-01-28T17:18:38+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_197669254_Subscription_Monthly_M.jpg https://www.oncozine.com/onvasertib-confirmed-tumor-regression-clinical-benefit-in-kras-mutated-mcrc/ 2020-01-30T02:53:13+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_234893442_Subscription_Monthly_M.jpg https://www.oncozine.com/treatments-targeting-metastatic-colorectal-cancer-with-mutated-braf-v600e-improve-hrqol/ 2020-01-30T04:25:14+00:00 https://www.oncozine.com/wp-content/uploads/2020/01/AdobeStock_164902722-copy-scaled.jpeg https://www.oncozine.com/trialjectory-partners-with-precipio-providing-patients-with-diagnostics-clinical-trial-matching/ 2020-01-31T23:23:33+00:00 https://www.oncozine.com/wp-content/uploads/2019/02/Fotolia_184218989_Subscription_Monthly_M.jpg https://www.oncozine.com/reversal-of-fortune-how-a-vilified-drug-became-a-life-saving-agent-in-the-war-against-cancer/ 2020-02-04T23:28:15+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/Onco_oncozine_dossier_ad.png https://www.oncozine.com/wp-content/uploads/2017/03/480-thalidomide_Distaval_1-241x300.gif https://www.oncozine.com/wp-content/uploads/2017/03/482-thalidomide_Distaval-211x300.gif https://www.oncozine.com/wp-content/uploads/2013/11/Kevadon_o-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/484-Distaval-300x241.png https://www.oncozine.com/wp-content/uploads/2017/03/486-Frances_O_Kelsey02.png https://www.oncozine.com/wp-content/uploads/2017/03/488-Thalidomide_Children-300x192.png https://www.oncozine.com/wp-content/uploads/2017/03/490-thalidomide_celgene-300x169.jpg https://www.oncozine.com/wp-content/uploads/2017/03/492-WilliamG.KaelinJr.MD.jpg https://www.oncozine.com/cancer-vaccine-rindopepimut-bevacizumab-may-improve-outcomes-in-egfrviii-recurrent-glioblastoma/ 2020-02-07T10:06:57+00:00 https://www.oncozine.com/wp-content/uploads/2017/07/Glioblastoma_with_extreme_nuclear_enlargement_-_very_high_mag.jpg https://www.oncozine.com/wp-content/uploads/2020/02/john-h-sampson-md-phd-mba-mhsc.jpg https://www.oncozine.com/study-shows-single-human-papillomavirus-vaccine-dose-may-be-effective-against-cervical-cancer/ 2020-02-10T12:30:23+00:00 https://www.oncozine.com/wp-content/uploads/2018/09/Fotolia_217339058_Subscription_Monthly_M.jpg https://www.oncozine.com/enfortumab-vedotin-pembrolizumab-to-shrink-tumors-in-the-majority-of-bladder-cancer-patients/ 2020-02-11T17:42:24+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/AdobeStock_76577781-scaled.jpeg https://www.oncozine.com/tucatinib-validated-by-ema-for-treatment-of-locally-advanced-or-metastatic-her2-breast-cancer/ 2020-02-11T22:49:28+00:00 https://www.oncozine.com/wp-content/uploads/2017/11/Fotolia_169706158_Subscription_Monthly_M.jpg https://www.oncozine.com/nccn-guidelines-to-recommend-siltuximab-for-patients-with-imcd-plasmacytic-or-mixed-histology/ 2020-02-12T04:45:22+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_128056450_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/02/Benjamin_Castleman.jpg https://www.oncozine.com/new-surgeon-generals-report-presents-the-unfiltered-truth-about-tobacco/ 2020-02-12T20:57:05+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_69579283_Subscription_Monthly_M.jpg https://www.oncozine.com/tobacco-control-in-the-united-states-has-saved-8-million-lives-in-last-50-years/ 2020-02-12T21:40:03+00:00 https://www.oncozine.com/wp-content/uploads/2014/05/Fotolia_28377833_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2017/03/380-holford_Theodore.jpg https://www.oncozine.com/study-shows-unacceptable-disparities-in-hiring-between-white-and-ethnic-minority-doctors/ 2020-02-13T02:49:45+00:00 https://www.oncozine.com/wp-content/uploads/2017/12/Fotolia_102100404_Subscription_Monthly_M.jpg https://www.oncozine.com/researchers-develop-multitasking-ai-tool-to-extract-cancer-data/ 2020-02-13T23:17:11+00:00 https://www.oncozine.com/wp-content/uploads/2020/02/summit-supercomputer-scaled.jpg https://www.oncozine.com/wp-content/uploads/2020/02/ORNL-001.jpg https://www.oncozine.com/study-shows-self-eating-genes-may-act-as-tumor-suppressors-in-ovarian-cancer/ 2020-02-14T04:08:34+00:00 https://www.oncozine.com/wp-content/uploads/2020/02/Joshep_Delaney.jpg https://www.oncozine.com/rutgers-researchers-find-e-cigarette-use-among-teens-to-be-higher-than-previously-thought/ 2020-02-14T06:09:49+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_121043144_Subscription_Monthly_M.jpg https://www.oncozine.com/combination-of-lung-cancer-screening-and-smoking-cessation-may-help-reduce-mortality/ 2020-02-18T15:51:24+00:00 https://www.oncozine.com/wp-content/uploads/2014/01/Fotolia_99982712_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/02/Meza_R_UoM.jpg https://www.oncozine.com/combination-enfortumab-vedotin-pembrolizumab-granted-breakthrough-therapy-in-bladder-cancer/ 2020-02-19T17:59:15+00:00 https://www.oncozine.com/wp-content/uploads/2020/02/fda2020.jpg https://www.oncozine.com/phase-ii-trial-of-cabiralizumab-nivolumab-does-not-meet-primary-endpoint-in-pancreatic-cancer/ 2020-02-21T06:19:41+00:00 https://www.oncozine.com/wp-content/uploads/2020/02/Pancreatic_Cancer.jpg https://www.oncozine.com/the-emotional-and-psychological-struggle-of-being-a-doctor/ 2020-02-22T06:39:07+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_234893442_Subscription_Monthly_M.jpg https://www.oncozine.com/smoking-cessation-as-an-integral-part-of-the-treatment-of-patients-with-cancer/ 2020-02-24T19:23:34+00:00 https://www.oncozine.com/wp-content/uploads/2014/05/Fotolia_28377833_Subscription_Monthly_M.jpg https://www.oncozine.com/radiation-inflammation-and-triple-negative-breast-cancer-a-study/ 2020-02-24T19:25:24+00:00 https://www.oncozine.com/wp-content/uploads/2020/02/Inflammation-Caused-by-Radiation-Can-Drive-Triple-negative-Breast-Cancer-According-to-Research-at-ChristianaCare-s-Cawley-Center-for-Translational-Cancer-Research.jpg https://www.oncozine.com/wp-content/uploads/2020/02/Inflammation-Caused-by-Radiation-scaled.jpg https://www.oncozine.com/nivolumab-ipilimumab-shows-continued-survival-in-patients-with-metastatic-renal-cell-carcinoma/ 2020-02-25T18:16:58+00:00 https://www.oncozine.com/wp-content/uploads/2020/02/OpdivoLarge-605x340-1.jpg https://www.oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/u-s-fda-accepts-priority-review-for-lisocabtagene-maraleucel-r-r-large-b-cell-lymphoma/ 2020-02-25T18:19:26+00:00 https://www.oncozine.com/wp-content/uploads/2020/02/BMS_2.png https://www.oncozine.com/wp-content/uploads/2020/02/LisoCel_MOA.png https://www.oncozine.com/researchers-observe-significant-weight-gain-following-breast-cancer/ 2020-02-25T21:44:11+00:00 https://www.oncozine.com/wp-content/uploads/2019/02/Fotolia_9415959_Subscription_Diet.jpg https://www.oncozine.com/wp-content/uploads/2020/02/Carolyn_Ee.jpg https://www.oncozine.com/drinking-milk-may-increase-rate-of-breast-cancer-by-up-to-50/ 2020-02-25T23:27:08+00:00 https://www.oncozine.com/wp-content/uploads/2020/02/Milk.jpg-scaled.jpeg https://www.oncozine.com/wp-content/uploads/2020/02/Garry-Frasier.llu_.edu_.jpg https://www.oncozine.com/building-evidence-for-abbreviated-mri-in-women-with-dense-breasts/ 2020-02-25T23:51:27+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_193186103_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/02/Christopher_Comstock.jpg https://www.oncozine.com/wp-content/uploads/2020/02/fatty-vs-dense-breast-tissue.jpg https://www.oncozine.com/ambrys-rnainsight-identifies-more-patients-with-increased-hereditary-cancer-risk-vs-dna-only/ 2020-02-26T03:26:07+00:00 https://www.oncozine.com/wp-content/uploads/2020/02/SuperLab-Ambry.png https://www.oncozine.com/wp-content/uploads/2020/02/Ambry-Genetics_RNAInsight.png https://www.oncozine.com/karius-secures-us-165-m-series-b-funding-expands-access-to-its-microbial-cell-free-dna-technology/ 2020-02-26T03:47:15+00:00 https://www.oncozine.com/wp-content/uploads/2020/02/Karius-SandHill-15-scaled.jpg https://www.oncozine.com/wp-content/uploads/2020/02/Karius-Test-Kit-scaled.jpg https://www.oncozine.com/fda-advisory-committee-favors-ramucirumab-as-first-line-treatment-for-egfr-mutated-nsclc/ 2020-03-04T19:28:48+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_82833114_Subscription_Monthly_M.jpg https://www.oncozine.com/researchers-develop-a-toolkit-for-image-based-systems-biology-of-tumor-hemodynamics/ 2020-03-05T18:28:12+00:00 https://www.oncozine.com/wp-content/uploads/2008/12/Fotolia_66802238_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/03/HemoSYS.jpg https://www.oncozine.com/wp-content/uploads/2020/03/Arvind-P.-Pathak-Ph.D.jpg https://www.oncozine.com/breast-cancer-and-resistance-to-hormone-therapy/ 2020-03-05T19:30:44+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_177556962_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/03/Eric-C-Chang-Ph.D.jpg https://www.oncozine.com/debio-0123-a-potent-wee1-inhibitor-to-be-assessed-in-first-in-human-dose-escalation-study/ 2020-03-06T16:53:10+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_201863659_Subscription_Monthly_M.jpg https://www.oncozine.com/priority-review-for-kites-kte-x19-biologics-license-application-in-r-r-mantle-cell-lymphoma/ 2020-03-06T19:50:48+00:00 https://www.oncozine.com/wp-content/uploads/2020/03/Mantle_cell_lymphoma-scaled.jpg https://www.oncozine.com/three-necessary-pillars-to-revolutionize-clinical-trial-design/ 2020-03-07T01:38:54+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/Clinical-Trial-Concept.jpg https://www.oncozine.com/annual-meeting-of-the-aacr-among-growing-number-of-conferences-to-be-postponed/ 2020-03-13T16:00:52+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/2824-AACR-2019-Annual-Meeting-033019-copy.jpg https://www.oncozine.com/plitidepsin-a-novel-anti-cancer-agent-possibly-active-against-covid18/ 2020-03-16T18:37:19+00:00 https://www.oncozine.com/wp-content/uploads/2020/03/corona-4901878_1280.jpg https://www.oncozine.com/want-to-improve-patient-relationships-let-them-express-their-preferences/ 2020-03-16T19:35:09+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_137289643_Subscription_Monthly_M.jpg https://www.oncozine.com/radiation-drugs-with-longer-shelf-life-brings-hope-for-cancer-patients-globally/ 2020-03-23T18:47:45+00:00 https://www.oncozine.com/wp-content/uploads/2017/11/Fotolia_114836215_Subscription_Monthly_M.jpg https://www.oncozine.com/china-based-biotech-laekna-acquires-global-rights-to-develop-and-commercialize-anti-pd-l1-antibody/ 2020-03-25T06:56:41+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_190278636_Subscription_Monthly_M.jpg https://www.oncozine.com/high-costs-of-screening-for-breast-cancer-but-benefits-remain-uncertain-for-women-in-their-40s/ 2020-03-25T18:33:54+00:00 https://www.oncozine.com/wp-content/uploads/2017/09/Fotolia_124257261_Breast-cancer.jpg https://www.oncozine.com/wp-content/uploads/2020/03/Gross_Yale-scaled.jpg https://www.oncozine.com/lung-cancer-studies-sponsored-by-pharma-are-not-more-biased-than-studies-sponsored-by-others/ 2020-03-25T22:51:36+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/A_Lung-Cancer_1.jpg https://www.oncozine.com/wp-content/uploads/2020/03/PedroAguiar-MD.jpg https://www.oncozine.com/asco-goes-virtual-world-conference-on-lung-cancer-postponed/ 2020-03-26T15:55:11+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/19ASCO_LF_0602_0221.jpg https://www.oncozine.com/wp-content/uploads/2020/03/ASCO2020.jpg https://www.oncozine.com/wp-content/uploads/2020/03/WCLC2020_logo.png https://www.oncozine.com/survey-shows-covid19-expected-to-slow-down-global-drug-development/ 2020-03-26T17:52:09+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_84467129.jpg https://www.oncozine.com/wp-content/uploads/2020/03/Elena-A-Christofides-MD-FACE.jpg https://www.oncozine.com/wp-content/uploads/2020/03/raymond_nomizu-scaled.jpg https://www.oncozine.com/study-sheds-light-on-how-to-best-deliver-nanoparticle-therapy/ 2020-03-27T06:08:07+00:00 https://www.oncozine.com/wp-content/uploads/2017/04/Fotolia_63809087_Subscription_Monthly_M-e1500444779687.jpg https://www.oncozine.com/wp-content/uploads/2020/03/Herception-Labeled-Nanoparticle_0.png https://www.oncozine.com/detect-cancer-early-liquid-biopsy-based-ctdna-methylation-as-a-promising-diagnostic-approach/ 2020-03-27T22:48:04+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_202377709_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/03/Circulating-tumor-DNA.jpg https://www.oncozine.com/wp-content/uploads/2020/03/LB1.jpeg https://www.oncozine.com/highly-focused-radiation-may-slow-down-progression-in-men-with-prostate-cancer/ 2020-03-28T00:22:48+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_204073525_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/03/Phuoc-Tho-Tran-M.D.-Ph.D.jpg https://www.oncozine.com/wp-content/uploads/2020/03/vcsPRAsset_1153391_128534_3ec9d079-b0d8-4287-850d-ef2961a2ef08_0.jpg https://www.oncozine.com/belong-life-launches-a-support-group-for-covid19-information-for-patients-and-caregivers/ 2020-03-28T01:05:10+00:00 https://www.oncozine.com/wp-content/uploads/2020/03/Belong.Life_.PM_.png https://www.oncozine.com/wp-content/uploads/2020/03/Dr.-Vorobiof-11.jpg https://www.oncozine.com/wp-content/uploads/2020/03/viber_image.png https://www.oncozine.com/positive-opinion-from-european-medicines-agency-for-sanofis-isatuximab-in-r-r-multiple-myeloma/ 2020-03-28T06:13:12+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/ASCO-2019-Sanofi-Booth.jpeg https://www.oncozine.com/wp-content/uploads/2020/03/Sanofi_Genzyme_-USA_27.03.2020-Packaging.jpg https://www.oncozine.com/study-shows-positive-topline-results-from-phase-iii-trial-of-venetoclax-azacitidine-in-aml/ 2020-03-30T19:54:23+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/AbbVie_ASCO-1JPG.jpeg https://www.oncozine.com/wp-content/uploads/2020/03/venetoclax-venclexta-tablets-500x500-1.jpg https://www.oncozine.com/new-regulatory-pathway-may-boost-immunotherapy/ 2020-03-30T21:55:46+00:00 https://www.oncozine.com/wp-content/uploads/2020/03/Mount-Sinai001.jpg https://www.oncozine.com/three-top-apps-for-tracking-fighting-and-beating-cancer/ 2020-03-30T22:32:03+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/Belong.jpg-scaled.jpeg https://www.oncozine.com/wp-content/uploads/2020/03/Belong.life_.png https://www.oncozine.com/wp-content/uploads/2020/03/cancer.net-mobile.jpg https://www.oncozine.com/wp-content/uploads/2020/03/CareZone_medications.jpg https://www.oncozine.com/phase-ii-trial-of-inovios-vgx-3100-show-efficacy-in-hpv-related-vulvar-pre-cancers/ 2020-03-31T05:07:14+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_219643525_Subscription_Monthly_M.jpg https://www.oncozine.com/gender-disparities-caregiving-may-negatively-affect-academic-productivity/ 2020-03-31T05:47:38+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_201606393_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/03/king_a.jpg https://www.oncozine.com/managing-the-viral-scourge-how-to-finds-hope-and-face-cancer-with-covid19/ 2020-03-31T16:40:04+00:00 https://www.oncozine.com/wp-content/uploads/2020/03/New_York_National_Guard_49667734346-scaled.jpg https://www.oncozine.com/potential-accelerated-approval-enfortumab-vedotin-pembrolizumab-in-metastatic-urothelial-cancer/ 2020-04-03T05:52:42+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/SeattleGen_ASCO2019.JPG.jpeg https://www.oncozine.com/encorafenib-cetuximab-approved-for-treatment-of-mcrc-with-braf-v600e-mutation/ 2020-04-13T15:43:30+00:00 https://www.oncozine.com/wp-content/uploads/2020/01/AdobeStock_164902722-copy-scaled.jpeg https://www.oncozine.com/selumetinib-increases-potential-for-successful-tumor-reduction-in-patients-with-neurofibromatosis/ 2020-04-14T01:03:28+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/AstraZeneca_ASCO_2019.jpeg https://www.oncozine.com/are-physicians-counseling-cancer-survivors-enough-to-adopt-a-healthy-lifestyle/ 2020-04-15T05:25:33+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_274813027_Subscription_Monthly_M.jpg https://www.oncozine.com/bold-therapeutics-initiates-partnership-with-university-of-ottawa-investigating-bold-100-in-covid19/ 2020-04-16T04:35:29+00:00 https://www.oncozine.com/wp-content/uploads/2016/07/Fotolia_94619649_Subscription_Monthly_M-e1490845631347.jpg https://www.oncozine.com/wp-content/uploads/2020/04/BOLD-100-Pancreatic_Cancer_Graph.jpg https://www.oncozine.com/wp-content/uploads/2020/04/Bold_100jpg.jpg https://www.oncozine.com/wp-content/uploads/2020/04/Mark-Bazett-PhD-Director-Preclinical-Development.jpg https://www.oncozine.com/researcher-embarks-on-first-in-human-clinical-trial-of-novel-immunotherapy-vaccine-for-brain-cancer/ 2020-04-18T00:52:24+00:00 https://www.oncozine.com/wp-content/uploads/2020/04/Brain_Tumor_Sayour_UF_Health-scaled.jpg https://www.oncozine.com/wp-content/uploads/2020/04/Elias-Sayour-MD-PhD.jpg https://www.oncozine.com/wp-content/uploads/2020/04/sri-ururangan-bio.jpg https://www.oncozine.com/samsung-bioepis-and-merck-launch-trastuzumab-biosimilar-in-the-united-states/ 2020-04-18T06:06:47+00:00 https://www.oncozine.com/wp-content/uploads/2016/05/Fotolia_62820037.jpg https://www.oncozine.com/wp-content/uploads/2020/04/Ontruzant.Merck_.Samsung.Bioepis.jpg https://www.oncozine.com/tucatinib-with-trastuzumab-capecitabine-approved-for-advanced-her2-breast-cancer/ 2020-04-21T03:01:59+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_177556962_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/04/logo-tukysa.png https://www.oncozine.com/wp-content/uploads/2020/04/Tukysa_150mg_60ct_75cc.jpg https://www.oncozine.com/study-shows-positive-correlation-between-previous-infection-and-cancer-diagnosis/ 2020-04-21T04:11:41+00:00 https://www.oncozine.com/wp-content/uploads/2018/04/Fotolia_143213711_Subscription_Monthly_M-1-e1555282936265.jpg https://www.oncozine.com/study-shows-women-of-indigenous-american-ancestry-to-have-higher-risk-of-her2-breast-cancer/ 2020-04-21T05:25:55+00:00 https://www.oncozine.com/wp-content/uploads/2018/02/Fotolia_157602231_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/04/Laura-Fejerman-PhD.jpg https://www.oncozine.com/collaboration-between-indivumed-and-personalis-expected-to-advance-precision-oncology/ 2020-04-21T19:01:34+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_190278636_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/04/Hartmut_Juhl_Indivumed.jpg https://www.oncozine.com/risk-of-recurrence-of-triple-negative-breast-cancer-may-be-predicted-by-molecular-biomarkers/ 2020-04-24T17:28:35+00:00 https://www.oncozine.com/wp-content/uploads/2018/02/Fotolia_157602231_Subscription_Monthly_M.jpg https://www.oncozine.com/drug-combination-demonstrates-significant-improved-pcr-in-high-risk-her2-negative-breast-cancer/ 2020-04-27T12:30:13+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/2824-AACR-2019-Annual-Meeting-033019-copy.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/study-shows-inhibition-of-the-menin-mll1-interaction-to-induce-a-response-in-mll-r-acute-leukemias/ 2020-04-27T22:38:23+00:00 https://www.oncozine.com/wp-content/uploads/2020/04/AACR_2018_Plen.Session_Mardis.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2020/04/Screen-Shot-2020-04-27-at-3.23.49-PM.png https://www.oncozine.com/preliminary-data-highlights-clinical-activity-of-raf-mek-and-fak-combination-in-kras-mutant-tumors/ 2020-04-27T22:41:23+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/19AACR_TB_009612.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/stro-002-shows-encouraging-results-in-phase-i-trial-in-treatment-of-ovarian-cancer/ 2020-04-28T05:20:09+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/AACR2016_4.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2020/04/Screen-Shot-2020-04-27-at-8.48.55-PM.png https://www.oncozine.com/aacr-2020-phase-i-study-of-com701-demonstrates-anti-tumor-activity-in-advanced-solid-tumors/ 2020-04-29T00:01:23+00:00 https://www.oncozine.com/wp-content/uploads/2020/04/AACR2019_Plen.Session_0221.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2020/04/Screen-Shot-2020-04-28-at-11.42.45-AM.png https://www.oncozine.com/wp-content/uploads/2020/04/Ryan-J.-Sullivan-M.D.-Harvard-Medical-School.jpg https://www.oncozine.com/aacr-2020-first-in-human-clinical-trial-for-universal-truucar-gc027-in-r-r-t-cell-all/ 2020-04-29T05:24:16+00:00 https://www.oncozine.com/wp-content/uploads/2020/04/AACR2019_AM_0234.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2020/04/Screen-Shot-2020-04-28-at-9.45.11-PM.png https://www.oncozine.com/new-mitomycin-containing-drug-offers-option-for-the-treatment-of-upper-tract-urothelial-cancer/ 2020-05-01T04:19:01+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/Fotolia_234893442_Subscription_Monthly_M-e1748002293540.jpg https://www.oncozine.com/fda-approval-of-combination-encorafenib-cetuximab-supported-by-su2c-research/ 2020-05-01T06:42:20+00:00 https://www.oncozine.com/wp-content/uploads/2020/01/AdobeStock_164902722-copy-scaled.jpeg https://www.oncozine.com/wp-content/uploads/2020/04/SungPoblete3.jpg https://www.oncozine.com/wp-content/uploads/2020/04/SHARP_Phillip_PhD_SAC_chair1.jpg https://www.oncozine.com/wp-content/uploads/2020/04/VOEST_Emile_E._MD_PhD_2x2.5_961.jpg https://www.oncozine.com/wp-content/uploads/2020/04/BERNARDS_Rene_PhD_8x10_3001-scaled.jpg https://www.oncozine.com/remegen-initiates-clinical-trial-for-distamab-vedotin-a-novel-anti-her2-antibody-drug-conjugate/ 2020-05-02T18:43:12+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_137289643_Subscription_Monthly_M.jpg https://www.oncozine.com/interim-results-of-phase-i-study-confirms-safety-with-early-signs-of-efficacy-for-trph-222-in-nhl/ 2020-05-19T01:05:15+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_185816154_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/05/Francisco-Hernandez-Ilizaliturri.png https://www.oncozine.com/dr-brawley-goes-to-baltimoreand-washington/ 2020-05-20T18:49:06+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/Otis-Brawley-2016.jpg https://www.oncozine.com/wp-content/uploads/2019/01/Gilman-Hall-Johns-Hopkins-University-Baltimore-MD.jpg https://www.oncozine.com/wp-content/uploads/2019/01/Otis-Brawley-3-1.jpg https://www.oncozine.com/wp-content/uploads/2016/04/Oncozine_FinalLogo01a.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Otis-Brawley_5x7-Portrait.jpg https://www.oncozine.com/daiichi-sankyo-submits-snda-to-japans-regulator-for-trastuzumab-deruxtecan-in-gastric-cancer/ 2020-05-22T04:25:23+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/DSC_6354.jpg https://www.oncozine.com/why-doctors-dont-trust-cannabis/ 2020-06-16T17:46:58+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_131471922_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/06/Eber-P78.jpg https://www.oncozine.com/wp-content/uploads/2020/06/Parke-Davis-cannabis-tincture.jpg https://www.oncozine.com/providing-the-legitimacy-of-cannabinoids-for-the-treatment-of-cancer/ 2020-06-16T17:47:56+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_233087215_Subscription_Monthly_M.jpg https://www.oncozine.com/the-value-of-biosimilars-in-the-pandemic-era/ 2020-06-16T17:49:05+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_167331259_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/04/Ontruzant.Merck_.Samsung.Bioepis.jpg https://www.oncozine.com/re-engineering-molecules-to-drive-innovation-in-cancer-immunotherapy/ 2020-06-16T17:50:04+00:00 https://www.oncozine.com/wp-content/uploads/2020/06/Alkermes_06.01.202.jpg https://www.oncozine.com/covid19-and-bladder-cancer-adapting-to-a-new-reality/ 2020-06-16T17:50:56+00:00 https://www.oncozine.com/wp-content/uploads/2020/05/Screen-Shot-2020-05-30-at-12.34.40-PM-e1590868367102.png https://www.oncozine.com/wp-content/uploads/2020/05/BCAN_-LOGO.jpg https://www.oncozine.com/asco-2020-oncoceutics-onc201-demonstrates-clinical-benefit/ 2020-06-16T17:51:44+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/19ASCO_KN_0071.jpg https://www.oncozine.com/wp-content/uploads/2020/05/ASCO2020.jpg https://www.oncozine.com/forward-ii-trial-of-mirvetuximab-soravtansine-bevacizumab-demonstrates-encouraging-outcomes/ 2020-06-16T17:52:47+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/Fotolia_237743640_Subscription_Monthly_M-e1600399749408.jpg https://www.oncozine.com/wp-content/uploads/2020/05/ASCO2020.jpg https://www.oncozine.com/what-to-expect-at-asco-2020-gsks-transformational-medicines/ 2020-06-16T17:53:54+00:00 https://www.oncozine.com/wp-content/uploads/2020/05/gsk-house.jpg https://www.oncozine.com/wp-content/uploads/2020/05/ASCO2020.jpg https://www.oncozine.com/the-road-to-recovery-must-include-communities-of-color/ 2020-06-16T17:57:46+00:00 https://www.oncozine.com/wp-content/uploads/2020/05/People_1280.jpg https://www.oncozine.com/prostate-cancer-treatment-do-your-homework-know-your-options/ 2020-06-16T18:00:54+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_204073525_Subscription_Monthly_M.jpg https://www.oncozine.com/sacituzumab-govitecan-approved-in-metastatic-triple-negative-breast-cancer/ 2020-06-17T04:43:40+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/Fotolia_225653074_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/04/Screen-Shot-2020-04-22-at-11.30.05-PM.png https://www.oncozine.com/public-private-partnership-to-improve-outcomes-for-veterans-at-risk-of-lung-cancer/ 2020-06-17T06:26:58+00:00 https://www.oncozine.com/wp-content/uploads/2020/06/USAVA-2012-scaled.jpg https://www.oncozine.com/wp-content/uploads/2020/06/RLW.jpg https://www.oncozine.com/aacr-2020-positive-preclinical-safety-and-efficacy-data-for-txr-311-in-hcc/ 2020-06-22T23:24:30+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Liver_Hepato.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2020/06/Screenshot-2020-06-22-14.36.45.png https://www.oncozine.com/pembrolizumab-approved-for-treatment-advanced-cutaneous-squamous-cell-carcinoma/ 2020-06-24T23:22:00+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Merck_ASCO_2019_1.jpeg https://www.oncozine.com/wp-content/uploads/2017/03/95-KEYTRUDApembrolizumab-300x273.jpg https://www.oncozine.com/trastuzumab-deruxtecan-launched-in-japan-for-her2-unresectable-or-metastatic-breast-cancer/ 2020-06-25T05:48:00+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_193186103_Subscription_Monthly_M.jpg https://www.oncozine.com/positive-chmp-opinion-for-samsung-bioepis-bevacizumab-biosimilar-candidate/ 2020-06-26T17:24:01+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Amsterdam-Rijksmuseum-Nikolai-Karaneschev.jpg https://www.oncozine.com/new-therapies-may-offer-hope-for-patients-with-metastatic-breast-cancer/ 2020-06-26T19:56:09+00:00 https://www.oncozine.com/wp-content/uploads/2018/02/Fotolia_157602231_Subscription_Monthly_M.jpg https://www.oncozine.com/a-new-strategy-for-the-production-of-site-specific-antibody-drug-conjugates/ 2020-07-19T19:51:52+00:00 https://www.oncozine.com/wp-content/uploads/2020/07/yong_tiger_zhang_USC.jpg https://www.oncozine.com/revitope-oncology-and-junshi-biosciences-agree-to-collaborate-in-develop-next-gen-immunotherapies/ 2020-07-20T03:05:05+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_131471922_Subscription_Monthly_M.jpg https://www.oncozine.com/scientists-discover-a-new-way-to-prevent-cell-death-in-colorectal-cancer/ 2020-07-20T21:59:23+00:00 https://www.oncozine.com/wp-content/uploads/2020/07/Lab-Belfast.jpg https://www.oncozine.com/wp-content/uploads/2020/07/Simon-McDade-and-Daniel-Longley.jpg https://www.oncozine.com/a-new-way-of-identifying-tumor-response-to-immunotherapy-may-improve-personalized-cancer-medicine/ 2020-07-20T23:35:30+00:00 https://www.oncozine.com/wp-content/uploads/2020/07/TGen_2020-06-22-16.11.25.png https://www.oncozine.com/tisotumab-vedotin-shows-positive-results-in-phase-ii-trial-in-cervical-cancer/ 2020-07-21T01:04:34+00:00 https://www.oncozine.com/wp-content/uploads/2020/07/Hybridoma-Tissue-Culture-Laboratory-scaled.jpg https://www.oncozine.com/olema-oncology-expands-breast-cancer-development-following-us-54-million-series-b-financing/ 2020-07-23T20:39:35+00:00 https://www.oncozine.com/wp-content/uploads/2017/11/Fotolia_169706158_Subscription_Monthly_M.jpg https://www.oncozine.com/glioblastoma-awareness-day-increasing-public-awareness-of-rare-but-lethal-disease/ 2020-07-24T04:31:06+00:00 https://www.oncozine.com/wp-content/uploads/2017/12/Fotolia_83157922_Subscription_Monthly_M.jpg https://www.oncozine.com/uci-anti-cancer-challenge-goes-virtual-with-fitness-challenges-webinars-and-wellness-courses/ 2020-07-24T05:15:38+00:00 https://www.oncozine.com/wp-content/uploads/2020/07/ACC_2019_27-768x512-1.jpg https://www.oncozine.com/wp-content/uploads/2020/07/van-etten-richard.jpg https://www.oncozine.com/q-biomed-continues-pre-clinical-evaluation-of-uttroside-b-for-the-treatment-of-liver-cancer/ 2020-07-24T06:07:08+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Liver_Hepato.jpg https://www.oncozine.com/accelerated-approval-for-kites-brexucabtagene-autoleucel-r-r-mantle-cell-lymphoma/ 2020-07-25T05:00:08+00:00 https://www.oncozine.com/wp-content/uploads/2020/07/Kite-2020-07-24-at-7.46.41-PM.png https://www.oncozine.com/wp-content/uploads/2017/11/Screen-Shot-2017-11-30-at-8.19.43-AM.png https://www.oncozine.com/wp-content/uploads/2020/07/127443_Wang_M.jpg https://www.oncozine.com/wp-content/uploads/2020/07/Kite_bag_and_box-0038-scaled.jpg https://www.oncozine.com/periodontal-disease-linked-to-the-development-of-colorectal-cancer/ 2020-07-29T10:10:44+00:00 https://www.oncozine.com/wp-content/uploads/2017/12/Fotolia_183631434_Subscription_Monthly_M-e1513299238684.jpg https://www.oncozine.com/wp-content/uploads/2020/07/Song_Head-shot_145x145.jpg https://www.oncozine.com/wp-content/uploads/2020/07/Lo_Chun-Han_145x145.jpg https://www.oncozine.com/baylor-college-received-ncis-specialized-programs-of-research-excellence-spore-grant-funding/ 2020-07-28T22:38:52+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/Fotolia_222115990_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/07/Ellis_J.Matthew.Baylor_breastcancer.jpg https://www.oncozine.com/anti-cd30-car-t-cell-therapy-shows-promising-results-in-relapsed-and-refractory-hodgkin-lymphoma/ 2020-07-29T06:02:21+00:00 https://www.oncozine.com/wp-content/uploads/2020/07/1200px-Hodgkin_lymphoma_cytology_large.jpg https://www.oncozine.com/wp-content/uploads/2020/07/caramos.jpeg https://www.oncozine.com/wp-content/uploads/2020/07/Barbara-Savoldo-MD-PhD.jpg https://www.oncozine.com/wp-content/uploads/2020/07/Helen_Heslop.jpeg https://www.oncozine.com/wp-content/uploads/2020/07/Grover-Natalie-Faculty.jpg https://www.oncozine.com/a-better-understanding-of-the-mediators-of-patient-recovery-after-her2-car-t-cell-therapy/ 2020-07-29T07:10:38+00:00 https://www.oncozine.com/wp-content/uploads/2020/07/V-foundation-grant-copy-Paul-Kuntz-TCH-Ahmed-Hegde-cropped-FTL.png https://www.oncozine.com/wp-content/uploads/2020/07/Meenakshi-G.-Hegde-MD.jpg https://www.oncozine.com/wp-content/uploads/2020/07/Sujith-K-Joseph-Ph.D..jpeg https://www.oncozine.com/wp-content/uploads/2020/07/Nabil-M-Ahmed-M.D..jpeg https://www.oncozine.com/study-evaluates-diagnostic-value-of-the-karius-test-for-pneumonia-in-immunocompromised-patients/ 2020-08-03T15:01:44+00:00 https://www.oncozine.com/wp-content/uploads/2020/08/Karius-CLS-Lab-1-e1596066381344.jpg https://www.oncozine.com/wp-content/uploads/2020/02/Karius-Test-Kit-scaled.jpg https://www.oncozine.com/wp-content/uploads/2020/07/stephen-p-bergin-md-Duke.jpg https://www.oncozine.com/inovio-receives-orphan-drug-designation-for-ino-3107-for-recurrent-respiratory-papillomatosis/ 2020-07-30T06:44:24+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/Fotolia_234893442_Subscription_Monthly_M-e1748002293540.jpg https://www.oncozine.com/fda-approves-tafasitamab-lenalidomide-for-the-treatment-of-adult-patients-with-r-r-dlbcl/ 2020-08-01T05:31:20+00:00 https://www.oncozine.com/wp-content/uploads/2017/10/Fotolia_86770989_Subscription_Monthly_M-e1507955178861.jpg https://www.oncozine.com/home-based-anticancer-therapy-without-oncologist-oversight-is-not-safe/ 2020-08-06T18:38:13+00:00 https://www.oncozine.com/wp-content/uploads/2018/04/Fotolia_17453642_Subscription_Monthly_M-1.jpg https://www.oncozine.com/wp-content/uploads/2020/08/Lori_J_Pierce.jpg https://www.oncozine.com/wp-content/uploads/2020/08/ASCO-Recommendation.png https://www.oncozine.com/gsks-belantamab-mafodotin-approved-as-monotherapy-for-adult-patients-with-r-r-multiple-myeloma/ 2020-08-06T19:41:13+00:00 https://www.oncozine.com/wp-content/uploads/2019/02/Fotolia_184218989_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/08/Belantamab-mafodotin-1024x176-1.png https://www.oncozine.com/wp-content/uploads/2019/08/halbarron.jpg https://www.oncozine.com/daiichi-sankyo-and-astrazeneca-to-jointly-evaluate-treatment-combination-for-egfr-mutated-nsclc/ 2020-08-07T03:50:13+00:00 https://www.oncozine.com/wp-content/uploads/2020/08/AstraZenca_Laboratory.jpg https://www.oncozine.com/diagnosed-with-a-rare-cancer-during-the-covid-19-pandemic-what-now/ 2020-08-18T01:58:19+00:00 https://www.oncozine.com/wp-content/uploads/2020/08/Vince-swimming2.jpg https://www.oncozine.com/wp-content/uploads/2020/08/TOB_Nuvance.png https://www.oncozine.com/wp-content/uploads/2020/08/Margo-Shoup-MD.jpg https://www.oncozine.com/wp-content/uploads/2020/08/Vince-with-Daughter.jpg https://www.oncozine.com/study-shows-benefit-of-camrelizumab-cisplatin-and-gemcitabine-in-nasopharyngeal-carcinoma/ 2020-08-19T17:35:24+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/Clinical-Trial-Concept.jpg https://www.oncozine.com/bolder-more-aggressive-steps-are-needed-to-reduce-disparities-and-achieve-equity-in-cancer-care/ 2020-08-19T22:56:22+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/19ASCO_MSG_SAT_0010.jpg https://www.oncozine.com/wp-content/uploads/2020/08/Lori_J_Pierce.jpg https://www.oncozine.com/wp-content/uploads/2020/08/ASCO-2020-Recommendations-.png https://www.oncozine.com/combinability-addressing-unmet-need-in-aml/ 2020-08-24T18:34:50+00:00 https://www.oncozine.com/wp-content/uploads/2020/08/Differentiation-in-bone-marrow_Lisa.jpg https://www.oncozine.com/gsk-receives-conditional-marketing-authorization-for-belantamab-mafodotin-in-multiple-myeloma/ 2020-08-26T22:38:29+00:00 https://www.oncozine.com/wp-content/uploads/2020/08/european-union-4225118_1280Pixabay.jpg https://www.oncozine.com/wp-content/uploads/2019/08/halbarron.jpg https://www.oncozine.com/nbe-therapeutics-signs-agreement-with-exelixis-to-advance-adcs-against-multiple-targets/ 2020-09-10T04:19:56+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/NBE-Therapeutics.jpg https://www.oncozine.com/silverback-therapeutics-initiates-phase-i-clinical-study-of-sbt6050/ 2020-09-10T04:56:26+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_190278636_Subscription_Monthly_M.jpg https://www.oncozine.com/arizona-doctoral-student-receives-nci-award-for-prostate-cancer-study/ 2020-09-10T19:03:49+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/Tucson_Arizona_Image_UoA.jpg https://www.oncozine.com/wp-content/uploads/2020/09/KendraMarr-e1599763231402.jpg https://www.oncozine.com/covid-19-oncology-nurses-survey-cancer-patients-who-are-self-isolated-at-home/ 2020-09-10T20:21:37+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_233831755_Subscription_Monthly_M.jpg https://www.oncozine.com/u-s-food-and-drug-administration-aproves-companion-diagnostic-for-pralsetinib/ 2020-09-10T23:29:25+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/Gavreto_pralsetinib_100_mg_capsules.jpg https://www.oncozine.com/tepotinib-shows-activity-in-advanced-nsclc-with-a-met-exon-14-skipping-mutation/ 2020-09-11T03:26:48+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_82833114_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Paul-K.-Paik-MD-Medical-Oncologist-.jpg https://www.oncozine.com/rapid-and-durable-remission-observed-with-lisocabtagene-maraleucel-in-r-r-large-b-cell-lymphomas/ 2020-09-11T05:05:07+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/juno-therapeutics-scientific-research_7.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Jeremy-Abramson-MD-Mass-General-Boston.jpg https://www.oncozine.com/interview-the-development-of-sermonix-lasofoxifene-in-advanced-or-metastatic-breast-cancer/ 2020-09-12T23:46:55+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/IMG_1509-scaled.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Sermonix-TOB-at-3.54.21-PM.png https://www.oncozine.com/wp-content/uploads/2020/09/David-Portman-headshot.jpg https://www.oncozine.com/adjuvant-dabrafenib-trametinib-in-resected-stage-iii-melanoma-w-braf-mutations-5-year-follow-up/ 2020-09-13T05:22:23+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/Fotolia_112737156_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Reinhard-Dummer-MD.09-PM.png https://www.oncozine.com/first-comprehensive-next-gen-sequencing-based-pan-tumor-liquid-biopsy-test-approved/ 2020-09-13T06:05:33+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/Foundation-Medicine-Lab-Staff.png https://www.oncozine.com/wp-content/uploads/2020/09/FoundationOne-Liquid-Kit.png https://www.oncozine.com/addressing-disparities-in-cancer-factors-influencing-care-access-and-outcomes/ 2020-09-16T17:44:12+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/ASH2019_004_o-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/black-women-experience-longer-waits-and-less-timely-treatment-for-breast-cancer/ 2020-09-21T08:30:42+00:00 https://www.oncozine.com/wp-content/uploads/2016/06/Fotolia_86830610_Subscription_Monthly_M.jpg https://www.oncozine.com/fda-alert-efficacy-and-potential-safety-concerns-with-atezolizumab-paclitaxel-in-breast-cancer/ 2020-09-16T19:24:22+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/FDA-Building-and-Sign.jpg https://www.oncozine.com/precision-technology-transforms-the-way-leading-hospitals-diagnose-and-treat-prostate-cancer/ 2020-09-16T20:33:04+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/Exact-Imaging-ExactVu.jpg https://www.oncozine.com/easing-the-burden-of-cancer-beyond-medicine-through-the-astellas-oncology-c3-prize/ 2020-09-17T18:04:56+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/Astellas-C3-nanny-Metwork-2019-Winner.png https://www.oncozine.com/genetic-tests-for-patients-with-precursor-lesions-helps-understand-pancreatic-cancer-risk/ 2020-09-17T18:14:28+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/Pancreatic-cancer-cells.jpg https://www.oncozine.com/esmo-2020-phase-iii-exploratory-analyses-aybintio-and-reference-bevacizumab-in-nsclc/ 2020-09-17T21:21:10+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/ESMO2018-456_o.jpg https://www.oncozine.com/wp-content/uploads/2017/03/981-esmo_logo_medium.jpg https://www.oncozine.com/jordan-gauthier-about-the-nccn-guidelines-for-patients-and-the-side-effects-of-car-t-therapy/ 2020-09-17T21:24:03+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_137289643_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Gauthier-primary.jpg https://www.oncozine.com/scientists-uncover-mechanism-limiting-checkpoint-inhibitors-find-solution-to-fix-the-problem/ 2020-09-17T23:36:56+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/Lombardi-release-image-2.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Samir-Khleif-MD-e1600380638563.jpg https://www.oncozine.com/esmo-2020-phase-i-data-of-xmt-1536-supports-continued-development-in-ovarian-cancer/ 2020-09-18T03:35:41+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/Fotolia_237743640_Subscription_Monthly_M-e1600399749408.jpg https://www.oncozine.com/wp-content/uploads/2017/03/981-esmo_logo_medium.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Mersana-_-ESMO-2020-Sep-17.png https://www.oncozine.com/aramis-study-show-significantly-longer-overall-survival-with-darolutamide-in-non-metastatic-crpc/ 2020-09-18T17:23:34+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/Fotolia_88060556_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/09/nubeqa-darolutamide-bayer.jpg https://www.oncozine.com/wp-content/uploads/2020/09/ARAMIS-Study..png https://www.oncozine.com/wp-content/uploads/2020/09/Adverse-Reactions-in-ARAMIS-AM.png https://www.oncozine.com/esmo-2020-study-shows-major-differences-in-access-to-cancer-drugs-and-clinical-trials/ 2020-09-19T02:20:54+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/ESMO_o.jpg https://www.oncozine.com/wp-content/uploads/2017/03/971-esmo_logo_medium.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Nils-Wilking-MD-PHD.jpg https://www.oncozine.com/eflornithine-sulindac-not-superior-to-either-drug-alone-in-familial-adenomatous-polyposis/ 2020-09-19T06:48:15+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_219643525_Subscription_Monthly_M.jpg https://www.oncozine.com/esmo-2020-checkmate-9er-provides-new-first-line-treatment-option-for-patients-advanced-rcc/ 2020-09-20T00:12:46+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/ESMo-2019-General-16_o.jpg https://www.oncozine.com/wp-content/uploads/2017/03/971-esmo_logo_medium.jpg https://www.oncozine.com/wp-content/uploads/2020/09/choueiri-toni_medium_front.jpg https://www.oncozine.com/durvalumab-demonstrates-sustained-overall-survival-in-unresectable-stage-iii-nsclc/ 2020-09-20T03:53:38+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/ESMO-2018_59.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Corinne-Faivre-Finn-NHS.jpg https://www.oncozine.com/wp-content/uploads/2020/09/14AACR_Balsega-X4-1920x1433_2.jpg https://www.oncozine.com/esmo-2020-olaparib-improves-median-time-without-disease-progression-in-brcam-ovarian-cancer/ 2020-09-20T06:16:46+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/ESMO-18_1.jpg https://www.oncozine.com/wp-content/uploads/2017/03/981-esmo_logo_medium.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Susana-Banerjee-MBBS-MA-Ph.D.-FRCP.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Ol-AZ-ESMO.png https://www.oncozine.com/esmo-2020-tert-promoter-mutations-may-not-be-indicative-of-sensitivity-to-temozolomide/ 2020-09-21T03:10:00+00:00 https://www.oncozine.com/wp-content/uploads/2017/07/Glioblastoma_with_extreme_nuclear_enlargement_-_very_high_mag.jpg https://www.oncozine.com/wp-content/uploads/2017/03/981-esmo_logo_medium.jpg https://www.oncozine.com/wp-content/uploads/2020/09/MGMT_TERT_ESMO-2020.jpg https://www.oncozine.com/esmo-2020-sacituzumab-govitecan-significantly-extends-overall-survival-in-patients-with-mtnbc/ 2020-09-21T05:45:26+00:00 https://www.oncozine.com/wp-content/uploads/2020/02/Inflammation-Caused-by-Radiation-Can-Drive-Triple-negative-Breast-Cancer-According-to-Research-at-ChristianaCare-s-Cawley-Center-for-Translational-Cancer-Research.jpg https://www.oncozine.com/wp-content/uploads/2017/03/975-esmo_logo_medium.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Aditya-Bardia-MD.png https://www.oncozine.com/esmo-2020-sotorasib-active-in-patients-with-kras-p-g12c-mutation-shows-promise-in-nsclc/ 2020-09-21T20:19:36+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/A_Lung-Cancer_1.jpg https://www.oncozine.com/wp-content/uploads/2017/03/981-esmo_logo_medium.jpg https://www.oncozine.com/wp-content/uploads/2020/09/David_hong.MD_.Anderson.jpg https://www.oncozine.com/esmo-2020-first-in-class-mk-4830-antibody-targeting-ilt4-shows-promising-preliminary-results/ 2020-09-21T22:06:20+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/ESMO-2018_3435.jpg https://www.oncozine.com/wp-content/uploads/2017/03/969-esmo_logo_medium.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Lillian-L-Siu-MD-FRCPC-Senior-Scientist-Princess-Margaret-Cancer-Centre-Cancer-Clinical-Research-Unit-CCRU-Princess-Margaret-Cancer-Centre-.jpg https://www.oncozine.com/esmo-2020-encouraging-early-stage-clinical-results-with-sacituzumab-govitecan-in-brain-cancer/ 2020-09-21T22:23:23+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/ESMO-2018-2.jpg https://www.oncozine.com/wp-content/uploads/2017/03/975-esmo_logo_medium.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Andrew-J.-Brenner-M.D.-Ph.D.-Texas-Oncology.jpg https://www.oncozine.com/wp-content/uploads/2020/09/SG-Brain-and-Glioblastoma.png https://www.oncozine.com/esmo-2020-enfortumab-vedotin-significantly-improves-overall-survival-in-urothelial-cancer/ 2020-09-22T06:50:22+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/SeattleGen_ASCO2019.JPG.jpeg https://www.oncozine.com/wp-content/uploads/2019/12/PADCEV.jpg https://www.oncozine.com/esmo-2020-tisotumab-vedotin-shows-meaningful-clinical-activity-in-cervical-cancer/ 2020-09-22T18:57:04+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/Functional-Characterization-Bioassays-Laboratory-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/981-esmo_logo_medium.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Robert-Coleman-Texas-Oncology.jpg https://www.oncozine.com/lantern-pharma-and-fox-chase-cancer-center-collaborate-in-developing-lp-184-in-pancreatic-cancer/ 2020-09-23T06:03:11+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/Fox-Chase-e1600840462162.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Igor_Astaturov_Chase_Fox.jpg https://www.oncozine.com/wp-content/uploads/2020/09/184.png https://www.oncozine.com/astellas-establishes-global-patient-centricity-leadership-includes-patient-perspective-in-research/ 2020-09-23T17:46:24+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/Astellas_2019ASCO_edit.jpeg-y-e1600882889919.jpeg https://www.oncozine.com/wp-content/uploads/2020/09/Astellas-C3-prize-.png https://www.oncozine.com/wp-content/uploads/2020/09/Anthony-Yanni-SVP-Head-of-Patient-Centricity.jpg https://www.oncozine.com/esmo-2020-sacituzumab-govitecan-shows-27-orr-in-heavily-pretreated-metastatic-urothelial-cancer/ 2020-09-25T06:29:50+00:00 https://www.oncozine.com/wp-content/uploads/2017/03/981-esmo_logo_medium.jpg https://www.oncozine.com/wp-content/uploads/2020/09/SG_-ESMO-UC.png https://www.oncozine.com/japan-approves-cetuximab-saratolacan-in-unresectable-locally-advanced-recurrent-head-neck-cancer/ 2020-09-25T18:26:09+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/NIR-PIT-NCI-Rakuten.png https://www.oncozine.com/wp-content/uploads/2020/09/kobayashi-hisataka-NCI.jpg https://www.oncozine.com/esmo-2020-derazantinib-in-preclinical-models-with-fgfr-aberrations-supports-gastric-cancer-study/ 2020-09-25T22:55:01+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/Basilea-Pharmaceutica.png https://www.oncozine.com/wp-content/uploads/2017/03/975-esmo_logo_medium.jpg https://www.oncozine.com/wp-content/uploads/2020/09/B-Esmo-ePosters.png https://www.oncozine.com/confirmatory-phase-iii-ascent-study-shows-significant-improved-overall-survival-in-mtnbc/ 2020-09-25T23:49:19+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/ESMO_2018_45.jpg https://www.oncozine.com/wp-content/uploads/2017/03/981-esmo_logo_medium.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Aditya-Bardia-MD.png https://www.oncozine.com/aacr-the-science-of-cancer-health-disparities/ 2020-10-02T17:01:16+00:00 https://www.oncozine.com/wp-content/uploads/2020/10/AACR_2015_1.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/disitamab-vedotin-receives-fda-breakthrough-therapy-designation-for-treatment-of-urothelial-cancer/ 2020-09-28T23:06:23+00:00 https://www.oncozine.com/wp-content/uploads/2022/01/drew-hays-tGYrlchfObE-unsplash-scaled-e1641628070409.jpg https://www.oncozine.com/filgrastim-sndz-zarxio-cost-effectiveness-prophylaxis-for-febrile-neutropenia-in-breast-cancer/ 2020-10-08T17:14:14+00:00 https://www.oncozine.com/wp-content/uploads/2020/10/Sandoz-2020-10-08-at-10.03.16-AM.png https://www.oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/nobel-prize-genetic-scissors-designed-to-rewrite-the-code-of-life/ 2020-10-11T18:35:19+00:00 https://www.oncozine.com/wp-content/uploads/2020/10/CRISPERCas9-NobelPM.png https://www.oncozine.com/wp-content/uploads/2020/10/Emmanuelle-Charpentier.jpg https://www.oncozine.com/wp-content/uploads/2020/10/doudna_keegan_houser.jpg https://www.oncozine.com/seattle-genetics-rebrands-itself-as-seagen/ 2020-10-11T22:05:21+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/seattle-genetics.jpg https://www.oncozine.com/wp-content/uploads/2017/03/351-Brentuximab_vedotin_Adcetris.jpg https://www.oncozine.com/wp-content/uploads/2020/04/Tukysa_150mg_60ct_75cc.jpg https://www.oncozine.com/study-shows-urine-based-liquid-biopsy-outperforms-urine-cytology-in-detecting-bladder-cancer/ 2020-10-12T03:41:08+00:00 https://www.oncozine.com/wp-content/uploads/2020/10/28263697589_52ef0f41da_o.jpg https://www.oncozine.com/persistent-poverty-and-cancer-deaths/ 2020-10-12T17:56:30+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_198929062_Subscription_Monthly_M.jpg https://www.oncozine.com/study-shows-proton-pump-inhibitors-negatively-impact-urothelial-cancer-treated-with-atezolizumab/ 2020-10-13T22:28:27+00:00 https://www.oncozine.com/wp-content/uploads/2018/03/Fotolia_166189806_Subscription_Monthly_M-1.jpg https://www.oncozine.com/broadening-the-applicability-of-car-t-immunotherapy-to-treat-the-untreatable/ 2020-10-14T02:30:00+00:00 https://www.oncozine.com/wp-content/uploads/2019/10/Fotolia_112622103_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/10/Figure-1-CAR-T.png https://www.oncozine.com/wp-content/uploads/2019/10/Figure-2-CAR-T-NKR2.png https://www.oncozine.com/car-t-cell-therapies-for-the-treatment-of-patients-with-acute-lymphoblastic-leukemia/ 2020-10-14T23:42:07+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_90793182_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/10/1280px-CAR_T-cell_Therapy.svg_.png https://www.oncozine.com/wp-content/uploads/2020/10/Approved-CAR-T-cell-2020-October.png https://www.oncozine.com/patient-first-specialty-rx-solutions-expedite-trials-enhance-compliance-and-improve-experience/ 2020-10-15T00:34:41+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_137289643_Subscription_Monthly_M.jpg https://www.oncozine.com/how-a-novel-microrobot-system-may-help-diagnose-and-deliver-therapies-inside-the-colon/ 2020-10-15T16:56:08+00:00 https://www.oncozine.com/wp-content/uploads/2020/10/Screen-Shot-2020-10-15-at-8.20.56-AM.png https://www.oncozine.com/wp-content/uploads/2020/10/tumbling-in-vivo.gif https://www.oncozine.com/wp-content/uploads/2020/10/cappelleri-penny.jpg https://www.oncozine.com/wp-content/uploads/2020/10/cappelleri-microtumschematic.jpg https://www.oncozine.com/fda-approves-pembrolizumab-in-adult-patients-with-relapsed-or-refractory-classical-hodgkin-lymphoma/ 2020-10-15T19:14:50+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Merck_ASCO_2019_1.jpeg https://www.oncozine.com/wp-content/uploads/2019/07/KEYTRUDA2.jpg https://www.oncozine.com/inhibition-of-hdac-mtor-may-improve-outcomes-in-relapsed-refractory-hodgkin-lymphoma/ 2020-10-16T01:02:23+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/Clinical-Trial-Concept.jpg https://www.oncozine.com/more-education-is-needed-to-increase-provider-geriatric-assessments-for-older-adults-with-cancer/ 2020-10-16T20:14:36+00:00 https://www.oncozine.com/wp-content/uploads/2020/08/Fotolia_104896219_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/08/Lori_J_Pierce.jpg https://www.oncozine.com/wp-content/uploads/2020/10/William-dale-MD-PHD.jpg https://www.oncozine.com/u-s-fda-approves-venetoclax-for-the-treatment-of-acute-myeloid-leukemia/ 2020-10-19T20:03:06+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/AbbVie_ASCO-1JPG.jpeg https://www.oncozine.com/wp-content/uploads/2020/03/venetoclax-venclexta-tablets-500x500-1.jpg https://www.oncozine.com/ctdna-predicts-outcomes-with-checkpoint-inhibition-in-melanoma-in-first-line-not-second-line/ 2020-10-19T20:55:22+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/Fotolia_112737156_Subscription_Monthly_M-1.jpg https://www.oncozine.com/treatment-informed-by-determarx-significantly-improves-lung-cancer-survival/ 2020-10-20T00:38:13+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/A_Lung-Cancer_1.jpg https://www.oncozine.com/wp-content/uploads/2020/10/Dr.-Woodard-Headshot.jpg https://www.oncozine.com/wp-content/uploads/2020/10/Oncocyte-Webinar.png https://www.oncozine.com/cervical-cancer-may-increase-risk-of-injury-during-diagnostic-workup/ 2020-10-22T19:09:15+00:00 https://www.oncozine.com/wp-content/uploads/2017/11/Fotolia_169424365_Cervical-Cancer-e1735612361179.jpg https://www.oncozine.com/wp-content/uploads/2020/10/Shen_Qing_foto-Gunilla-Sonnebring_2009.jpg https://www.oncozine.com/as-new-drugs-lag-accelerated-clinical-trials-lead-charge-in-brain-cancer-fight%ef%bb%bf/ 2020-10-27T21:51:45+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/0036Ivy.NS_.jpg https://www.oncozine.com/wp-content/uploads/2019/01/PRX-Logo-Horizontal-Color-NEW.png https://www.oncozine.com/nih-starts-clinical-trial-with-onc206-a-next-generation-imipridone/ 2020-10-30T19:07:20+00:00 https://www.oncozine.com/wp-content/uploads/2017/12/Fotolia_83157922_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/10/Mark-gilbert-NIH.jpg https://www.oncozine.com/european-commission-approves-niraparib-as-maintenance-treatment-in-advanced-ovarian-cancer/ 2020-10-30T22:47:29+00:00 https://www.oncozine.com/wp-content/uploads/2020/10/gsk_madrid_recce_sept18_phase_140.jpg https://www.oncozine.com/investigator-initiated-study-supports-potential-of-vs-6766-as-treatment-for-ras-mutant-tumors/ 2020-10-30T22:55:00+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_137289643_Subscription_Monthly_M.jpg https://www.oncozine.com/bayer-acquires-asklepios-biopharmaceutical-broadens-innovation-in-cell-and-gene-therapy/ 2020-10-30T23:47:37+00:00 https://www.oncozine.com/wp-content/uploads/2020/10/AskBio-Bioreactor-Bayer-2020-0250.jpg https://www.oncozine.com/fda-approves-foundationone-cdx-as-companion-diagnostic-for-larotrectinib/ 2020-10-31T01:20:18+00:00 https://www.oncozine.com/wp-content/uploads/2020/10/2019-7736-e1604107134749.jpg https://www.oncozine.com/wp-content/uploads/2020/10/FoundationOneCDx_Image-e1604106959178.jpg https://www.oncozine.com/wp-content/uploads/2018/11/Bayer_Vitrakvi_Product_Shot.jpg https://www.oncozine.com/foundationoneliquid-cdx-companion-diagnostic-approved-in-nsclc-advanced-ovarian-and-breast-cancer/ 2020-11-01T15:17:11+00:00 https://www.oncozine.com/wp-content/uploads/2019/02/Fotolia_96842386_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/11/Foundation-Medicine-Liquid-CDx.png https://www.oncozine.com/tobacco-companies-are-finally-moving-closer-to-revealing-the-truth-about-smoking-50-years-after-first-surgeon-general-report/ 2020-11-02T00:46:49+00:00 https://www.oncozine.com/wp-content/uploads/2014/01/Major-tobacco-companies-are-finally-telling-the-truth-about-tobacco.jpg https://www.oncozine.com/wp-content/uploads/2017/06/Onco_oncozine_dossier_ad-light-01.png https://www.oncozine.com/wp-content/uploads/2017/03/382-Chesterfield_Smoking_and_Health_Advertising-233x300.jpg https://www.oncozine.com/new-mechanisms-common-in-aging-may-contribute-to-melanoma-spread-and-resistance-to-treatment/ 2020-11-03T21:24:18+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/melanoma.jpg https://www.oncozine.com/wp-content/uploads/2020/11/Ashwani-Weeraratna-PhD-b24_0.png https://www.oncozine.com/new-melanoma-diagnostic-gene-expression-profile-tests-for-suspicious-pigmented-lesions/ 2020-11-03T23:31:24+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_167331259_Subscription_Monthly_M-1.jpg https://www.oncozine.com/trastuzumab-deruxtecan-granted-priority-review-in-her2-positive-metastatic-gastric-cancer/ 2020-11-04T01:52:16+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/Fotolia_195507244_Subscription_Monthly_M.jpg https://www.oncozine.com/milliporesigma-awards-grant-to-combined-therapeutics-for-novel-therapeutic-platform/ 2020-11-06T17:28:30+00:00 https://www.oncozine.com/wp-content/uploads/2020/11/Advance-Biotech-Grant-Millipore-Sigma-scaled-e1604681093871.jpg https://www.oncozine.com/scientific-advisory-board-of-patient-advocate-organizations-disagree-with-changes-to-mammography-guidelines/ 2020-11-10T05:07:13+00:00 https://www.oncozine.com/tgens-globalcure-targets-pancreatic-cancer/ 2020-11-10T05:08:27+00:00 https://www.oncozine.com/novel-cancer-vaccine-combines-chemo-immunotherapy-to-treat-triple-negative-breast-cancer-in-mice/ 2020-11-10T20:31:11+00:00 https://www.oncozine.com/wp-content/uploads/2020/11/Dendritic-Cell-on-Gelatin-Cryogel-2.jpg https://www.oncozine.com/wp-content/uploads/2020/11/David_Mooney-PhD-PM.png https://www.oncozine.com/wp-content/uploads/2020/11/Biomaterial-Based-Scaffold_Fig2c-1.jpg https://www.oncozine.com/its-a-good-news-bad-news-kind-of-thing/ 2020-11-13T03:22:53+00:00 https://www.oncozine.com/wp-content/uploads/2020/11/Al_Roker_in_May_2015-scaled.jpg https://www.oncozine.com/improving-the-identification-of-therapeutic-vulnerabilities-in-breast-cancer/ 2020-11-19T01:33:06+00:00 https://www.oncozine.com/wp-content/uploads/2020/11/3d-mammography-screening-Baylor.jpg https://www.oncozine.com/wp-content/uploads/2020/11/mjellis.jpeg https://www.oncozine.com/wp-content/uploads/2020/11/DRMani.png https://www.oncozine.com/wp-content/uploads/2020/11/SteveCarr.png https://www.oncozine.com/wp-content/uploads/2020/11/MichaelGillette_1_Broad_Institute.png https://www.oncozine.com/social-needs-linked-to-low-health-related-quality-of-life-among-african-american-cancer-survivors/ 2020-11-23T07:03:47+00:00 https://www.oncozine.com/wp-content/uploads/2016/06/Fotolia_86830610_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/11/hastert_theresa-Wayne-State.jpg https://www.oncozine.com/isofol-confirms-licensing-agreement-with-endo-ventures-paladin-labs-for-arfolitixorin-in-canada/ 2020-11-21T05:55:17+00:00 https://www.oncozine.com/wp-content/uploads/2020/01/AdobeStock_164902722-copy-scaled.jpeg https://www.oncozine.com/new-approach-to-address-the-unmet-medical-need-in-the-early-diagnostics-for-prostate-cancer/ 2020-11-21T16:28:07+00:00 https://www.oncozine.com/wp-content/uploads/2020/11/Verginia-APIS-2-AM.png https://www.oncozine.com/wp-content/uploads/2020/11/SBUR-Annual-Meeting.png https://www.oncozine.com/encouraging-clinical-data-for-controlled-il-12-for-the-treatment-of-glioblastoma-and-dipg/ 2020-11-23T21:03:15+00:00 https://www.oncozine.com/wp-content/uploads/2018/08/Fotolia_177448685_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2019/11/Screen-Shot-2019-11-21-at-9.33.17-PM.png https://www.oncozine.com/wp-content/uploads/2020/11/Controlled_IL-12.png https://www.oncozine.com/ema-recommends-approval-of-tagraxofusp-for-blastic-plasmacytoid-dendritic-cell-neoplasm/ 2020-11-26T19:32:08+00:00 https://www.oncozine.com/wp-content/uploads/2020/08/european-union-4225118_1280Pixabay.jpg https://www.oncozine.com/wp-content/uploads/2020/11/EMA-Logo.jpg https://www.oncozine.com/wp-content/uploads/2020/11/blastic-plasmacytoid-dendritic-cell-neoplasm-article.jpg https://www.oncozine.com/pro-inflammatory-response-may-identify-cancer-patients-at-risk-of-adverse-outcomes-from-covid-19/ 2020-11-26T21:14:04+00:00 https://www.oncozine.com/wp-content/uploads/2020/11/Coronavirus-1024x506px.jpg https://www.oncozine.com/wp-content/uploads/2017/11/ESMO-ASIA.png https://www.oncozine.com/wp-content/uploads/2020/11/biomarkers-of-pro-inflammatory-response-may-identifiy-cancer-patients-at-risk-of-adverse-outcomes-from-sars-cov-2-infection_full_front.jpg https://www.oncozine.com/innovative-risk-assessment-tool-measures-patients-local-immune-response-to-the-cancer/ 2020-11-26T23:38:39+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/ESMO-ASIA-1-2018.jpg https://www.oncozine.com/wp-content/uploads/2017/11/ESMO-ASIA.png https://www.oncozine.com/wp-content/uploads/2020/11/Jerome-Galon-INSERM.png https://www.oncozine.com/wp-content/uploads/2020/11/immunoscore-classification-significantly-associates-with-time-to-recurrance-in-asian-patients-with-early-stage-colon-cancer_full_front.jpg https://www.oncozine.com/study-show-pembrolizumab-to-be-safe-in-treatment-metastatic-castration-resistant-prostate-cancer/ 2020-11-27T01:44:53+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/ESMO-ASIA-2-2018.jpg https://www.oncozine.com/wp-content/uploads/2017/11/ESMO-ASIA.png https://www.oncozine.com/wp-content/uploads/2020/11/Anthony-M-Joshua-NSW-Austrealia.jpg https://www.oncozine.com/wp-content/uploads/2020/11/pembrolizumab-combinations-show-promise-in-mcrpc_full_front.jpg https://www.oncozine.com/pembrolizumab-axitinib-outperforms-sunitinib-in-treatment-of-metastatic-renal-cell-carcinoma/ 2020-11-27T04:01:04+00:00 https://www.oncozine.com/wp-content/uploads/2017/11/38482347191_de7fbd2eee_k.jpg https://www.oncozine.com/wp-content/uploads/2017/11/ESMO-ASIA.png https://www.oncozine.com/wp-content/uploads/2020/11/pembrolizumab-plus-axitinib-outperforms-sunitinib-in-patients-with-metastatic-renal-cell-carcinoma-fig1_full_front.jpg https://www.oncozine.com/wp-content/uploads/2020/11/pembrolizumab-plus-axitinib-outperforms-sunitinib-in-patients-with-metastatic-renal-cell-carcinoma-fig2_full_front.jpg https://www.oncozine.com/europe-validates-application-for-tepotinib-for-advanced-nsclc-with-metex14-skipping-alterations/ 2020-11-27T22:52:37+00:00 https://www.oncozine.com/wp-content/uploads/2020/11/Tepotinib-PR-Image-Lung-Cancer-March-2020-scaled.jpg https://www.oncozine.com/wp-content/uploads/2020/11/EMA-Logo.jpg https://www.oncozine.com/wp-content/uploads/2020/11/2020-Garijo-Belen-highres-scaled.jpg https://www.oncozine.com/u-s-fda-approves-naxitamab-for-the-treatment-of-neuroblastoma/ 2020-11-28T03:59:35+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_250596036_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/11/Nai-King-Cheung-MSK-1200x800-1.jpg https://www.oncozine.com/positive-data-from-phase-i-safety-trial-of-sdx-7320-in-late-stage-solid-tumors/ 2020-11-30T13:44:32+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_84467129.jpg https://www.oncozine.com/artificial-intelligence-may-predict-response-to-immune-checkpoint-blockade-in-metastatic-melanoma/ 2020-11-30T15:09:35+00:00 https://www.oncozine.com/wp-content/uploads/2020/11/Fotolia_1132263_Big_Data-e1606748844640.jpg https://www.oncozine.com/cancer-results-in-more-than-4-million-years-of-life-lost-prematurely/ 2020-11-30T18:14:24+00:00 https://www.oncozine.com/wp-content/uploads/2019/03/NIH_Clinical_Research_Center_aerial.jpg https://www.oncozine.com/mens-health-focus-on-prostate-screening-2/ 2020-12-04T04:05:41+00:00 https://www.oncozine.com/wp-content/uploads/2016/07/Fotolia_78918767_Subscription_Monthly_M.jpg http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/9-psainfographic-1.jpg?width=400 https://www.oncozine.com/coronavirus-prevention-for-cancer-patients-and-their-caregivers/ 2020-12-04T04:16:44+00:00 https://www.oncozine.com/wp-content/uploads/2016/06/Fotolia_86830610_Subscription_Monthly_M.jpg https://www.oncozine.com/how-cold-weather-affects-cancer-patients/ 2020-12-04T04:45:10+00:00 https://www.oncozine.com/wp-content/uploads/2020/12/winter-landscape.jpg https://www.oncozine.com/facing-your-cancer-fears/ 2020-12-04T05:01:56+00:00 https://www.oncozine.com/wp-content/uploads/2020/12/woman-2696408_1280.jpg https://www.oncozine.com/telehealth-101-for-cancer-patients/ 2020-12-04T05:22:41+00:00 https://www.oncozine.com/wp-content/uploads/2020/12/6948764580_465c28b18c_o-scaled.jpg https://www.oncozine.com/healthy-living-tips-for-cancer-patients/ 2020-12-04T05:57:09+00:00 https://www.oncozine.com/wp-content/uploads/2020/12/Girl-Workout-1629726..jpeg https://www.oncozine.com/dexamethasone-decreases-the-efficacy-of-immune-checkpoint-inhibitors-in-patients-with-glioblastoma/ 2020-12-04T22:43:40+00:00 https://www.oncozine.com/wp-content/uploads/2017/07/Glioblastoma_with_extreme_nuclear_enlargement_-_very_high_mag.jpg https://www.oncozine.com/wp-content/uploads/2020/11/david_reardon_MD_Dana-Farber-Cancer-Institute.jpg https://www.oncozine.com/ash-2020-new-clinical-data-demonstrating-impact-of-clonoseq-assay/ 2020-12-06T15:10:21+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_202377709_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/ash-2020-belantamab-mafodotin-standard-therapies-in-treatment-of-multiple-myeloma/ 2020-12-06T05:17:51+00:00 https://www.oncozine.com/wp-content/uploads/2020/12/GSK-Scietists-Conducting-Research-scaled-e1607231236634.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/ash-2020-clinical-trials-generate-new-insights-and-help-inform-evidence-based-decisions-for-care/ 2020-12-07T04:54:09+00:00 https://www.oncozine.com/wp-content/uploads/2017/12/ASH2017.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/asco-2020-how-disparities-and-inequities-affect-health/ 2020-12-07T16:59:20+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/ASH2019_002-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/ash-2020-reaching-a-broader-patient-population-with-cellular-therapies-for-hard-to-treat-cancers/ 2020-12-07T17:32:28+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/ASH2019_001_o-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/wp-content/uploads/2020/12/Caron-jacobson-MD.jpg https://www.oncozine.com/wp-content/uploads/2020/12/robbie-majzner-MDS.jpg https://www.oncozine.com/five-year-update-of-echelon-1-and-echelon-2-and-other-results-with-brentuximab-vedotin/ 2020-12-08T17:06:42+00:00 https://www.oncozine.com/wp-content/uploads/2020/12/ASH-meeting-001.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/wp-content/uploads/2020/12/ECHELON-1.png https://www.oncozine.com/wp-content/uploads/2020/12/Phase-III-Echelon-2-Clinical-trial.png https://www.oncozine.com/ash-2020-inherited-blood-disorders-treated-with-crispr-cas9/ 2020-12-08T17:48:24+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/ASH2019_005-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/ash-2020-preclinical-models-identifies-cd74-as-potential-target-for-the-treatment-of-aml/ 2020-12-09T01:49:22+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/ASH2019_004_o-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/wp-content/uploads/2020/12/Bill-Newell-Sutro-e1607475446970.jpg https://www.oncozine.com/wp-content/uploads/2020/12/soheil-meshinchi-Fred-Hutch.jpg https://www.oncozine.com/reprogramming-myeloid-derived-suppressor-cells-and-tumor-associated-macrophages-to-treat-cancer/ 2020-12-09T19:51:27+00:00 https://www.oncozine.com/wp-content/uploads/2020/12/walther-ratliffLO-2.jpg https://www.oncozine.com/wp-content/uploads/2020/12/low-labLO-2.jpg https://www.oncozine.com/ash-2020-researchers-trace-potential-cancer-origins-to-early-childhood-decades-before-diagnosis/ 2020-12-09T23:39:15+00:00 https://www.oncozine.com/wp-content/uploads/2020/12/19ASH_008-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/wp-content/uploads/2020/12/Jyoti-Nangalia-MD.jpg https://www.oncozine.com/ash-2020-novel-gene-therapy-found-to-be-safe-and-effective-in-treatment-of-hemophilia-b/ 2020-12-10T03:46:43+00:00 https://www.oncozine.com/wp-content/uploads/2008/12/Fotolia_95239759_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/wp-content/uploads/2020/12/Steven-Pipe-2019.jpg https://www.oncozine.com/ash-2020-study-shows-asciminib-to-be-safe-and-effective-for-hard-to-treat-chronic-myeloid-leukemia/ 2020-12-10T06:03:41+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/19ASH_TB_01041-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/wp-content/uploads/2020/12/Prof-Dr.-Andreas_hochhaus-image-by-Anna-Schroll-UK.jpg https://www.oncozine.com/sabcs-2020-abemaciclib-continues-to-benefit-patients-with-high-risk-hr-her2-early-stage-bc/ 2020-12-11T02:54:52+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/19SABCS_TB_Overview-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo-300x212.jpg https://www.oncozine.com/wp-content/uploads/2020/12/Rastogi-priya-UPMC.jpg https://www.oncozine.com/first-in-human-study-to-determine-effectiveness-of-novel-non-invasive-therapy-for-brain-cancer/ 2020-12-12T02:15:12+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/0154-2.jpg https://www.oncozine.com/wp-content/uploads/2019/11/Screen-Shot-2019-11-21-at-9.33.17-PM.png https://www.oncozine.com/first-in-class-noninvasive-therapy-for-glioblastoma-enters-phase-0-trial-at-ivy-brain-tumor-center/ 2020-12-14T16:01:22+00:00 https://www.oncozine.com/wp-content/uploads/2020/12/SonALAsense-Brain-Image-e1607743260444.png https://www.oncozine.com/wp-content/uploads/2020/12/Stuart-Marcus-MD-PhD-SonALAsense-Founder-CEO-CMO-Photo-e1607742047260.jpg https://www.oncozine.com/ash-2020-multi-cytokine-inhibitor-shows-positive-results-in-refractory-cutaneous-t-cell-lymphoma/ 2020-12-15T01:18:54+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/ASH-2018-General-1.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/wp-content/uploads/2020/12/Bioniz-Technology_MOA-image.jpg https://www.oncozine.com/wp-content/uploads/2020/12/Christiane-Querfeld-M.D.-Ph.D-e1607708401423.jpg https://www.oncozine.com/wp-content/uploads/2020/12/Nazil_Azimi-Bioniz.jpg https://www.oncozine.com/study-confirms-safety-of-head-and-neck-cancer-surgery-during-the-covid-19-pandemic/ 2020-12-24T17:58:21+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/Fotolia_114181222_Subscription_Monthly_M.jpg https://www.oncozine.com/analysis-shows-incidence-of-advanced-stage-esophageal-adenocarcinoma-increasing-in-younger-adults/ 2020-12-24T18:44:08+00:00 https://www.oncozine.com/wp-content/uploads/2017/10/Fotolia_86770989_Subscription_Monthly_M-e1507955178861.jpg https://www.oncozine.com/wp-content/uploads/2020/12/Codipilly_Don_145x145.jpg https://www.oncozine.com/phase-i-study-shows-positive-interim-results-of-trph-222-in-patients-with-r-r-non-hodgkin-lymphoma/ 2020-12-24T22:51:52+00:00 https://www.oncozine.com/wp-content/uploads/2020/12/ASH-2018-General-Views-19-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/wp-content/uploads/2020/12/TRPH-222-AE-Phase-I-study-ASH-2020.png https://www.oncozine.com/patient-advocates-emphasize-that-they-want-every-cancer-patient-to-be-treated-as-an-individual/ 2020-12-25T06:21:00+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_205060840_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2020/12/Chris_Van_Hollen_official_portrait_115th_Congress.jpg https://www.oncozine.com/wp-content/uploads/2020/12/Buddy_Carter_Official_Portrait_114th_Congress-scaled.jpg https://www.oncozine.com/scalp-cooling-in-esmos-clinical-practice-guidelines-to-help-prevent-chemotherapy-induced-alopecia/ 2020-12-26T05:22:34+00:00 https://www.oncozine.com/wp-content/uploads/2020/12/Patient-scalp-cooling-with-Paxman-System-scaled.jpg https://www.oncozine.com/sabcs-2020-circulating-tumor-cell-may-predict-treatment-response-and-prognosis-in-mbc/ 2020-12-26T05:23:52+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/18SABCS-001.jpg https://www.oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo.jpg https://www.oncozine.com/wp-content/uploads/2020/12/Prof.-Dr.-Wolfgang-Janni.jpg https://www.oncozine.com/sabcs-2020-improved-outcomes-with-neratinib-based-regimens-in-cns-metastases-from-her2-bc/ 2020-12-26T05:24:59+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/18SABCS_SM_32.jpg https://www.oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo.jpg https://www.oncozine.com/wp-content/uploads/2020/12/Cristina-Saura-Manich-VHIO-Barcelona.jpg https://www.oncozine.com/sabcs-2020-plinabulin-standard-of-care-reduces-profound-neutropenia-breast-cancer-treatment/ 2020-12-26T05:25:54+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/18SABCS_00261.jpg https://www.oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo.jpg https://www.oncozine.com/wp-content/uploads/2020/12/Poster-SABCS-2020-BeyondSpring.png https://www.oncozine.com/sabcs-2020-physicians-significantly-under-recognize-common-symptoms-among-younger-black-patients/ 2020-12-26T05:27:08+00:00 https://www.oncozine.com/wp-content/uploads/2020/12/SABCS_TB_04201-2019-scaled-e1608940679522.jpg https://www.oncozine.com/wp-content/uploads/2017/03/859-sabcslogo_2012.gif https://www.oncozine.com/wp-content/uploads/2020/12/Reshma-Jagsi-MD-DPhil-Oncology-Radiation-Michigan-Medicine.jpg https://www.oncozine.com/what-to-expect-at-sabcs-2020-updated-data-for-tucatinib/ 2020-12-26T05:29:13+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/18SABCS_TB_a.jpg https://www.oncozine.com/wp-content/uploads/2017/03/859-sabcslogo_2012.gif https://www.oncozine.com/sabcs-2020-persistent-drug-use-following-mastectomy-and-reconstructive-surgery/ 2020-12-29T03:31:58+00:00 https://www.oncozine.com/wp-content/uploads/2020/08/Fotolia_111153659_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo.jpg https://www.oncozine.com/wp-content/uploads/2020/12/Jacob-Cogan-MD-Columbia-University.png https://www.oncozine.com/theranostics-technology-a-new-approach-to-cancer-diagnosis-and-treatment/ 2020-12-30T00:59:03+00:00 https://www.oncozine.com/wp-content/uploads/2020/12/Theranostics-005.png https://www.oncozine.com/analysis-shows-healthy-diets-associated-lower-cancer-risk/ 2021-01-05T19:09:48+00:00 https://www.oncozine.com/wp-content/uploads/2018/08/Fotolia_111774771_Subscription_Monthly_M.jpg https://www.oncozine.com/how-artificial-intelligence-helps-oncologists-see-and-act-on-invisible-socioeconomic-risk-factors/ 2021-01-30T16:26:45+00:00 https://www.oncozine.com/wp-content/uploads/2021/01/CAH85_06_01_383-1-scaled.jpg https://www.oncozine.com/wp-content/uploads/2021/01/CAH01_120415_0974-edit-1-1-scaled.jpg https://www.oncozine.com/changing-the-conversation/ 2021-02-02T20:16:28+00:00 https://www.oncozine.com/wp-content/uploads/2021/02/Upper_limb_lymphedema-e1612295728106.jpg https://www.oncozine.com/sotorasib-received-breakthrough-therapy-in-china/ 2021-02-03T01:09:27+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/A_Lung-Cancer_1.jpg https://www.oncozine.com/new-test-may-help-doctors-better-and-more-accurately-diagnose-childhood-cancers/ 2021-02-08T17:09:18+00:00 https://www.oncozine.com/wp-content/uploads/2021/02/AdobeStock_267016701-v2-scaled-e1612804048911.jpeg https://www.oncozine.com/wp-content/uploads/2019/09/jillworkhighrescropheadshot.jpg.jpeg https://www.oncozine.com/an-evolution-to-genomic-testing-for-dcis/ 2021-02-08T20:02:28+00:00 https://www.oncozine.com/wp-content/uploads/2017/09/Fotolia_124257261_Breast-cancer.jpg https://www.oncozine.com/wp-content/uploads/2021/02/PreludeDX001.png https://www.oncozine.com/improving-lung-cancer-patient-access-to-comprehensive-biomarker-testing/ 2021-02-21T22:19:21+00:00 https://www.oncozine.com/wp-content/uploads/2016/06/Fotolia_77551782_Subscription_Monthly_M.jpg https://www.oncozine.com/study-shows-investment-is-desperately-needed-to-bring-down-pancreatic-cancer-death-rates-in-europe/ 2021-02-23T02:12:25+00:00 https://www.oncozine.com/wp-content/uploads/2020/02/Pancreatic_Cancer.jpg https://www.oncozine.com/the-history-reality-and-promise-of-immunotherapy-for-cancer/ 2021-02-26T02:18:31+00:00 https://www.oncozine.com/wp-content/uploads/2020/08/Fotolia_104896219_Subscription_Monthly_M.jpg https://www.oncozine.com/remembering-emil-jay-freireich-the-man-who-made-vince-devita-a-believer/ 2021-02-26T02:28:06+00:00 https://www.oncozine.com/wp-content/uploads/2021/02/Emil-Freireich-MD-Anderson-e1613239589441.jpg https://www.oncozine.com/wp-content/uploads/2021/02/VincentDeVitaProfile.jpg https://www.oncozine.com/european-medicines-agency-adopts-positive-opinion-for-dostarlimab-in-advanced-endometrial-cancer/ 2021-02-27T01:23:53+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_125743946_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/02/Axel-Hoos.jpg https://www.oncozine.com/understanding-how-hibernating-cancer-evade-chemotherapy-aids-development-of-more-effective-drugs/ 2021-03-14T20:55:31+00:00 https://www.oncozine.com/wp-content/uploads/2021/03/shutterstock_574965784_sm_used-w-permission.jpg https://www.oncozine.com/wp-content/uploads/2021/03/Ari-M.-Melnick-By-Patricia-Kuharic-Permission-Weil-Cornell-Medicine.jpg https://www.oncozine.com/study-shows-mechanism-of-tumor-growth-and-metastasis-in-breast-cancer/ 2021-03-15T02:23:02+00:00 https://www.oncozine.com/wp-content/uploads/2021/03/Metastasis-Ford-University-of-Colorado-Cancer-Center-e1615774652602.png https://www.oncozine.com/wp-content/uploads/2021/03/Heide-Ford-PhD-University-of-Colorado.jpg https://www.oncozine.com/targeted-prostate-cancer-screen-may-prevent-one-in-six-deaths/ 2021-03-15T02:51:29+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_111509573_Subscription_Monthly_M.jpg https://www.oncozine.com/more-cancer-deaths-due-to-covid-19-related-delayed-cancer-screening-and-reduction-in-treatments-m/ 2021-03-16T00:14:57+00:00 https://www.oncozine.com/wp-content/uploads/2021/03/cancer-screening_Covid-University-of-Colorado.png https://www.oncozine.com/wp-content/uploads/2021/03/Jennifer-Diamond-jpg.jpeg https://www.oncozine.com/wp-content/uploads/2021/03/Cathy.Bradley.Headshot.jpg https://www.oncozine.com/revealing-the-blind-spot-in-cancer-treatment-with-host-response-profiling/ 2021-03-23T02:19:19+00:00 https://www.oncozine.com/wp-content/uploads/2021/03/shutterstock_OncoHost_297595064-scaled.jpg https://www.oncozine.com/how-meaningful-will-changes-be-to-ethical-guidelines-following-jose-baselgas-fall/ 2021-03-23T15:27:36+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/2018ASCO_Jose-Baselga.jpg https://www.oncozine.com/daiichi-sankyo-accelerates-biologics-license-application-for-trastuzumab-deruxtecan/ 2021-03-23T23:22:53+00:00 https://www.oncozine.com/wp-content/uploads/2019/03/DSC_6355.jpg https://www.oncozine.com/wp-content/uploads/2019/01/PRX-Logo-Horizontal-Color-NEW.png https://www.oncozine.com/jose-baselga-a-leading-cancer-researcher-dies-at-61/ 2021-03-24T01:24:44+00:00 https://www.oncozine.com/wp-content/uploads/2021/03/Jose_Baselga-e1616537602477.jpg https://www.oncozine.com/wp-content/uploads/2021/03/BASELGA-scaled.jpg https://www.oncozine.com/combination-of-slc-391-pembrolizumab-enters-clinical-trial-advanced-nsclc/ 2021-03-31T20:54:53+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Merck_ASCO_2019_1.jpeg https://www.oncozine.com/are-cytology-and-imaging-adequate-for-the-diagnostic-management-of-brain-metastasis/ 2021-04-02T00:16:08+00:00 https://www.oncozine.com/wp-content/uploads/2021/04/Brain_M.jpg.png https://www.oncozine.com/a-spaceship-on-mars-and-screening-for-gynecologic-cancer/ 2021-04-06T23:45:10+00:00 https://www.oncozine.com/wp-content/uploads/2018/03/Fotolia_166189806_Subscription_Monthly_M-2.jpg https://www.oncozine.com/wp-content/uploads/2021/04/Its-Time-You-Knew_3D-1.png https://www.oncozine.com/amunbio-and-northshore-university-to-advance-cancer-immunotherapy-with-engineered-oncolytic-viruses/ 2021-04-15T02:21:20+00:00 https://www.oncozine.com/wp-content/uploads/2021/04/amunbio41415353_l-scaled-e1618325575362.jpg https://www.oncozine.com/rare-pathogenic-germline-variants-linked-to-worse-survival-outcomes-in-neuroblastoma/ 2021-04-17T03:01:04+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_250596036_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/tebentafusp-significantly-improves-overall-survival-in-patients-with-metastatic-uveal-melanoma/ 2021-04-17T22:04:22+00:00 https://www.oncozine.com/wp-content/uploads/2021/04/Blue_Green_Eye-edit-e1618696538356.png https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2021/04/Tebentafusp-IMCgp100.png https://www.oncozine.com/wp-content/uploads/2021/04/Jessica-Hassel-MD-Heidelberg-PM.png https://www.oncozine.com/improving-accuracy-in-predicting-response-to-neoadjuvant-treatment-in-patients-with-breast-cancer/ 2021-04-18T20:23:20+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_202377709_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/chronos-3-trial-combination-of-copanlisib-rituximab-reduces-risk-of-disease-progression-in-nhl/ 2021-04-19T00:02:51+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/AACR2016_4.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2021/04/matasar-main-1200x800-1-e1618778483104.jpg https://www.oncozine.com/wp-content/uploads/2021/04/CHRONOS-3-PM.png https://www.oncozine.com/first-patient-dosed-in-phase-iii-trial-evaluating-avb-500-in-platinum-resistant-ovarian-cancer/ 2021-04-28T01:54:32+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/Fotolia_237743640_Subscription_Monthly_M-e1600399749408.jpg https://www.oncozine.com/among-medically-under-served-alaska-native-people-cologuard-crc-screening-is-most-cost-effective/ 2021-04-29T01:31:06+00:00 https://www.oncozine.com/wp-content/uploads/2021/04/BadgerLab-75-scaled.jpg https://www.oncozine.com/wp-content/uploads/2021/04/Diana-Redwood.jpeg https://www.oncozine.com/lacutamab-trial-advances-in-clinical-development-program/ 2021-04-29T02:47:56+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/Clinical-Trial-Concept.jpg https://www.oncozine.com/study-finds-link-between-consuming-sugary-drinks-and-an-increased-risk-of-colorectal-cancer/ 2021-05-06T23:31:31+00:00 https://www.oncozine.com/wp-content/uploads/2021/05/IMG_9524-scaled.jpg https://www.oncozine.com/wp-content/uploads/2021/05/Yin-Cao_Wash-U_headshot-350x389-1-250x345-1.jpg https://www.oncozine.com/personalized-cancer-dna-vaccines-target-unique-cancer-mutations/ 2021-05-05T02:57:03+00:00 https://www.oncozine.com/wp-content/uploads/2021/05/WUST_CancerVaccine_Article-Image.jpg https://www.oncozine.com/removing-barrier-340b-hospitals-offer-more-pharmacy-medication-access-services/ 2021-05-05T23:20:51+00:00 https://www.oncozine.com/wp-content/uploads/2021/05/Pharmacy-Museum-001.jpg https://www.oncozine.com/wp-content/uploads/2021/05/Sandra-F-Durley.jpg https://www.oncozine.com/study-shows-combining-bmi-with-body-shape-may-be-a-better-predictor-of-cancer-risk/ 2021-05-10T14:24:06+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_180537644_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/05/EASO.png https://www.oncozine.com/inflammasomes-linked-to-obesity-related-colorectal-cancer/ 2021-05-10T14:27:58+00:00 https://www.oncozine.com/wp-content/uploads/2021/05/Fanily-at-hone-3-AM.png https://www.oncozine.com/wp-content/uploads/2021/05/EASO.png https://www.oncozine.com/an-essential-protein-may-lead-to-a-new-treatment-option-for-breast-cancer/ 2021-05-10T14:50:31+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_193186103_Subscription_Monthly_M.jpg https://www.oncozine.com/potential-withdrawal-of-accelerated-approved-therapeutic-agents-may-harm-cancer-patients/ 2021-05-11T20:53:49+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/FDA-Building-and-Sign.jpg https://www.oncozine.com/danish-study-higher-body-mass-index-during-childhood-may-result-in-lower-risk-of-breast-cancer/ 2021-05-11T22:42:24+00:00 https://www.oncozine.com/wp-content/uploads/2021/05/Girl-2018-2021.png https://www.oncozine.com/wp-content/uploads/2021/05/EASO.png https://www.oncozine.com/wp-content/uploads/2021/05/Dorthe-Corfitzen-Pedersen.jpg https://www.oncozine.com/wp-content/uploads/2021/05/Highr-BMI-Childhod-1.png https://www.oncozine.com/study-high-bmi-body-fat-and-large-waist-and-hips-pose-similar-risk-in-development-of-cancer/ 2021-05-11T23:20:18+00:00 https://www.oncozine.com/wp-content/uploads/2019/02/Fotolia_9415959_Subscription_Diet.jpg https://www.oncozine.com/wp-content/uploads/2021/05/EASO.png https://www.oncozine.com/wp-content/uploads/2021/05/Cancer-and-Obesity-poster.png https://www.oncozine.com/controlling-the-cellular-outposts-of-the-immune-system/ 2021-05-12T18:35:33+00:00 https://www.oncozine.com/wp-content/uploads/2021/05/blobid1_1620822197554.jpg https://www.oncozine.com/loncastuximab-tesirine-offers-a-therapeutic-option-for-heavily-pretreated-patients-with-r-r-dlbcl/ 2021-05-18T21:51:03+00:00 https://www.oncozine.com/wp-content/uploads/2009/07/Fotolia_84467586.jpg https://www.oncozine.com/how-to-humanize-healthcare-a-bold-new-vision-that-puts-people-first/ 2021-05-19T17:11:48+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_137289643_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/05/Humanizing-Healthcare-9.30.38-AM.png https://www.oncozine.com/noninvasive-nasal-swab-test-can-significantly-improve-early-lung-cancer-detection/ 2021-05-20T00:00:20+00:00 https://www.oncozine.com/wp-content/uploads/2021/05/SAB_7242adj3-Veracyte-scaled.jpg https://www.oncozine.com/safety-and-efficacy-of-crofelemer-in-preventing-diarrhea-in-patients-receiving-targeted-therapies/ 2021-05-20T21:06:11+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_234893442_Subscription_Monthly_M.jpg https://www.oncozine.com/non-invasive-screening-innovative-technology-may-halt-progression-of-liver-disease-to-liver-cancer/ 2021-05-21T01:24:00+00:00 https://www.oncozine.com/wp-content/uploads/2016/06/Fotolia_86830610_Subscription_Monthly_M.jpg https://www.oncozine.com/world-kidney-cancer-day-2021-we-need-to-talk-about-how-were-feeling/ 2021-05-22T00:54:29+00:00 https://www.oncozine.com/wp-content/uploads/2018/02/Fotolia_88982501_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/05/WKCD-image.png https://www.oncozine.com/wp-content/uploads/2021/05/william-kaelin-interview-bcrf-courtesy-dana-farber.jpg https://www.oncozine.com/humanizing-healthcare-a-conversation-with-summer-knight-md-mba/ 2021-05-28T23:00:09+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_205060840_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/05/Humanizing-Healthcare-9.30.38-AM.png https://www.oncozine.com/lymphedema-a-constant-reminder-a-patients-cancer-journey/ 2021-06-03T18:55:23+00:00 https://www.oncozine.com/wp-content/uploads/2021/02/Upper_limb_lymphedema-e1612295728106.jpg https://www.oncozine.com/wp-content/uploads/2021/06/Jessie-Z-Yu-MD-Baylor.jpeg https://www.oncozine.com/study-no-fda-approved-targeted-therapy-likely-to-benefit-lung-squamous-cell-carcinoma-patients/ 2021-06-04T22:19:23+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/A_Lung-Cancer_1.jpg https://www.oncozine.com/sns-301-pembrolizumab-well-tolerated-as-treatment-of-squamous-cell-carcinoma-of-the-head-and-neck/ 2021-06-05T16:27:06+00:00 https://www.oncozine.com/wp-content/uploads/2021/05/1280px-Oral_cancer_1_squamous_cell_carcinoma_histopathology.jpg https://www.oncozine.com/immunotherapy-resistance-in-leiomyosarcoma-subtypes-may-benefit-from-personalized-treatments/ 2021-06-05T22:51:36+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/19ASCO_LF_0602_0221.jpg https://www.oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/wp-content/uploads/2021/06/ROMAN-G-MD-AT-RUTGERS-.jpg https://www.oncozine.com/palliative-care-may-improve-outcomes-and-quality-of-life-for-patients-with-cancer/ 2021-06-05T23:33:31+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_205060840_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/06/Motolani-Ogunsanya-Ph.D..jpg https://www.oncozine.com/community-cancer-centers-aim-to-diversify-cancer-research/ 2021-06-06T01:02:40+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/Fotolia_140491283_Subscription_Monthly_M-e1677010389386.jpg https://www.oncozine.com/wp-content/uploads/2021/06/ACCC-logo.png https://www.oncozine.com/wp-content/uploads/2021/06/oyer-md.jpg https://www.oncozine.com/comprehensive-genomic-and-transcriptomic-profiling-predicts-pan-tumor-benefit-of-pembrolizumab/ 2021-06-06T08:41:10+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/19ASCO_KN_0071.jpg https://www.oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/new-saliva-test-detects-head-and-neck-cancer-shows-promissing-results/ 2021-06-06T18:49:34+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_202377709_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/wp-content/uploads/2021/06/NA2.jpg https://www.oncozine.com/cancer-patients-concerned-about-vaccine-despite-few-adverse-effects/ 2021-06-06T21:01:21+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/COVID-19-web-banner-e1623012663834.jpg https://www.oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/wp-content/uploads/2021/06/Cancer-Represented-Study-001.png https://www.oncozine.com/a-study-of-the-4-1bb-agonist-ator-1017-shows-positive-results/ 2021-06-06T23:22:39+00:00 https://www.oncozine.com/wp-content/uploads/2016/06/Fotolia_63809087_Subscription_Monthly_M-e1490965290993.jpg https://www.oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/wp-content/uploads/2021/06/ATOR-1017-MoA-Alligator-bioscience.png https://www.oncozine.com/toripalimab-standard-of-care-delays-disease-progression-in-advanced-nasopharyngeal-carcinoma/ 2021-06-07T22:14:03+00:00 https://www.oncozine.com/wp-content/uploads/2016/06/Fotolia_86830610_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/single-and-dual-immunotherapy-regimens-may-offer-improved-overall-survival-in-esophageal-cancer/ 2021-06-08T06:26:29+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/ASCO-2017-00345-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/immunotherapy-after-surgery-extends-disease-free-survival-for-select-patients-with-kidney-cancer/ 2021-06-08T07:27:47+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Merck-_-ASCO-2019-2_JPG.jpeg https://www.oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/advancing-treatment-options-with-immunotherapies-in-non-hodgkins-lymphoma/ 2021-06-09T00:06:16+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/Genentech-2-2015-ASCO-4.50.44-PM.png https://www.oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/study-with-vic-trastuzumab-duocarmazine-meets-primary-endpoint/ 2021-06-09T00:32:43+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/sarah-cervantes-BOBMNKVry0Q-unsplash-scaled.jpg https://www.oncozine.com/glioblastoma-trial-with-personalized-cancer-vaccine-shows-improved-progression-free-survival/ 2021-06-09T20:45:02+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/Glioblastoma.png https://www.oncozine.com/wp-content/uploads/2021/06/bota_A_daniela_MD-1.jpg https://www.oncozine.com/studies-confirm-safety-and-effectiveness-of-covid-19-vaccination-in-people-with-cancer/ 2021-06-10T21:33:08+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/COVID-19-web-banner-e1623012663834.jpg https://www.oncozine.com/study-shows-inadequate-screening-for-older-women-may-contribute-to-high-cancer-rates-and-mortality/ 2021-06-11T00:37:09+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_125743946_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/06/Rebecca-Perkins-53.png https://www.oncozine.com/combination-therapy-achieved-durable-remission-for-patients-with-cll/ 2021-06-11T21:01:45+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_235928524_Subscription_Monthly_M.jpg https://www.oncozine.com/researchers-find-possible-link-between-prostate-cancer-and-schizophrenia/ 2021-06-11T21:32:14+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/photo-1618590067824-5ba32ca76ce9.jpeg https://www.oncozine.com/study-sheds-light-on-treatment-options-for-medulloblastoma/ 2021-06-11T22:10:47+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/CT_brain_scan_of_child_with_medulloblastoma_and_resulting_hydrocephalus-scaled.jpg https://www.oncozine.com/wp-content/uploads/2021/06/Medulloblastoma-001.jpg https://www.oncozine.com/wp-content/uploads/2021/06/Jeff-M.-Michalski-MD-MBA-FASTRO-280x386-1.jpg https://www.oncozine.com/confirming-the-link-between-prostate-cancer-and-obesity/ 2021-06-11T22:38:57+00:00 https://www.oncozine.com/wp-content/uploads/2018/09/Fotolia_88682252_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/06/INRS-Professor-Marie-E%CC%81lise-Parent-INRS.jpg https://www.oncozine.com/study-shows-a-new-link-between-high-fat-diets-and-colorectal-cancer/ 2021-06-12T21:16:48+00:00 https://www.oncozine.com/wp-content/uploads/2020/01/AdobeStock_164902722-copy-scaled.jpeg https://www.oncozine.com/wp-content/uploads/2021/06/Miyeko-Mana-ASU.png https://www.oncozine.com/substantial-survival-improvement-with-axicabtagene-ciloleucel-in-r-r-follicular-lymphoma/ 2021-06-13T21:20:09+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/IMG_0290-scaled-e1623618786911.jpg https://www.oncozine.com/vitamin-d-deficiency-may-increase-risk-for-addiction-to-opioids-and-sun-seeking-behavior/ 2021-06-13T22:08:35+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/mathilde-langevin-8nPbfQLMg1A-unsplash-scaled-e1623621942393.jpg https://www.oncozine.com/selective-il-2-partial-agonist-stk-012-promotes-anti-tumor-response-without-related-toxicities/ 2021-06-13T23:35:31+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/19AACR_TB_009612.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2021/06/STK-012-AACR-PM-e1623627210193.png https://www.oncozine.com/orthogonal-il-2-ligand-drives-deeper-and-more-durable-response-of-cd-19-car-t/ 2021-06-14T00:08:43+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/19AACR_TB_Pano1.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/novel-targeted-treatment-for-patients-with-kras-g12c-mutated-lung-cancer/ 2021-06-15T04:49:31+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/ASCO17_SM_0073.jpg https://www.oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/wp-content/uploads/2021/06/QIAGEN-therascreen%C2%AE-KRAS-RGQ-PCR.jpeg https://www.oncozine.com/wp-content/uploads/2021/06/Ramaswamy-Govindan-MD.jpg https://www.oncozine.com/wp-content/uploads/2021/06/LungTumor_before-after_sized.jpg https://www.oncozine.com/postponing-lung-cancer-surgery-more-than-12-weeks-after-diagnosis-associated-recurrence-and-death/ 2021-06-15T06:27:08+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_82833114_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/06/Varun-Puri-MD-MSCI-Siteman-Cancer-Center.jpg https://www.oncozine.com/improved-os-with-bemarituzumab-chemotherapy-in-fgfr2b-gastric-and-gastroesophageal-cancers/ 2021-06-15T07:20:06+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/19ASCO_MSG_SAT_0010.jpg https://www.oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/red-meat-consumption-linked-to-dna-damage-associated-mutations-in-colorectal-canccer/ 2021-06-17T10:10:57+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/rene-lehmkuhl-qt5vUn3KQOM-unsplash-2-e1623789407822.jpg https://www.oncozine.com/wp-content/uploads/2021/06/Marios-Giannakis-MD-PhD.jpg https://www.oncozine.com/disitamab-vedotin-conditionally-approved-by-chinese-regulator-for-treatment-of-gastric-cancer/ 2021-06-16T00:59:26+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/RC48-vial-BIG-1920x1079-1.jpg https://www.oncozine.com/wp-content/uploads/2021/06/dr-jianmin-fang-profile.jpg https://www.oncozine.com/new-pathway-may-enable-targeted-brain-tumor-therapy-beyond-blood-brain-barrier/ 2021-06-16T23:12:58+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/brain001patrys.jpg https://www.oncozine.com/scientists-find-mechanism-that-helps-the-cell-survive-the-damage-caused-by-chemotherapy/ 2021-06-16T23:49:31+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/Binding-of-PrimPol-to-ICL-lesions-in-DNA.jpg https://www.oncozine.com/wp-content/uploads/2021/06/Binding-of-PrimPol-to-ICL-lesions-in-DNA.jpg https://www.oncozine.com/wp-content/uploads/2021/06/CINO-Researchers.jpg https://www.oncozine.com/cancer-cells-grown-in-a-dish-have-little-in-common-with-cancer-cells-in-people/ 2021-06-18T13:42:30+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/Scientist-with-a-Petri-dish-Unisplash-scaled-e1624016533405.jpg https://www.oncozine.com/validated-technology-may-offer-real-possibilities-to-improve-care-for-glioblastoma-patients/ 2021-06-19T03:27:37+00:00 https://www.oncozine.com/wp-content/uploads/2017/12/Fotolia_83157922_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2018/08/John_McCain_-_Guard_Association_of_the_United_States_General_Conference.jpg https://www.oncozine.com/wp-content/uploads/2021/06/Matthew-Gevaert-Ph.D.-Chief-Executive-Officer.jpg https://www.oncozine.com/bet-inhibitors-may-help-overcome-a-newly-recognized-form-of-resistance-to-prostate-cancer-drugs/ 2021-06-21T01:15:18+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/Neuroendocrine-prostate-cancer-cells..jpg https://www.oncozine.com/a-potential-intervention-makes-treatment-resistant-cancers-responsive-to-immunotherapies/ 2021-06-21T19:23:46+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/massachusetts-general-hospital-research-center.jpg https://www.oncozine.com/wp-content/uploads/2021/06/Shadmehr-Shawn-Demehri-Mass-General.jpg https://www.oncozine.com/significant-survival-benefit-for-head-neck-cancer-patients-receiving-neoadjuvant-immunotherpy/ 2021-06-28T21:27:08+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_131471922_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/06/Geerts-R.-Kersten-CEO-Cel-Sci.png https://www.oncozine.com/destiny-breast9-doses-first-patient/ 2021-06-30T20:43:50+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/Fotolia_87499980_Subscription_Monthly_M.jpg https://www.oncozine.com/valemetostat-promises-durable-tumor-response-in-peripheral-t-cell-lymphoma-and-t-cell-leukemia/ 2021-06-30T22:53:34+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/EHA_2019_1_n.jpg https://www.oncozine.com/wp-content/uploads/2017/03/56-ehalogo.gif https://www.oncozine.com/wp-content/uploads/2021/06/DS-Val-2.31.56.png https://www.oncozine.com/study-shows-that-multiple-myeloma-patients-had-a-widely-variable-response-to-covid-19-vaccines/ 2021-06-30T23:44:04+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/COVID-19-web-banner-e1623012663834.jpg https://www.oncozine.com/breast-cancer-response-to-tumor-stiffness-may-predict-bone-metastasis/ 2021-07-02T06:40:39+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/Fotolia_225653074_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/07/gus_mouneimne_Arizona-scaled.jpg https://www.oncozine.com/wp-content/uploads/2021/07/Casey_romanoski_UoA.jpg https://www.oncozine.com/first-ever-language-guide-a-lexicon-to-promote-best-practices-for-submitted-abstracts/ 2021-07-02T19:28:32+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/A_Lung-Cancer_1.jpg https://www.oncozine.com/wp-content/uploads/2021/07/Language-Guide-FINAL-May-2021_Page_1.jpg https://www.oncozine.com/machine-learning-may-help-predict-when-immunotherapy-is-effective/ 2021-07-02T21:19:08+00:00 https://www.oncozine.com/wp-content/uploads/2021/07/mathew-schwartz-iGheu30xAi8-unsplash-scaled.jpg https://www.oncozine.com/wp-content/uploads/2021/07/Federica-Eduati-TU-Eindhoven-Assistant-Professor.jpg https://www.oncozine.com/wp-content/uploads/2021/07/Lapuente_Santana_Oscar_PhD.jpg https://www.oncozine.com/wp-content/uploads/2021/07/Maisa-van-Gelderen-PhD-Candidate-at-Amsterdam-UMC.jpg https://www.oncozine.com/wp-content/uploads/2021/07/Francesca-Finotello-PhD-a-PostDoc-at-the-Biocenter-Division-of-Bioinformatics-of-the-University-of-Innsbruck-Austria.-.jpg https://www.oncozine.com/wp-content/uploads/2021/07/Peter-Hilbers-Phd-Eindhoven.jpg https://www.oncozine.com/new-treatment-options-for-patients-diagniosed-with-the-deadliest-forms-of-cancer/ 2021-07-03T01:37:51+00:00 https://www.oncozine.com/wp-content/uploads/2021/07/University-of-Leeds_2.jpg https://www.oncozine.com/wp-content/uploads/2021/07/Darren-Tomlinson-PhD-Leeds-Welcom-Trust.jpg https://www.oncozine.com/postmenopausal-bleeding-may-be-a-sign-of-increased-risk-of-endometrial-cancer-in-obese-asian-women/ 2021-07-03T02:02:34+00:00 https://www.oncozine.com/wp-content/uploads/2019/02/Fotolia_9415959_Subscription_Diet.jpg https://www.oncozine.com/study-shows-94-of-cancer-patients-respond-well-to-covid-19-vaccines/ 2021-07-04T01:40:15+00:00 https://www.oncozine.com/wp-content/uploads/2018/09/Fotolia_217339058_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/07/1200px-moderna.jpg https://www.oncozine.com/study-suggests-common-denominators-link-all-cancers/ 2021-07-18T01:16:06+00:00 https://www.oncozine.com/wp-content/uploads/2021/07/Rod-Bremner-abd-Joel-Pearon-e1626570552464.jpg https://www.oncozine.com/patients-with-relapsed-refractory-aml-may-benefit-from-treatment-with-ficlatuzumab-chemotherapy/ 2021-07-18T21:58:36+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_200359299_Subscription_Monthly_M-e1626644890152.jpg https://www.oncozine.com/in-states-that-expanded-medicaid-cancer-mortality-rates-declined-more-steeply/ 2021-07-21T23:28:18+00:00 https://www.oncozine.com/wp-content/uploads/2018/02/Fotolia_78447100_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/07/Duke-Nosayaba-Nosa-Osazuwa-Peters.jpg https://www.oncozine.com/the-national-cancer-act-at-50-the-greatest-scientific-discovery-effort-in-history/ 2021-07-22T04:54:06+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/president-nixon-signs-the-1971-national-cancer-act-embed.jpg https://www.oncozine.com/wp-content/uploads/2021/07/Centers-of-thr-Cancer-Universe_Cover_.jpg https://www.oncozine.com/breakthrough-therapy-designation-for-venetoclax-azacitidine-in-myelodysplastic-syndromes/ 2021-07-22T07:36:20+00:00 https://www.oncozine.com/wp-content/uploads/2020/02/fda2020.jpg https://www.oncozine.com/regular-blood-monitoring-and-a-tailored-treatment-approach-in-mycosis-fungoides-and-sezary-syndrome/ 2021-07-22T23:07:24+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/Clinical-Trial-Concept.jpg https://www.oncozine.com/dostarlimab-approved-for-treatment-of-mismatch-repair-deficient-recurrent-advanced-solid-tumorsld/ 2021-08-18T06:15:52+00:00 https://www.oncozine.com/wp-content/uploads/2020/10/gsk_madrid_recce_sept18_phase_140.jpg https://www.oncozine.com/wp-content/uploads/2021/08/jemperli-logo.webp https://www.oncozine.com/wp-content/uploads/2021/08/CDx_MMR_OWP_Figure_web_ready_2880pxW-scaled.jpg https://www.oncozine.com/wp-content/uploads/2021/08/Jubilee-Brown-Professor-and-Division-Director-of-Gynecologic-Oncology.jpg https://www.oncozine.com/folate-receptor-alpha-targeting-antibody-drug-conjugate-gets-fda-fast-track-designation/ 2021-08-18T20:59:23+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/Fotolia_237743640_Subscription_Monthly_M-e1600399749408.jpg https://www.oncozine.com/adagene-and-merck-to-advance-adg106-an-anti-cd137-agonist-in-combination-with-pembrolizumab/ 2021-08-24T01:22:03+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Merck-_-ASCO-2019-2_JPG.jpeg https://www.oncozine.com/anixa-biosciences-receives-u-s-patent-for-ovarian-cancer-vaccine-technology/ 2021-08-24T05:30:23+00:00 https://www.oncozine.com/wp-content/uploads/2021/08/Cleveland-clinic-2920.jpg https://www.oncozine.com/survey-finds-oncologists-have-grown-more-comfortable-with-car-t-therapy/ 2021-08-24T05:33:54+00:00 https://www.oncozine.com/wp-content/uploads/2021/08/iStock-904801742-scaled.jpg https://www.oncozine.com/wp-content/uploads/2021/08/Cart-T_therapies-e1629762319971.jpg https://www.oncozine.com/treating-the-patient-vs-the-disease-can-boost-survivorship-in-communities-of-color/ 2021-08-25T00:37:35+00:00 https://www.oncozine.com/wp-content/uploads/2016/06/Fotolia_86830610_Subscription_Monthly_M.jpg https://www.oncozine.com/balstilimab-monotherapy-shows-positive-results-in-phase-2-trial/ 2021-08-26T18:22:29+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_219643525_Subscription_Monthly_M.jpg https://www.oncozine.com/fda-approves-ivosidenib-for-the-treatment-of-idh1-mutated-cholangiocarcinoma/ 2021-08-26T20:09:40+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/FDA-Building-and-Sign.jpg https://www.oncozine.com/wp-content/uploads/2021/08/Rachna-T.-Shroff-MD-associate-professor-of-medicine-University-of-Arizona-scaled.jpg https://www.oncozine.com/wp-content/uploads/2021/08/Servier-2-2021-08-26-at-11.47.17-AM-e1630006829772.png https://www.oncozine.com/the-role-of-liquid-biopsies-in-cancer-care/ 2021-08-31T23:47:59+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_202377709_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/08/Roy-et-all-Trends-in-Molecular-Medicine-e1630339101834.jpg https://www.oncozine.com/image-guided-superficial-radiotherapy-highly-effective-in-treating-skin-cancers-without-surgery/ 2021-09-08T22:22:03+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/Fotolia_112737156_Subscription_Monthly_M-1.jpg https://www.oncozine.com/results-of-a-phase-0-1-trial-of-ribociclib-everolimus-in-recurrent-high-grade-glioma/ 2021-09-09T19:48:32+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/0036Ivy.NS_.jpg https://www.oncozine.com/wp-content/uploads/2021/09/EANO.jpg https://www.oncozine.com/cervical-cancer-eliminated-by-2030-in-low-poverty-communities-high-poverty-communities-lag-behind/ 2021-09-10T22:56:31+00:00 https://www.oncozine.com/wp-content/uploads/2005/09/Fotolia_121690457_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/09/Jennifer_Spencer_PHD_Headshot.jpg https://www.oncozine.com/most-blood-cancer-patients-benefit-from-an-additional-covid-19-vaccine-dose/ 2021-09-14T18:44:57+00:00 https://www.oncozine.com/wp-content/uploads/2021/09/hakan-nural-9c3C_KojYMQ-unsplash-scaled-e1631644927996.jpg https://www.oncozine.com/report-shows-340b-non-profit-charity-hospitals-make-a-handsome-profit-on-cancer-drugs/ 2021-09-14T20:45:01+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_198929062_Subscription_Monthly_M.jpg https://www.oncozine.com/lack-of-evidence-for-telemedicine-in-prevention-and-surveillance-for-recurrences-and-new-cancers/ 2021-09-14T23:22:22+00:00 https://www.oncozine.com/wp-content/uploads/2021/09/telemedicine-6166814_1280-Pixaby-e1631661389182.webp https://www.oncozine.com/safron-ii-study-of-single-fraction-vs-multifraction-stereotactic-ablative-body-radiotherapy/ 2021-09-15T01:21:45+00:00 https://www.oncozine.com/wp-content/uploads/2021/09/SHANKAR_SIVA_01.jpg https://www.oncozine.com/wp-content/uploads/2021/09/Arya-amini-MD-City-of-Hope.webp https://www.oncozine.com/precision-medicine-patient-outcomes-in-early-phase-clinical-trials/ 2021-09-15T03:05:37+00:00 https://www.oncozine.com/wp-content/uploads/2021/09/Pri%CC%81ncipe-Felipe-Science-Museum-Valencia-Spain.webp https://www.oncozine.com/no-benefit-of-additional-tumor-testing-in-her2-negative-mbc-with-confirmed-germline-brca-mutations/ 2021-09-15T03:50:00+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_177556962_Subscription_Monthly_M.jpg https://www.oncozine.com/majority-of-hospital-executives-acknowledge-the-need-to-invest-more-to-maximize-staff-efficiency/ 2021-09-15T18:56:57+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_233831755_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/09/ZEBRA-2021-09-15-at-11.41.34-AM.png https://www.oncozine.com/increased-risk-of-sudden-cardiac-death-of-ibrutinib-combination-with-rituximab-and-ace-inhibitors/ 2021-09-15T19:33:32+00:00 https://www.oncozine.com/wp-content/uploads/2021/09/Imbruvica.jpg https://www.oncozine.com/wp-content/uploads/2020/11/EMA-Logo.jpg https://www.oncozine.com/epidemiology-forecast-her2-hr-breast-cancer-diagnosed-incident-set-to-reach-114000-by-2030/ 2021-09-15T20:13:04+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_137289643_Subscription_Monthly_M.jpg https://www.oncozine.com/manageable-safety-shows-epcoritamab-in-treatment-of-heavily-pretreated-b-cell-non-hodgkin-lymphoma/ 2021-09-16T23:15:12+00:00 https://www.oncozine.com/wp-content/uploads/2020/07/Hybridoma-Tissue-Culture-Laboratory-scaled.jpg https://www.oncozine.com/tisotumab-vedotin-approved-for-the-treatment-of-recurrent-or-metastatic-cervical-cancer/ 2021-09-22T03:56:20+00:00 https://www.oncozine.com/wp-content/uploads/2021/09/Genmab-RD-Center-01-Stijn-Doors-scaled.jpg https://www.oncozine.com/wp-content/uploads/2021/09/Carton_w_Vial-Seagen-GenMab.jpg https://www.oncozine.com/zanidatamab-shows-promising-response-in-first-line-her2-positive-gastroesophageal-adenocarcinoma/ 2021-09-22T23:52:31+00:00 https://www.oncozine.com/wp-content/uploads/2019/10/Zymeworks_0930.jpeg https://www.oncozine.com/wp-content/uploads/2021/09/ESMO-Logo-2021.png https://www.oncozine.com/wp-content/uploads/2021/09/Zanidatamab-2021-ESMO.png https://www.oncozine.com/cabozantinib-atezolizumab-shows-encouraging-activity-and-acceptable-tolerability-in-advanced-rcc/ 2021-09-23T02:03:03+00:00 https://www.oncozine.com/wp-content/uploads/2018/02/Fotolia_88982501_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/09/Sumanta-K.-Pal-MD-City-of-Hope.webp https://www.oncozine.com/population-based-study-show-people-with-intellectual-disability-at-increased-risk-of-cancer/ 2021-09-23T03:20:18+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/ESMO-2018-2.jpg https://www.oncozine.com/wp-content/uploads/2021/09/ESMO-Logo-2021.png https://www.oncozine.com/wp-content/uploads/2021/09/liu_qianwei_Karolinska-Institutet-foto_gunilla_sonnebring.jpg https://www.oncozine.com/keynote-122-pembrolizumab-vs-chemotherapy-in-platinum-pretreated-nasopharyngeal-carcinoma/ 2021-09-23T18:32:11+00:00 https://www.oncozine.com/wp-content/uploads/2021/09/ESMO_ECC2015_2_n.jpg https://www.oncozine.com/wp-content/uploads/2021/09/ESMO-Logo-2021.png https://www.oncozine.com/wp-content/uploads/2021/09/Prof-Anthiony-TC-Chan-Hong-Kong-%E9%99%B3%E5%BE%B7%E7%AB%A0%E6%95%99%E6%8E%88.png https://www.oncozine.com/wp-content/uploads/2021/09/09-20-2021-ESMO-Overall-survival-in-the-intention-to-treat-population-in-the-KEYNOTE-122-study.-%C2%A9-Anthony-T.C.-Chan.-.jpg https://www.oncozine.com/ras-wild-type-metastatic-colorectal-cancer-and-results-from-the-randomized-panama-trial/ 2021-09-23T19:17:24+00:00 https://www.oncozine.com/wp-content/uploads/2020/01/AdobeStock_164902722-copy-scaled.jpeg https://www.oncozine.com/verastem-and-amgen-to-jointly-evaluate-vs-6766-sotorasib-in-kras-g12c-mutant-nsclc/ 2021-09-28T00:29:45+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/ESMO_2018_65.jpg https://www.oncozine.com/wp-content/uploads/2021/09/ESMO-Logo-2021.png https://www.oncozine.com/cd3xcd123-bispecific-antibody-apvo436-shows-benefit-in-relapsed-aml-and-mds/ 2021-09-29T06:08:28+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_200359299_Subscription_Monthly_M-e1626644890152.jpg https://www.oncozine.com/wp-content/uploads/2021/09/APVO436.png https://www.oncozine.com/advanced-technology-helps-to-better-detect-monitor-and-treat-brain-cancer/ 2021-10-06T02:42:22+00:00 https://www.oncozine.com/wp-content/uploads/2021/10/shutterstock_337047998.jpg https://www.oncozine.com/enhancing-the-immune-system-may-help-combat-colorectal-cancer/ 2021-10-06T06:55:10+00:00 https://www.oncozine.com/wp-content/uploads/2021/10/moscat_molecular_cell.png https://www.oncozine.com/wp-content/uploads/2021/10/Dr.-Jorge-Moscat.png https://www.oncozine.com/wp-content/uploads/2021/10/Maria-T.-Diaz-Meco.png https://www.oncozine.com/researchers-identify-new-drug-target-for-the-treatment-of-myelodysplastic-syndrome-s/ 2021-10-08T09:11:10+00:00 https://www.oncozine.com/wp-content/uploads/2021/10/01.jpg https://www.oncozine.com/wp-content/uploads/2021/10/Eirini-Papapetrou-MD-PhD.jpg https://www.oncozine.com/novel-imaging-agents-in-development-for-prostate-cancer/ 2021-10-10T23:00:50+00:00 https://www.oncozine.com/wp-content/uploads/2016/07/Fotolia_78918767_Subscription_Monthly_M.jpg https://www.oncozine.com/novel-egfrviii-selective-adc-shows-activity-against-glioblastoma-patient-derived-xenografts/ 2021-10-11T21:43:14+00:00 https://www.oncozine.com/wp-content/uploads/2021/10/photo-1576086265779-619d2f54d96b-scaled.webp https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/trastuzumab-duocarmazine-superior-to-physicians-choice-in-advanced-metastatic-her2-breast-cancer/ 2021-10-12T07:20:06+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/ESMO-2019-General-7_o.jpg https://www.oncozine.com/wp-content/uploads/2021/09/ESMO-Logo-2021.png https://www.oncozine.com/how-the-transperineal-approach-to-prostate-biopsy-benefits-clinicians-and-patients/ 2021-10-13T20:06:36+00:00 https://www.oncozine.com/wp-content/uploads/2021/10/PrecisionPoint%E2%84%A2-System.png https://www.oncozine.com/new-study-investigates-single-dose-radiation-treatment-for-prostate-cancer/ 2021-10-14T05:59:14+00:00 https://www.oncozine.com/new-ai-based-technology-may-help-to-quickly-identify-genetic-causes-of-serious-disease-in-children/ 2021-10-14T10:46:34+00:00 https://www.oncozine.com/wp-content/uploads/2021/10/Low-Res_UUHC_130528_017.jpg.png https://www.oncozine.com/wp-content/uploads/2021/10/Low-Res_UUHC_140131_019.jpg.png https://www.oncozine.com/sunscreen-with-zinc-oxide-loses-effectiveness-and-may-become-toxic-after-2-hours/ 2021-10-15T06:41:11+00:00 https://www.oncozine.com/wp-content/uploads/2021/10/artem-beliaikin-i93OgkKVHPI-unsplash-1-e1634292608775.jpg https://www.oncozine.com/cannabidiol-oil-may-be-linked-to-lung-cancer-regression/ 2021-10-15T14:42:36+00:00 https://www.oncozine.com/wp-content/uploads/2021/10/crystalweed-cannabis-nFumIdf3IHE-unsplash-scaled.jpg https://www.oncozine.com/paving-the-way-for-a-more-targeted-treatment-of-cancer/ 2021-10-17T06:46:21+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_193186103_Subscription_Monthly_M.jpg https://www.oncozine.com/is-the-glass-half-full-or-half-empty-for-health-plans/ 2021-10-22T22:19:17+00:00 https://www.oncozine.com/survivors-of-childhood-cancer-may-face-increased-risk-of-suicide/ 2021-10-25T08:01:48+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_267016701_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/10/Barnes_Justin_MD_WUS.jpg https://www.oncozine.com/patient-derived-cancer-model-for-plinabulin-monotherpy-confirms-data-for-the-treatment-of-sclc/ 2021-10-28T06:34:15+00:00 https://www.oncozine.com/wp-content/uploads/2018/04/Fotolia_43349819_Subscription_Monthly_M-e1523928869263-1.jpg https://www.oncozine.com/finding-new-approaches-to-diagnose-pancreatic-cancer-early/ 2021-11-01T18:01:52+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_137289643_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/11/William-Fisher-MD-FACS-Baylor.jpeg https://www.oncozine.com/thwarting-an-elusive-cancer/ 2021-11-02T01:22:39+00:00 https://www.oncozine.com/wp-content/uploads/2020/12/SonALAsense-Brain-Image-e1607743260444.png https://www.oncozine.com/cancer-centers-can-leverage-data-operations-to-overcome-post-pandemic-clinical-trial-challenges/ 2021-11-03T02:27:15+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/Clinical-Trial-Concept.jpg https://www.oncozine.com/the-path-toward-curative-treatments-in-cervical-cancer/ 2021-11-03T08:07:27+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_125743946_Subscription_Monthly_M.jpg https://www.oncozine.com/ivy-brain-tumor-center-and-gsk-evaluate-niraparib-in-phase-0-gilobastoma-study/ 2021-11-03T18:06:46+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/0154-2.jpg https://www.oncozine.com/phase-3-zanidatamab-study-in-first-line-her2-gastroesophageal-adenocarcinoma-enrolls-patients/ 2021-11-10T17:37:50+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_84467129.jpg https://www.oncozine.com/wp-content/uploads/2021/11/TOB-Zymeworks-2021.jpg.png https://www.oncozine.com/a-novel-conditioning-regimen-may-minimize-toxicity-and-reduce-treatment-related-aes-in-hsct/ 2021-11-12T22:20:09+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_235928524_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/11/John-F.-DiPersio-MD-PhD.jpg https://www.oncozine.com/precision-oncology-advancing-the-development-of-liquid-biopsy-based-diagnostics-with-ngs/ 2021-11-16T21:08:36+00:00 https://www.oncozine.com/wp-content/uploads/2021/11/NGS-national-cancer-institute-s9WLlvDlbx4-unsplash-scaled-e1637096835544.jpg https://www.oncozine.com/exercise-may-help-reduce-arm-and-shoulder-disability-and-pain-after-breast-cancer-surgery/ 2021-11-17T02:14:35+00:00 https://www.oncozine.com/wp-content/uploads/2021/11/breast-cancer-national-cancer-institute-z8ofh6Zkn4k-unsplash-scaled.jpg https://www.oncozine.com/wp-content/uploads/2021/11/alastait.jpeg https://www.oncozine.com/wp-content/uploads/2021/11/Julie-Bruce-.png https://www.oncozine.com/personalized-treatment-of-medulloblastoma/ 2021-11-18T15:25:44+00:00 https://www.oncozine.com/wp-content/uploads/2021/11/male-researcher-Childrens-National-Washington-e1637136251204.jpg https://www.oncozine.com/wp-content/uploads/2021/11/Catherine-Bollard-M.D.-M.B.Ch_.B..png https://www.oncozine.com/wp-content/uploads/2021/11/Brian-Rood-M.D.-Oncologist-Childrens-National.jpg https://www.oncozine.com/wp-content/uploads/2021/11/Samuel_Rivero-Hinojosa_PhD-2.png https://www.oncozine.com/addressing-cancer-related-distress-for-improved-medical-and-psychosocial-outcomes/ 2021-11-23T13:06:20+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_234893442_Subscription_Monthly_M.jpg https://www.oncozine.com/nearly-30-of-parents-and-caregivers-hesitate-to-vaccinate-children-with-cancer-against-covid-19/ 2021-11-23T13:27:40+00:00 https://www.oncozine.com/wp-content/uploads/2018/03/Fotolia_113696480_Subscription_Monthly_M-1.jpg https://www.oncozine.com/wp-content/uploads/2021/11/Kyle-Walsh-Duke.jpg https://www.oncozine.com/improving-early-detection-to-help-the-identification-of-people-at-risk-of-pancreatic-cancer/ 2021-11-24T05:14:55+00:00 https://www.oncozine.com/wp-content/uploads/2020/02/SuperLab-Ambry.png https://www.oncozine.com/wp-content/uploads/2021/11/PRCEDE-2021-11-23.png https://www.oncozine.com/leveling-the-playing-field-in-personalized-cancer-care/ 2021-12-01T01:24:07+00:00 https://www.oncozine.com/wp-content/uploads/2021/11/P001.png https://www.oncozine.com/wp-content/uploads/2021/11/P003.png https://www.oncozine.com/how-to-develop-pain-medication-with-fewer-side-effects/ 2021-12-01T05:10:23+00:00 https://www.oncozine.com/wp-content/uploads/2021/11/A-Pain-medication-with-Fewer-side-effects.png https://www.oncozine.com/wp-content/uploads/2021/11/Dr-Ken-Ng-1.jpg https://www.oncozine.com/wp-content/uploads/2021/11/Sam-Carr-PhD.jpg https://www.oncozine.com/wp-content/uploads/2021/11/CLS-Canada-s-experimental-facility-from-above-scaled.jpg https://www.oncozine.com/awareness-education-and-early-detection-best-defense-in-preventing-hepatitis-and-liver-cancer/ 2021-12-01T08:05:44+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_197669254_Subscription_Monthly_M.jpg https://www.oncozine.com/metastatic-breast-cancer-patients-benefit-from-targeted-therapies-matched-to-genomic-alterations/ 2021-12-07T22:09:32+00:00 https://www.oncozine.com/wp-content/uploads/2020/12/SABCS_TB_04201-2019-scaled-e1608940679522.jpg https://www.oncozine.com/wp-content/uploads/2021/12/SABCS-2021-cluster-logo.png https://www.oncozine.com/wp-content/uploads/2021/12/Fabrice-Andre%CC%81-SABCS-AACR-e1638913499760.jpg https://www.oncozine.com/why-are-we-not-talking-about-cancer-deaths-due-to-covid-19/ 2021-12-09T21:59:37+00:00 https://www.oncozine.com/wp-content/uploads/2021/11/CA-at-World-Cancer-Leaders-Summit-Mexico-City-2017-scaled.jpg https://www.oncozine.com/wp-content/uploads/2021/11/CA-at-WCLS-2021.png https://www.oncozine.com/elacestrant-first-oral-selective-estrogen-receptor-degrader-shows-benefit-over-standard-of-care/ 2021-12-10T05:20:00+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/18SABCS_TB_a.jpg https://www.oncozine.com/wp-content/uploads/2021/12/SABCS-2021-cluster-logo.png https://www.oncozine.com/wp-content/uploads/2021/12/Sir-George-Thomas-Beatson-MD.-scaled.jpg https://www.oncozine.com/wp-content/uploads/2020/09/Aditya-Bardia-MD.png https://www.oncozine.com/combination-of-plinabulin-pegfilgrastim-in-breast-cancer-improves-health-related-quality-of-life/ 2021-12-18T20:38:10+00:00 https://www.oncozine.com/wp-content/uploads/2021/12/2021-SABCS-001-scaled.jpg https://www.oncozine.com/wp-content/uploads/2021/12/SABC-PEG2-2021.png https://www.oncozine.com/u-s-fda-approves-phase-3-study-design-for-zilovertamab-in-the-treatment-of-mantle-cell-lymphoma/ 2022-01-04T22:50:45+00:00 https://www.oncozine.com/wp-content/uploads/2020/03/Mantle_cell_lymphoma-scaled.jpg https://www.oncozine.com/wp-content/uploads/2022/01/Zilovertamab-PM.png https://www.oncozine.com/war-on-cancer-at-50-the-origin-story-begins-with-a-socialite-citizen-lobbyist/ 2022-01-06T20:58:11+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Signing_the_national_cancer_act-e1641502609271.jpg https://www.oncozine.com/genetically-modified-gamma-delta-t-cell-therapy-in-newly-diagnosed-glioblastoma-multiforme/ 2022-01-08T04:33:14+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/brain001patrys.jpg https://www.oncozine.com/rain-therapeutics-and-roche-to-study-milademetan-anti-pd-l1-immunotherapy-in-solid-tumors/ 2022-01-08T07:53:57+00:00 https://www.oncozine.com/wp-content/uploads/2022/01/drew-hays-tGYrlchfObE-unsplash-scaled-e1641628070409.jpg https://www.oncozine.com/study-shows-psychological-distress-leads-to-more-care-and-higher-medical-costs-for-cancer-survivors/ 2022-01-10T07:10:55+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/Fotolia_73643780_Subscription_Monthly_M.jpg https://www.oncozine.com/black-owned-hospice-seeks-to-bring-greater-ease-in-dying-to-black-families/ 2022-01-11T05:13:11+00:00 https://www.oncozine.com/wp-content/uploads/2022/01/hush-naidoo-jade-photography-pA0uoltkwao-unsplash-scaled.jpg https://www.oncozine.com/a-novel-color-coded-test-helps-to-quickly-reveal-if-medical-nanoparticles-deliver-their-payload/ 2022-01-11T06:48:32+00:00 https://www.oncozine.com/wp-content/uploads/2022/01/nano-particle-based-cancer-treatment.jpg https://www.oncozine.com/wp-content/uploads/2022/01/blobid0_1641406304691.png https://www.oncozine.com/lasofoxifene-alone-or-combined-with-a-cdk-inhibitor-may-limits-progression-in-ai-resistant-tumors/ 2022-01-15T06:00:42+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/18SABCS_TB_00298a.jpg https://www.oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo.jpg https://www.oncozine.com/wp-content/uploads/2022/01/Geoffrey-Greene-MD-PhD-Chicago.jpg https://www.oncozine.com/interleukin-7-revs-up-the-immune-system-against-glioblastoma/ 2022-01-17T18:31:59+00:00 https://www.oncozine.com/wp-content/uploads/2022/01/IL7forGlioblastomaImage-600x400-1.jpg https://www.oncozine.com/study-shows-33-objective-response-rate-with-stro-002-in-patients-with-advanced-ovarian-cancer/ 2022-01-21T10:10:38+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/Fotolia_237743640_Subscription_Monthly_M-e1600399749408.jpg https://www.oncozine.com/younger-individuals-have-the-highest-risk-of-presenting-with-distant-stage-colorectal-cancer/ 2022-01-28T06:00:00+00:00 https://www.oncozine.com/wp-content/uploads/2018/03/Fotolia_169254752_Subscription_Monthly_M-1-2.jpg https://www.oncozine.com/radiation-therapy-for-dcis-does-not-seem-to-increase-cardiovascular-disease-risk/ 2022-02-01T02:07:44+00:00 https://www.oncozine.com/rural-residents-hold-more-fatalistic-beliefs-and-perceive-more-cancer-related-information-overload/ 2022-02-01T23:55:45+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_233831755_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/02/Jakob-D-Jensen-PhD-Utah.jpg https://www.oncozine.com/the-importance-of-real-world-data-in-cancer-care-to-improve-patient-quality-of-life/ 2022-02-03T16:19:35+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_167331259_Subscription_Monthly_M-1.jpg https://www.oncozine.com/wp-content/uploads/2022/02/OncoZine-Visual_Corp-Comms-for-Alan-Braly-FMI-story.png https://www.oncozine.com/why-taking-a-less-personalized-approach-may-increase-access-to-cancer-care-for-elderly-patients/ 2022-02-02T16:28:13+00:00 https://www.oncozine.com/wp-content/uploads/2022/02/nanobiotix-at-astro-scaled-1.jpg https://www.oncozine.com/proof-of-concept-for-novel-image-guided-magnetic-thermoseed-navigation-and-tumor-ablation-therapy/ 2022-02-02T06:50:55+00:00 https://www.oncozine.com/wp-content/uploads/2022/02/MINIMA-graphic-illustration-e1643783645336.png https://www.oncozine.com/wp-content/uploads/2022/02/Mark-Lythgoe.png https://www.oncozine.com/relaunching-the-cancer-moonshot-building-on-continued-progress-and-scientific-advances/ 2022-02-03T04:42:46+00:00 https://www.oncozine.com/wp-content/uploads/2022/02/Joe-Biden-scaled.jpg https://www.oncozine.com/genetic-alterations-increase-the-risk-of-developing-nash-and-fatty-liver-in-normal-weight-people/ 2022-02-07T22:16:58+00:00 https://www.oncozine.com/wp-content/uploads/2022/02/Fatty-Liver-Beleguer-et-al.-2022.webp https://www.oncozine.com/identifying-germline-signatures-to-predict-adverse-events-from-anti-pd1-pdl1-therapies/ 2022-02-07T23:17:07+00:00 https://www.oncozine.com/wp-content/uploads/2022/02/Dr.-Joanne-Weidhaas-UCLA.png https://www.oncozine.com/identify-signaling-mechanisms-in-pancreatic-cancer-cells-may-help-provide-treatment-targets/ 2022-02-08T00:20:29+00:00 https://www.oncozine.com/wp-content/uploads/2022/02/UCLA-Image-News-article-January-17-2022-e1644279245695.webp https://www.oncozine.com/wp-content/uploads/2022/02/150162_RaduCaius-UCLA.jpg https://www.oncozine.com/wp-content/uploads/2022/02/donahue-timothy-MD_UCLA-Health.webp https://www.oncozine.com/results-from-a-meta-analysis-guides-treatment-planning-for-patients-with-high-risk-prostate-cancer/ 2022-02-08T01:30:07+00:00 https://www.oncozine.com/wp-content/uploads/2022/02/UCLA-News-article-January-20-2022-e1644283716193.webp https://www.oncozine.com/wp-content/uploads/2022/02/Amar-U.-Kishan-MD.webp https://www.oncozine.com/study-quantifies-the-impact-of-three-prostate-cancer-therapy-intensification-strategies/ 2022-02-08T02:48:35+00:00 https://www.oncozine.com/wp-content/uploads/2022/02/Amar-Kishan-MD-UCLA.webp https://www.oncozine.com/wp-content/uploads/2022/02/Amar-U.-Kishan-MD.webp https://www.oncozine.com/wp-content/uploads/2022/02/Daniel-Spratt-MD-Seidman.png https://www.oncozine.com/guideline-on-external-beam-radiation-for-primary-liver-cancer-outline-best-patient-centered-care/ 2022-02-08T05:28:14+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Liver_Hepato.jpg https://www.oncozine.com/wp-content/uploads/2022/02/SA-and-HC.png https://www.oncozine.com/wp-content/uploads/2022/02/Fig-1-ASTRO-January-2022.jpg https://www.oncozine.com/wp-content/uploads/2022/02/Fig-2-ASTRO-January-2022.jpg https://www.oncozine.com/wp-content/uploads/2022/02/Fig-3-ASTRO-January-2022.jpg https://www.oncozine.com/wp-content/uploads/2022/02/Fig-4-ASTRO-January-2022.jpg https://www.oncozine.com/combination-therapies-may-improve-outcomes-due-to-independent-rather-than-synergistic-drug-action/ 2022-02-08T07:21:16+00:00 https://www.oncozine.com/wp-content/uploads/2020/08/Fotolia_104896219_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/02/sorger_peter_phd.jpg https://www.oncozine.com/wp-content/uploads/2022/02/Adam-Palmer-PhD-portrait.jpg https://www.oncozine.com/health-care-paradox-medicare-penalizes-dozens-of-hospitals-it-also-gives-five-stars/ 2022-02-08T19:50:03+00:00 https://www.oncozine.com/wp-content/uploads/2022/02/Hospital-and-nurse.jpg https://www.oncozine.com/wp-content/uploads/2022/02/andrew-ryan-University-of-Michigan.jpg https://www.oncozine.com/wp-content/uploads/2022/02/Nancy-Foster-VP-American-Hospital-Association.jpg https://www.oncozine.com/wp-content/uploads/2022/02/Karen-Joynt-Maddox-MD-MPH.jpg https://www.oncozine.com/posttraumatic-stress-disorder-frequently-occurring-but-often-overlooked-in-cancer-patients/ 2022-02-08T22:39:16+00:00 https://www.oncozine.com/wp-content/uploads/2022/02/2560px-Canva_-_Woman_Feeling_Emotional_Stress.jpg https://www.oncozine.com/gift-brings-together-researchers-and-spurs-the-next-generation-of-pre-clinical-cancer-research/ 2022-02-09T00:12:07+00:00 https://www.oncozine.com/wp-content/uploads/2022/02/henry-and-marie-jose-e-kravis-5.jpg https://www.oncozine.com/wp-content/uploads/2022/02/Joan-massague_180416_30.jpg https://www.oncozine.com/racial-disparities-in-healthcare-why-more-black-women-die-from-breast-cancer/ 2022-02-09T02:47:52+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_55861092_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/02/Svasti-Haricharan_sbp_july_2018-3233.jpg https://www.oncozine.com/study-provides-insights-into-the-genomic-basis-of-cancer-metastasis/ 2022-02-09T05:53:31+00:00 https://www.oncozine.com/wp-content/uploads/2022/02/tontonoz-1200x800-1.jpg https://www.oncozine.com/wp-content/uploads/2022/02/schultz-sanchez-vega-1200x800-1.jpg https://www.oncozine.com/phase-i-iia-trial-show-58-overall-response-rate-in-mcrc-patients-treated-with-arfolitixorin/ 2022-02-09T12:23:20+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_137289643_Subscription_Monthly_M.jpg https://www.oncozine.com/immune-cell-fingerprints-on-tumors-metastasized-to-the-brain-may-offer-clues-for-future-therapies/ 2022-02-09T23:24:59+00:00 https://www.oncozine.com/wp-content/uploads/2022/02/Brain_metastasis_-_high_mag-scaled.jpg https://www.oncozine.com/wp-content/uploads/2022/02/Roose_Jeroenphd.jpg https://www.oncozine.com/wp-content/uploads/2022/02/zena-werb-cancer.jpg https://www.oncozine.com/pembrolizumab-shows-significantly-prolonged-event-free-survival-in-high-risk-early-stage-tnbc/ 2022-02-10T03:02:02+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Merck_ASCO_2019_1.jpeg https://www.oncozine.com/wp-content/uploads/2019/07/KEYTRUDA2.jpg https://www.oncozine.com/wp-content/uploads/2022/02/Schmid-Peter-Professor-FRCP-MD-PhD.jpg https://www.oncozine.com/study-shows-new-genetic-risk-score-stratifies-lifetime-risk-of-dying-of-prostate-cancer/ 2022-02-24T05:42:51+00:00 https://www.oncozine.com/wp-content/uploads/2022/02/ASC-GU-2020-1-e1679355830457.jpg https://www.oncozine.com/wp-content/uploads/2017/03/877-ASco_logo_sm.jpg https://www.oncozine.com/trph-222-a-novel-adc-shows-positive-results-in-the-treatment-of-b-cell-non-hodgkins-lymphoma/ 2022-02-25T01:57:33+00:00 https://www.oncozine.com/wp-content/uploads/2022/02/adc-1.jpg https://www.oncozine.com/first-in-human-phase-0-1-study-of-non-invasive-sonodynamic-therapy-shows-positive-results/ 2022-02-26T00:18:42+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/0154.jpg https://www.oncozine.com/wp-content/uploads/2021/09/ESMO-Logo-2021.png https://www.oncozine.com/wp-content/uploads/2019/04/Nader-Sanai_MD.jpg https://www.oncozine.com/zanidatamab-shows-encouraging-antitumor-activity-in-heavily-pretreated-her2-positive-breast-cancer/ 2022-02-26T00:29:20+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/18SABCS_SM_32.jpg https://www.oncozine.com/wp-content/uploads/2021/12/SABCS-2021-cluster-logo.png https://www.oncozine.com/wp-content/uploads/2021/12/Zanidatamab-P2-13-07-2021-12-08.png https://www.oncozine.com/wp-content/uploads/2021/12/Zanidatamab-2021-12-08-OT1-14-01.png https://www.oncozine.com/enzalutamide-reduces-risk-of-death-by-34-in-men-with-metastatic-hormone-sensitive-prostate-cancer/ 2022-02-26T00:31:11+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/ESMO_2018_45.jpg https://www.oncozine.com/wp-content/uploads/2021/09/ESMO-Logo-2021.png https://www.oncozine.com/wp-content/uploads/2021/09/Andrew-John-Armstrong-MD.jpg https://www.oncozine.com/study-confirms-that-children-of-cancer-patients-are-too-often-excluded-from-the-disease-journey/ 2022-02-26T00:32:37+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/ESMO-2019-General-12_o.jpg https://www.oncozine.com/wp-content/uploads/2021/09/ESMO-Logo-2021.png https://www.oncozine.com/wp-content/uploads/2021/09/Sinen-Korbi-MD-e1631598398669.jpg https://www.oncozine.com/esmo-2021-oncology-research-has-recovered-from-pandemic-related-setbacks/ 2022-02-26T00:33:49+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/ESMO_2019-Opening-1_o.jpg https://www.oncozine.com/wp-content/uploads/2021/09/ESMO-Logo-2021.png https://www.oncozine.com/adagrasib-shows-positive-results-as-monotherapy-and-in-combination-with-cetuximab-in-crc/ 2022-02-27T18:29:16+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/ESMO-2019-General-8_o.jpg https://www.oncozine.com/wp-content/uploads/2021/09/ESMO-Logo-2021.png https://www.oncozine.com/wp-content/uploads/2018/10/Fotolia_178119603_Subscription_Monthly_M-960x290.jpg https://www.oncozine.com/esmo-2021-ct041-a-new-car-t-for-the-treatment-of-in-advanced-gastric-cancer/ 2022-02-27T19:37:23+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/ESMO-2019-General_1_o.jpg https://www.oncozine.com/wp-content/uploads/2022/02/Lin-shen-China-Oncologist.png https://www.oncozine.com/ribociclib-trial-data-shows-longest-median-os-ever-reported-in-hr-her2-advanced-breast-cancer/ 2022-02-28T02:40:23+00:00 https://www.oncozine.com/wp-content/uploads/2017/09/ESMO-2017-1.jpg https://www.oncozine.com/wp-content/uploads/2022/02/gabriel_n_hortobagy-MD-Anderson.jpg https://www.oncozine.com/combination-trials-with-immune-checkpoint-inhibitors-may-not-result-in-synergistic-effects/ 2022-02-28T20:55:37+00:00 https://www.oncozine.com/wp-content/uploads/2016/06/Fotolia_63809087_Subscription_Monthly_M-e1490965290993.jpg https://www.oncozine.com/wp-content/uploads/2022/02/Adam-Palmer-PhD-portrait.jpg https://www.oncozine.com/wp-content/uploads/2022/02/Immune-Checlpoint-Inhibitors-at-1.09.16-PM.png https://www.oncozine.com/city-of-hope-to-acquire-cancer-treatment-centers-of-america/ 2022-03-02T01:37:56+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/City_of_Hope_Duarte1024x682.jpg https://www.oncozine.com/wp-content/uploads/2022/03/CTCA-CoH.png https://www.oncozine.com/european-medicines-agency-recommends-approval-of-enfortumab-vedotin-monotherapy-in-bladder-cancer/ 2022-03-02T04:31:58+00:00 https://www.oncozine.com/wp-content/uploads/2022/03/European-Medicines-Agency.jpg https://www.oncozine.com/wp-content/uploads/2019/12/PADCEV.jpg https://www.oncozine.com/home-infusion-therapy-4-trends-through-2027/ 2022-03-04T18:52:56+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_159799208_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/03/Home-Infusion-at-9.55.46-PM.png https://www.oncozine.com/first-pateint-dosed-with-allogeneic-off-the-shelf-invariant-natural-killer-t-cell-therapy/ 2022-03-04T22:51:22+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_201606393_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2021/11/Jennifer_Buell.jpg https://www.oncozine.com/wp-content/uploads/2022/03/MiNk-iNK-001.png https://www.oncozine.com/study-shows-molecular-mechanisms-that-may-cause-racial-disparity-in-tnbc/ 2022-03-15T22:39:10+00:00 https://www.oncozine.com/wp-content/uploads/2022/03/28264909965_50a62be18e_o.jpg https://www.oncozine.com/wp-content/uploads/2022/03/Large-5905740.jpg https://www.oncozine.com/wp-content/uploads/2022/03/blobid0_1647278199074.jpg https://www.oncozine.com/clinically-relevant-pfs-tivo-3-trial-confirms-superiority-of-tivozanib-vs-sorafenib/ 2022-03-15T23:21:17+00:00 https://www.oncozine.com/wp-content/uploads/2022/03/i-CvvGX6T-X3.jpg https://www.oncozine.com/wp-content/uploads/2022/03/Atkins-Michael-Benjamin-Hematology-and-Oncology-MGUH-DC.jpg https://www.oncozine.com/predictors-of-adherence-changing-factors-that-influence-colorectal-cancer-screening/ 2022-03-16T00:24:50+00:00 https://www.oncozine.com/wp-content/uploads/2022/03/26178661437_9e81072aaa_o.png https://www.oncozine.com/wp-content/uploads/2022/03/ASPO-Logo.png https://www.oncozine.com/olaparib-as-adjuvant-treatment-in-germline-brca-mutated-her2-negative-high-risk-early-breast-cancer/ 2022-03-16T03:53:23+00:00 https://www.oncozine.com/wp-content/uploads/2022/03/Laobratory-at-Astra-Zeneca-Test-High-Res-e1647402695534.jpg https://www.oncozine.com/wp-content/uploads/2022/03/Professor-Andrew-Tutt.jpg https://www.oncozine.com/the-immune-system-is-very-complicated-and-its-on-a-chip/ 2022-03-16T05:07:36+00:00 https://www.oncozine.com/wp-content/uploads/2022/03/Organ-Chip-282A6210.jpg-e1647407138244.webp https://www.oncozine.com/wp-content/uploads/2022/03/Organ-on-a-Chip-Flu-Vaccine-Response_illustration.jpg.webp https://www.oncozine.com/wp-content/uploads/2022/03/Organ-on-a-Chip-Flu-Vaccine-Response_Fig-1b.jpg.webp https://www.oncozine.com/cancer-screening-in-limbo-what-are-the-implications/ 2022-03-16T19:30:32+00:00 https://www.oncozine.com/wp-content/uploads/2019/02/Fotolia_96842386_Subscription_Monthly_M.jpg https://www.oncozine.com/sanofi-and-seagen-to-collaborate-in-the-funding-and-development-of-3-novel-adcs/ 2022-03-18T18:49:25+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/ASCO-2019-Sanofi-Booth.jpeg https://www.oncozine.com/first-of-its-kind-tracking-tool-for-oncology-related-state-legislation/ 2022-03-18T21:13:36+00:00 https://www.oncozine.com/wp-content/uploads/2018/02/Fotolia_78447100_Subscription_Monthly_M.jpg https://www.oncozine.com/spurred-by-the-pandemic-esource-is-changing-oncology-trials/ 2022-03-19T04:51:22+00:00 https://www.oncozine.com/wp-content/uploads/2018/10/Clinical-Trial-Concept.jpg https://www.oncozine.com/a-novel-extracellular-vesicle-protein-based-blood-test-identifies-95-of-stage-1-pancreatic-cancer/ 2022-03-23T01:18:30+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_202377709_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/03/lippman-director-moores-Cancer-Center.jpg https://www.oncozine.com/mobocertinib-granted-conditional-marketing-authorization-in-great-britain/ 2022-03-23T07:14:56+00:00 https://www.oncozine.com/wp-content/uploads/2022/03/Takeda-2020.jpg https://www.oncozine.com/ivy-brain-tumor-center-evaluates-azd1390-in-patients-diagnosed-with-in-recurrent-grade-iv-gliomas/ 2022-03-24T06:03:23+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/0036Ivy.NS_.jpg https://www.oncozine.com/wp-content/uploads/2022/03/AZD1390-2.jpg https://www.oncozine.com/uk-nice-upholds-its-decision-not-to-approve-cabazitaxel-for-use-on-the-nhs/ 2022-04-01T19:39:24+00:00 https://www.oncozine.com/improve-patient-outcomes-in-kidney-cancer-through-collaboration/ 2022-04-07T05:01:59+00:00 https://www.oncozine.com/wp-content/uploads/2018/02/Fotolia_88982501_Subscription_Monthly_M.jpg https://www.oncozine.com/a-multi-analyte-cell-free-dna-based-blood-test-for-early-detection-of-hepatocellular-carcinoma/ 2022-04-07T05:18:45+00:00 https://www.oncozine.com/wp-content/uploads/2022/04/Exhibit-Hall-1.webp https://www.oncozine.com/wp-content/uploads/2022/04/ACMGLogo.webp https://www.oncozine.com/wp-content/uploads/2022/04/0011.png https://www.oncozine.com/study-shows-how-the-covid-19-pandemic-is-disrupting-cancer-screening/ 2022-04-07T05:53:00+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_167331259_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/04/Jody-Hoyos-prevent-cancer-foundation.jpg https://www.oncozine.com/what-to-expect-at-aacr-long-term-outcomes-for-sotorasib-in-kras-g12c-mutated-nsclc/ 2022-04-07T19:25:13+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/New_Orleans_Louisiana_AACR16.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/asco-2021-promising-data-for-the-treatment-of-non-hodgkins-lymphoma/ 2022-04-12T01:14:27+00:00 https://www.oncozine.com/wp-content/uploads/2022/04/Vancouver-BC-e1649709765934.jpg https://www.oncozine.com/wp-content/uploads/2022/04/ASCO-2021.png https://www.oncozine.com/wp-content/uploads/2022/04/Laurie-H.-Sehn-MD.png https://www.oncozine.com/wp-content/uploads/2021/06/Polivy_ADC_MOA.png https://www.oncozine.com/building-on-a-longstanding-commitment-asco-establishes-center-for-equity-diversity-and-inclusion/ 2022-04-12T17:48:05+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/ASCO17_SM_0073.jpg https://www.oncozine.com/wp-content/uploads/2017/03/875-ASco_logo_sm.jpg https://www.oncozine.com/wp-content/uploads/2022/04/Sybil-Green-e1649784026630.jpg https://www.oncozine.com/profiling-the-tumor-microenvironment-to-optimize-cancer-drug-development-and-clinical-trial-success/ 2022-04-13T00:16:28+00:00 https://www.oncozine.com/wp-content/uploads/2022/04/Picture7-e1649797921683.png https://www.oncozine.com/wp-content/uploads/2022/04/Table-001-TME.png https://www.oncozine.com/wp-content/uploads/2022/04/Workflow.png https://www.oncozine.com/wp-content/uploads/2022/04/Pic2.png https://www.oncozine.com/wp-content/uploads/2022/04/Pic3.png https://www.oncozine.com/wp-content/uploads/2022/04/Pic5.png https://www.oncozine.com/pediatric-cancer-patients-in-lower-middle-income-countries-higher-mortality-risk-due-to-covid-19/ 2022-04-13T02:11:50+00:00 https://www.oncozine.com/wp-content/uploads/2022/04/Young-child-waiting-to-receive-dental-care.-Sri-Lanka.-Photo-Simone-D.-McCourtie-World-Bank-Photo-ID-SDM-LK-204--scaled.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2022/04/Elhadi_Muhammed-e1649735468675.jpg https://www.oncozine.com/study-confirms-covid-19-vaccine-may-provide-protection-for-cancer-patients-with-b-cell-deficiencies/ 2022-04-13T04:53:39+00:00 https://www.oncozine.com/wp-content/uploads/2022/04/AACR-2016-New-Orleans.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2022/04/Walz_Juliane.jpg https://www.oncozine.com/wp-content/uploads/2022/04/Tandler_Claudia.jpg https://www.oncozine.com/existing-data-may-help-identify-ancestry-associated-features-across-multiple-cancer-types/ 2022-04-13T04:57:02+00:00 https://www.oncozine.com/wp-content/uploads/2020/09/Foundation-Medicine-Lab-Staff.png https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/all-patients-with-certain-gene-regulation-patterns-may-be-less-likely-to-respond-to-car-t-therapy/ 2022-04-13T06:18:31+00:00 https://www.oncozine.com/wp-content/uploads/2022/04/Khan_Javed-Genentech.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2022/04/Katherine-Masih-MD-PhD-e1649827955403.jpg https://www.oncozine.com/wp-content/uploads/2022/04/Rebecca-A.-Gardner-MD-e1649828155402.jpg https://www.oncozine.com/wp-content/uploads/2022/04/Rimas-Orentas-PhD-e1649828307533.jpg https://www.oncozine.com/latino-children-may-face-higher-risk-of-relapse-of-all-compared-to-non-latino-white-children/ 2022-04-13T18:39:34+00:00 https://www.oncozine.com/wp-content/uploads/2018/11/Fotolia_20736088_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2022/04/Philip-J-Lupo-PhD.jpg https://www.oncozine.com/what-to-expect-at-aacr-2022-cell-therapy-and-preventive-medicine/ 2022-04-13T18:59:57+00:00 https://www.oncozine.com/wp-content/uploads/2019/11/City_of_Hope_Duarte1024x682.jpg https://www.oncozine.com/race-act-more-cancer-drugs-to-be-studied-for-use-in-pediatric-patients/ 2022-04-19T05:46:12+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_267016701_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2022/04/McKelvey_Brittany.jpg https://www.oncozine.com/study-shows-lung-cancer-patients-with-a-ctla-4-variant-may-beter-respond-to-immunotherapy/ 2022-04-19T19:51:49+00:00 https://www.oncozine.com/wp-content/uploads/2022/04/AACR-2016-New-Oreleans-005-scaled.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2022/04/Allen_India-e1650396801247.jpg https://www.oncozine.com/novel-car-t-cell-therapy-in-solid-tumors-showed-early-signs-of-efficacy/ 2022-04-19T21:41:12+00:00 https://www.oncozine.com/wp-content/uploads/2022/04/AACR-Annual-Meeting-2016-New-Orleans.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2022/04/Haanen_John.jpg https://www.oncozine.com/breast-specific-gamma-imaging-proves-highly-sensitive-for-the-detection-of-ductal-carcinoma-in-situ/ 2022-04-19T22:02:31+00:00 https://www.oncozine.com/study-show-recurrent-non-invasive-breast-tumors-may-not-always-be-related-to-the-primary-lesion/ 2022-04-19T22:44:50+00:00 https://www.oncozine.com/wp-content/uploads/2017/11/Fotolia_169706158_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2022/04/Kader_Tanjina-AACR.jpg https://www.oncozine.com/nk-cells-complexed-with-cd30-cd16a-bispecific-antibody-offers-potential-treatment-for-r-r-lymphoma/ 2022-04-20T04:35:06+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/2824-AACR-2019-Annual-Meeting-033019-copy.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2022/04/Nieto_Yago-AACR-2022.jpg https://www.oncozine.com/sotorasib-may-offer-long-term-clinical-benefit-in-patients-with-non-small-cell-lung-cancer/ 2022-04-20T05:34:10+00:00 https://www.oncozine.com/wp-content/uploads/2017/07/AACR-2017-2.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2022/04/Dy_Grace-AACR.jpg https://www.oncozine.com/artificial-intelligence-may-predict-adverse-events-from-novel-drug-combinations/ 2022-04-20T06:43:06+00:00 https://www.oncozine.com/wp-content/uploads/2022/04/Westerman_Bart.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2022/04/adverse-events-atlas-graphic.png https://www.oncozine.com/bioinformatics-approach-helps-optimizes-the-selection-of-combination-cancer-therapies/ 2022-04-20T17:56:43+00:00 https://www.oncozine.com/wp-content/uploads/2022/04/adaptiveimage.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2022/04/Anil-Korkut-Ph.D.-MD-Anderson-scaled.jpg https://www.oncozine.com/neoadjuvant-nivolumab-chemotherapy-significantly-improves-survival-in-resectable-nsclc/ 2022-04-20T20:01:58+00:00 https://www.oncozine.com/wp-content/uploads/2022/04/AACR-2016-annual-meeting-scaled.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/global-burden-of-disease-new-cancer-cases-cancer-deaths-and-disability-adjusted-life-years/ 2022-04-21T03:48:07+00:00 https://www.oncozine.com/wp-content/uploads/2022/04/world-map-scaled.jpg https://www.oncozine.com/wp-content/uploads/2022/04/Kocarnik_Jonathan-e1650511928753.png https://www.oncozine.com/alectinib-shows-activity-in-alk-rearranged-metastatic-solid-tumors-other-than-nsclc/ 2022-04-21T04:50:03+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/AACR2016_4.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2022/04/funda_meric-bernstam.jpg https://www.oncozine.com/lonza-to-manufacture-ovarian-drug-candidate-for-vivesto/ 2022-05-05T00:02:46+00:00 https://www.oncozine.com/wp-content/uploads/2019/03/Lonza_12.jpg https://www.oncozine.com/insights-from-ash-treating-myeloma-is-a-marathon-not-a-sprint/ 2022-05-06T06:32:52+00:00 https://www.oncozine.com/wp-content/uploads/2017/09/Fotolia_140248248_multiple_myeloma.jpg https://www.oncozine.com/wp-content/uploads/2022/04/Rifkin-Robert-e1651381787533.jpg https://www.oncozine.com/surgical-site-infections-a-preventable-roadblock-to-optimal-cancer-care/ 2022-05-09T22:27:07+00:00 https://www.oncozine.com/wp-content/uploads/2022/05/Surgery-JC-Gellidon-UNSplash-1550831106-0994-1-scaled-e1652135032131.webp https://www.oncozine.com/cancer-moonshot-funding-should-focus-on-prevention-not-just-cure-or-treatment/ 2022-05-12T18:00:41+00:00 https://www.oncozine.com/wp-content/uploads/2018/08/Fotolia_177448685_Subscription_Monthly_M.jpg https://www.oncozine.com/tackling-the-complexities-of-cancer-treatment-data-can-drive-value-based-care/ 2022-05-11T16:30:11+00:00 https://www.oncozine.com/wp-content/uploads/2020/11/Fotolia_1132263_Big_Data-e1606748844640.jpg https://www.oncozine.com/bioimpedance-spectroscopy-better-than-tape-measure-for-preventing-breast-cancer-related-lymphedema/ 2022-05-13T17:30:23+00:00 https://www.oncozine.com/wp-content/uploads/2022/05/angiola-harry-nJv6xnlpNaA-unsplash-scaled.jpg https://www.oncozine.com/wp-content/uploads/2022/05/Lymohedima-Oncozine-.png https://www.oncozine.com/researchers-identify-a-new-subset-of-high-risk-pediatric-liver-cancer/ 2022-05-18T02:15:02+00:00 https://www.oncozine.com/wp-content/uploads/2022/05/national-cancer-institute-qgKF2QkwReU-unsplash-scaled-e1652838278181.jpg https://www.oncozine.com/wp-content/uploads/2022/05/sumazin.png https://www.oncozine.com/wp-content/uploads/2022/05/2k9-0493-DSC_8398_Dr._Delores_Lopez-Terrada.jpg https://www.oncozine.com/polypharmacy-how-cancer-patients-face-higher-risks-of-drug-interactions/ 2022-05-18T02:15:52+00:00 https://www.oncozine.com/wp-content/uploads/2022/05/haley-lawrence-HTttz00wkzU-unsplash-scaled.jpg https://www.oncozine.com/wp-content/uploads/2022/05/Erika-e-Ramsdale-Rchester.jpg https://www.oncozine.com/combating-financial-hurdles-setting-up-physicians-for-short-and-long-term-financial-success/ 2022-05-18T16:00:54+00:00 https://www.oncozine.com/wp-content/uploads/2022/05/scott-graham-5fNmWej4tAA-unsplash-scaled.jpg https://www.oncozine.com/study-isatuximab-combination-provides-unprecedented-median-pfs-in-treatment-of-multiple-myeloma/ 2022-05-18T06:52:21+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/ASCO-2019-Sanofi-Booth.jpeg https://www.oncozine.com/pivotal-phase-2-clinical-trial-shows-positive-results-with-tucatinib-trastuzumab-in-her2-mcrc/ 2022-05-23T15:09:55+00:00 https://www.oncozine.com/wp-content/uploads/2020/01/AdobeStock_164902722-copy-scaled.jpeg https://www.oncozine.com/liquid-biopsies-as-a-non-invasive-assessable-cancer-diagnostic-tool-3__trashed/ 2022-05-24T23:50:22+00:00 https://www.oncozine.com/wp-content/uploads/2016/08/Lab-Fotolia.jpg https://www.oncozine.com/age-related-lung-changes-a-pathway-for-metastatic-growth-of-dormant-melanoma-cancer/ 2022-06-01T22:10:28+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/Ashani-Weeraratna-e1654121246698.jpg https://www.oncozine.com/wp-content/uploads/2020/11/Ashwani-Weeraratna-PhD-b24_0.png https://www.oncozine.com/an-rx-for-american-healthcare-more-physician-entrepreneurship/ 2022-06-02T00:23:29+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/akram-huseyn-brbF5FSnSgI-unsplash-scaled-e1654118629436.jpg https://www.oncozine.com/asco-2022-servier-commits-to-bringing-the-promise-of-tomorrow-to-cancer-patient-today/ 2022-06-02T05:36:00+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/IMG_0331-scaled-e1654128737170.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/asco-2022-cornerstone-to-present-promising-research-findings-in-three-rare-cancer/ 2022-06-02T06:48:49+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/IMG_0243-scaled-e1654152372575.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/asco-2022-new-data-shows-benefit-of-glofitamab-a-bispecific-antibody-for-treatment-of-r-r-dlbcl/ 2022-06-02T20:19:33+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/Genentech-2-2015-ASCO-4.50.44-PM.png https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/what-can-we-do-to-better-manage-our-pharmaceutical-waste/ 2022-06-08T01:16:42+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/nathan-dias-ftWQP8MNG4g-unsplash-scaled-e1654650762474.jpg https://www.oncozine.com/wp-content/uploads/2022/06/2022-06-07_pharmacy-e1654650153452.png https://www.oncozine.com/momentum-study-oral-treatment-improves-care-of-patients-with-myelofibrosis/ 2022-06-08T06:20:49+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/Ruben-Mesa_MD_UT-Health-San-Antonio-MD-Anderson.jpg.png https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/alleviating-targeted-therapy-side-effects-essential-for-patient-qol-and-best-outcomes/ 2022-06-09T05:47:46+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/towfiqu-barbhuiya-C-zwLtPSErc-unsplash-scaled-e1654753585870.jpg https://www.oncozine.com/shes-31-has-stage-4-kidney-cancer-and-talked-openly-about-it-in-a-job-interview/ 2022-06-12T00:43:45+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/gadelrab_coleman.jpg-2.webp https://www.oncozine.com/pioneering-novel-targeted-treatments-in-lung-cancer/ 2022-06-12T01:31:43+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/Low-Res_DSC_8417.jpg-e1654997444644.png https://www.oncozine.com/wp-content/uploads/2022/06/Low-Res_180308ck_Scaglioni_020_Final.jpeg.png https://www.oncozine.com/omitting-radiotherapy-after-breast-conserving-surgery-in-low-grade-luminal-a-breast-cancer-patients/ 2022-06-12T21:47:40+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22_SM_0349-scaled-e1655061395486.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/wp-content/uploads/2022/06/ASCO-2022-001.png https://www.oncozine.com/study-demonstrates-bridge-therapy-to-be-benefit-in-some-children-with-high-risk-neuroblastoma/ 2022-06-13T04:00:17+00:00 https://www.oncozine.com/wp-content/uploads/2018/06/Fotolia_117609459_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/06/desai-ami-bio-261x347-1.jpg https://www.oncozine.com/oral-targeted-therapy-significantly-increases-overall-response-rate-in-pediatric-low-grade-gliomas/ 2022-06-13T05:08:50+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/IMG_0262-scaled.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/wp-content/uploads/2022/06/Hudson-Asco-pers-001.png https://www.oncozine.com/panitumumab-mfolfox6-significantly-improves-os-in-patients-with-ras-wild-type-mcrc/ 2022-06-13T06:47:50+00:00 https://www.oncozine.com/wp-content/uploads/2022/03/Takeda-2020.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/wp-content/uploads/2022/06/Paradigm-ASCO-2.jpg https://www.oncozine.com/wp-content/uploads/2022/06/2022-06-12_23-44-45.jpg https://www.oncozine.com/ribociclib-letrozole-maintained-an-os-benefit-for-postmenopausal-patients-with-hr-her2-mbc/ 2022-06-13T16:40:25+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/ASCO-2022-003-e1655138308355.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/wp-content/uploads/2022/06/dr-hope-rugo-md-106-320x320-2x.jpg https://www.oncozine.com/high-dose-ifosfamide-is-superior-for-treating-recurrent-and-primary-refractory-ewing-sarcoma/ 2022-06-13T17:41:29+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/19ASCO_KN_0071.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/wp-content/uploads/2022/06/ASCO-Sarcoma-Keedy.jpg https://www.oncozine.com/novel-drug-combination-demonstrates-promise-results-in-treating-pancreatic-neuroendocrine-tumors/ 2022-06-13T20:29:04+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/ASCO17_SM_3597.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/wp-content/uploads/2022/06/Kunz-Pamela-2022-scaled.jpg https://www.oncozine.com/sacituzumab-govitecan-increases-pfs-for-patients-with-most-common-type-of-advanced-breast-cancer/ 2022-06-14T02:25:27+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/IMG_0290-scaled.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/wp-content/uploads/2022/06/ASCO-SG-2-2022-1.jpg https://www.oncozine.com/nimotuzumab-significantly-improves-overall-survival-for-k-ras-wild-type-advanced-pancreatic-cancer/ 2022-06-14T06:32:57+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/ASCO-2022--scaled-e1655188196606.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/wp-content/uploads/2022/06/ASCO-Kras-China-Eng-003.jpg https://www.oncozine.com/a-perspective-on-the-evolving-treatment-of-rectal-cancer/ 2022-06-14T06:39:43+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/Sanoff-Hanna-md-phd-UNC-Lineberger-wc.jpg.png https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/wp-content/uploads/2022/06/Sanoff-Hanna-md-phd-UNC-Lineberger-wc.jpg.png https://www.oncozine.com/ibrutinib-standard-of-care-therapy-improves-pfs-by-50-in-older-patients-with-newly-diagnosed-mcl/ 2022-06-14T07:53:36+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/ASCO-2022-009-e1655192966909.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/wp-content/uploads/2022/06/ASCO-2022-MCL-001.jpg https://www.oncozine.com/her-first-colonoscopy-cost-her-us-0-her-second-cost-us-2185-why/ 2022-06-15T02:11:44+00:00 https://www.oncozine.com/wp-content/uploads/2022/05/Elizabeth-M-2.jpg https://www.oncozine.com/preventive-care-may-be-free-but-follow-up-diagnostic-tests-can-bring-big-bills/ 2022-06-15T03:01:25+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/Fotolia_225653074_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/06/fendrick-mark-MD-Institute-Healthcare-Policy.jpg https://www.oncozine.com/novel-adc-doubles-progression-free-survival-in-metastatic-breast-cancer-with-low-her2-expression/ 2022-06-15T03:12:46+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/i-7BPWsRQ-scaled-e1655079865242.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/wp-content/uploads/2022/06/ASCO-Destiny4.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO-Trastu.jpg https://www.oncozine.com/ongoing-studies-with-belantamab-mafodotin-in-patients-with-relapsed-refractory-multiple-myeloma/ 2022-06-17T05:25:44+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/ASCO-2022-045-e1655441692843.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/wp-content/uploads/2022/06/FUawBeKXEAIa0zW-e1655427527923.jpeg https://www.oncozine.com/wp-content/uploads/2022/06/HANG-QUACH-University-of-Melbourne400x400.jpg https://www.oncozine.com/cabozantinib-pembrolizumab-shows-orr-of-54-in-treatment-of-recurrent-or-metastaric-hnscc/ 2022-06-18T01:33:07+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/ASCO17_SM_0073.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/wp-content/uploads/2022/06/nabil-saba-2011.jpg https://www.oncozine.com/asco-2022-exploring-ancestry-specific-genetic-risk-for-triple-negative-breast-cancer/ 2022-06-18T03:47:58+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/photo-1579154341140-5aa3a445d43b-e1655524020403.jpeg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/wp-content/uploads/2022/06/Michael-J.-Hall-MD-MS-Department-of-Clinical-Geneticsl.jpg https://www.oncozine.com/asco-2022-racial-differences-in-treatment-and-outcomes-of-first-line-therapies-for-kidney-cancer/ 2022-06-18T05:32:23+00:00 https://www.oncozine.com/wp-content/uploads/2018/02/Fotolia_88982501_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/wp-content/uploads/2022/06/Daniel-Geynisman-640x860-FOX-Chase.jpg https://www.oncozine.com/surgery-rather-than-radiation-associated-with-lower-stroke-risk-in-head-and-neck-cancer-patients/ 2022-06-18T06:45:27+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/i-c5ZM8TC-X3-e1655533579437.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/wp-content/uploads/2022/06/Lova-L.-Sun-MD-MSCE.jpg https://www.oncozine.com/biomarkers-predict-better-immunotherapy-treatment-outcomes-for-patients-with-pancreatic-cancer/ 2022-06-18T22:48:27+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22_SM_0228-scaled-e1655589574654.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/encouraging-results-for-cabozantinib-mono-and-combination-therapy-across-different-tumor-types/ 2022-06-19T06:13:55+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/IMG_0301-scaled-e1655617765338.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/promising-activity-with-zanidatamab-in-first-line-setting-of-her2-breast-gastroesophageal-cancer/ 2022-06-21T06:21:10+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/Zymeworks_0930-copy-2-e1655792409382.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/soft-tissue-sarcomas-changes-the-biology-of-immune-cells-surrounding-tumors-to-promote-tumor-growth/ 2022-06-23T01:22:32+00:00 https://www.oncozine.com/wp-content/uploads/2016/06/Fotolia_63809087_Subscription_Monthly_M-e1490965290993.jpg https://www.oncozine.com/wp-content/uploads/2022/06/guarnerio_jlenia.jpg https://www.oncozine.com/wp-content/uploads/2022/06/shiaostephen.shiaos-cede-sinai.jpg https://www.oncozine.com/wp-content/uploads/2022/06/theodorescud-cedar-sinai.jpg https://www.oncozine.com/statue-of-a-woman-with-incurable-breast-cancer-unveiled-in-front-of-the-norwegian-parliament/ 2022-06-23T01:47:52+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/Norway-001.jpg https://www.oncozine.com/wp-content/uploads/2022/06/Norwegian-parlemement-scaled.jpg https://www.oncozine.com/wp-content/uploads/2022/06/Norway-3.jpg https://www.oncozine.com/activating-the-immune-response-enables-liver-cancer-patients-immune-system-to-kill-cancerous-cells/ 2022-06-23T03:16:26+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/Fotolia_194566205_Subscription_Monthly_M-e1655953870592.jpg https://www.oncozine.com/wp-content/uploads/2022/06/koltsova-ekaterina.koltsovae-cedars-sinai.jpg https://www.oncozine.com/wp-content/uploads/2022/06/grivennikov-sergey.grivennikos-Cedars-sinai.jpg https://www.oncozine.com/wp-content/uploads/2022/06/theodorescud-cedar-sinai.jpg https://www.oncozine.com/soraya-shows-consistent-safety-profile-for-mirvetuximab-soravtansine-in-ovarian-cancer-shows/ 2022-06-24T04:32:58+00:00 https://www.oncozine.com/wp-content/uploads/2017/06/2017asco_dm_00089-X4.jpeg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/activity-of-tivozanib-in-non-clear-cell-rcc-subgroups-a-phase-2-randomized-discontinuation-trial/ 2022-07-09T04:18:51+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/robina-weermeijer-sRXCFkJahGk-unsplash-scaled.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/asco-2022-maturation-of-overall-survival-in-tivo-3-with-long-term-follow-up/ 2022-07-09T05:10:24+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/julien-tromeur-_zkb2-BXoTk-unsplash-scaled.jpg https://www.oncozine.com/wp-content/uploads/2022/06/ASCO22-Logo-360x103-1.png https://www.oncozine.com/new-treatment-option-disrupting-the-difficult-to-treat-tumor-microenvironment-of-pancreatic-cancer/ 2022-07-09T06:01:16+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/800_arsen-osipov-md.jpg https://www.oncozine.com/wp-content/uploads/2022/06/theodorescud-cedar-sinai.jpg https://www.oncozine.com/adults-with-blood-cancers-respond-to-booster-but-not-to-the-initial-dose-of-covid-19-vaccines/ 2022-07-11T10:07:47+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/COVID-19-web-banner-e1623012663834.jpg https://www.oncozine.com/us-fda-grants-priority-review-for-the-cd20xcd3-t-cell-engaging-bispecific-antibody-mosunetuzumab/ 2022-07-09T21:44:46+00:00 https://www.oncozine.com/wp-content/uploads/2020/12/ASH-2018-General-Views-19-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/a-less-invasive-treatment-option-for-colorectal-cancer-could-save-over-uk-1-billion/ 2022-07-12T02:11:37+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/Colin-Watts-Unsplash-photo-1580971266928-ff5d40c194a7.webp https://www.oncozine.com/diagnosis-debt-in-america-cancer-patients-endure-debt-on-top-of-disease/ 2022-07-12T06:28:00+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/KNN-NPR-Peters3_3300x2200online.jpg-e1657606019526.webp https://www.oncozine.com/wp-content/uploads/2022/07/KNN-NPR-2022-07-11_23-09-12.jpg https://www.oncozine.com/wp-content/uploads/2022/07/KNN-NPR-2-2022-07-11_23-11-51.jpg https://www.oncozine.com/diagnosis-debt-100-million-people-in-america-are-saddled-with-health-care-debt/ 2022-07-12T07:48:48+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/KHH-ariane-buck-1_3840x2560.jpg.webp https://www.oncozine.com/wp-content/uploads/2022/06/KHH-What-2022-01-06-12_00-01-45.jpg https://www.oncozine.com/wp-content/uploads/2022/06/KHH-33-2022-06-11_23-48-11.jpg https://www.oncozine.com/wp-content/uploads/2022/06/KHH-2-2022-06-11_23-49-14.jpg https://www.oncozine.com/wp-content/uploads/2022/06/KHH-3-2022-06-11_23-49-57.jpg https://www.oncozine.com/wp-content/uploads/2022/06/KHH-4-2022-06-11_23-50-29.jpg https://www.oncozine.com/wp-content/uploads/2022/06/KHH-5-2022-06-11_23-50-59.jpg https://www.oncozine.com/wp-content/uploads/2022/06/KHH-2022-6-06-11_23-51-36.jpg https://www.oncozine.com/wp-content/uploads/2022/06/KHH-2022-7-06-11_23-52-09.jpg https://www.oncozine.com/fda-accepts-byondis-bla-for-vic-trastuzumab-duocarmazine-in-her2-mbc/ 2022-07-12T20:49:15+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/Libby-Penner-Unsplash-photo-1587235442328-a5fa2b18f0fe.webp https://www.oncozine.com/the-oncozine-brief-its-time-you-knew-the-power-of-your-choices-to-prevent-womens-cancer/ 2022-07-15T04:53:57+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/Vonecia-Carswell-Unsplash-photo-1522543558187-768b6df7c25c.webp https://www.oncozine.com/wp-content/uploads/2022/07/Valena-Wright-MD-2.jpg https://www.oncozine.com/wp-content/uploads/2022/07/Its-Time-You-Knew_3D-1.png https://www.oncozine.com/the-oncozine-brief-lynch-syndrome-and-genetic-testing/ 2022-07-15T05:05:52+00:00 https://www.oncozine.com/wp-content/uploads/2022/05/Fotolia_235928524_Subscription_Monthly_M_2-e1657861485521.jpg https://www.oncozine.com/wp-content/uploads/2022/07/Ambry-OncoZine-Brief.jpg https://www.oncozine.com/the-oncozine-brief-lessons-from-covid-19-help-transform-patient-access-to-clinical-trials/ 2022-07-15T05:37:23+00:00 https://www.oncozine.com/wp-content/uploads/2017/10/Fotolia_86770989_Subscription_Monthly_M-e1507955178861.jpg https://www.oncozine.com/wp-content/uploads/2022/07/lamont.png https://www.oncozine.com/european-cancer-organization-wins-award-with-time-to-act-campaign/ 2022-07-19T18:07:52+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/Covid-19-ECO-launch.png https://www.oncozine.com/wp-content/uploads/2022/07/ECO-Eurpean-Cncer-Organization-logo.png https://www.oncozine.com/wp-content/uploads/2022/07/Andreas-Charalambous-European-Cancer-Org.jpg https://www.oncozine.com/wp-content/uploads/2022/07/Professor-Mark-Lawler.jpg https://www.oncozine.com/wp-content/uploads/2022/07/Mirjam_Crul_PhD_210x210.png https://www.oncozine.com/study-uses-real-world-oncology-data-to-understand-lung-cancer-treatment/ 2022-07-19T18:41:51+00:00 https://www.oncozine.com/wp-content/uploads/2020/11/Fotolia_1132263_Big_Data-e1606748844640.jpg https://www.oncozine.com/wp-content/uploads/2022/07/Sean-Khozin-MD-MPH.jpg https://www.oncozine.com/cancer-gene-regulating-rna-dark-matter-offer-promising-steps-in-developing-new-diagnostic-tools/ 2022-07-19T20:49:16+00:00 https://www.oncozine.com/wp-content/uploads/2016/06/Fotolia_138827008_Subscription_Monthly_M-e1658263551212.jpg https://www.oncozine.com/wp-content/uploads/2022/07/Mutant-KRAS-graphical-abstract.png https://www.oncozine.com/study-shows-junk-dna-not-harmless-and-inert-could-lead-to-cancer-by-stopping-copying-of-dna/ 2022-07-20T03:54:10+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_201863659_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/07/gideon-coster-PHD.jpg https://www.oncozine.com/wp-content/uploads/2022/07/prof-kristian-helin.jpg https://www.oncozine.com/study-benefits-of-nhs-breast-screening-program-outweighs-the-risk-of-over-diagnosis/ 2022-07-20T04:50:29+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/National-Cancer-Institute-Unsplash-photo-1579154341098-e4e158cc7f55.webp https://www.oncozine.com/wp-content/uploads/2022/07/Stephen-W.-Duffy-Professor-of-Cancer-Screening.jpg https://www.oncozine.com/wp-content/uploads/2022/07/Professor-Peter-Sasieni.jpg https://www.oncozine.com/how-the-gli1-protein-breaks-free-to-cause-deadly-cancers/ 2022-07-20T05:48:52+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/Fotolia_94619649_Subscription_Monthly_M-e1490845631347_BBB-e1658295931416.jpg https://www.oncozine.com/medical-aid-in-dying-primarily-for-well-educated-and-white-patients-diagnosed-with-cancer/ 2022-07-20T06:47:42+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/kinga-cichewicz-5NzOfwXoH88-unsplash-scaled-e1658299384716.jpg https://www.oncozine.com/wp-content/uploads/2022/07/jgs17925-fig-0001-m.webp https://www.oncozine.com/caregivers-may-show-higher-levels-of-anxiety-than-the-patients-they-support/ 2022-07-20T21:16:29+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/Fotolia_140491283_Subscription_Monthly_M_BBB-e1658348210261.jpg https://www.oncozine.com/wp-content/uploads/2022/07/Elizabeth-ODonnell-MD.jpg https://www.oncozine.com/danish-study-shows-hormone-replacement-therapy-does-not-lead-to-recurrence-of-breast-cancer/ 2022-07-21T00:34:28+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/Fotolia_205060840_Subscription_Monthly_M-BBBC-e1658363656793.jpg https://www.oncozine.com/discovery-of-a-novel-mechanism-in-cancer-cells-could-enable-a-more-targeted-treatment/ 2022-07-21T19:17:08+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/zhu-hongzhi-tzFVsg6nWtM-unsplash-scaled-e1658430843665.jpg https://www.oncozine.com/wp-content/uploads/2022/07/Semih-Akincilar-A-Star-Singapore.jpg-e1658428731943.png https://www.oncozine.com/identifying-the-right-target-to-prevent-a-relapse-of-medulloblastoma/ 2022-07-21T20:20:20+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/brain001patrys.jpg https://www.oncozine.com/wp-content/uploads/2022/07/Jezabel-Rodriguez-Blanco-Ph.D.jpg.png https://www.oncozine.com/taking-off-the-breaks-to-strengthen-the-immune-response-to-cancer/ 2022-07-22T17:52:17+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/Armin-Rehm-left-and-Uta-Hopken-right-%C2%A9-Anyess-von-Bock-IMG_3706-e1658511172748.jpg https://www.oncozine.com/wp-content/uploads/2022/07/17382239521_fdcf015286_o.jpg.png https://www.oncozine.com/a-new-biomimetic-formulation-for-the-treatment-of-glioblastoma/ 2022-07-22T19:07:30+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/Glioblastoma.png https://www.oncozine.com/wp-content/uploads/2022/07/Preparation-of-biomimetic-formulation-and-tumor-inhibition-mechanism.png https://www.oncozine.com/wp-content/uploads/2022/07/Evaluation-of-the-synergistic-therapeutic-effect-of-personalized-biomimetic-formulation-in-PDX-model.png https://www.oncozine.com/study-suggest-cancer-specific-collagen-to-be-a-highly-specific-therapeutic-target/ 2022-07-22T22:03:27+00:00 https://www.oncozine.com/wp-content/uploads/2019/07/Fotolia_185816154_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/07/Raghu-Kalluri-MD-Anderson.jpg.png https://www.oncozine.com/a-systematic-evaluation-of-the-interactions-between-nanoparticles-and-cancer-cell/ 2022-07-22T22:08:56+00:00 https://www.oncozine.com/wp-content/uploads/2022/01/nano-particle-based-cancer-treatment.jpg https://www.oncozine.com/disclosing-maternal-genetic-cancer-risk-does-not-impact-the-health-behavior-of-children/ 2022-07-22T22:49:42+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/Leah-Hetteberg-Unsplash-photo-1615332590711-8a5a3364631c-e1658529475601.webp https://www.oncozine.com/improving-serious-illness-conversations-in-an-outpatient-oncology-setting/ 2022-07-22T23:48:44+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/Wasp_Cullinan_SIC_image_sized.jpg-e1658533637627.png https://www.oncozine.com/telephone-based-treatment-in-the-lung-cancer-screening-setting-improves-smoking-cessation/ 2022-07-23T00:45:11+00:00 https://www.oncozine.com/wp-content/uploads/2014/01/Fotolia_99982712_Subscription_Monthly_M.jpg https://www.oncozine.com/fda-grants-breakthrough-device-designation-to-a-liquid-biopsy-liver-cancer-detection-test/ 2022-07-23T21:56:50+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_202377709_Subscription_Monthly_M.jpg https://www.oncozine.com/researchers-aim-to-transform-cancer-diagnosis-treatment-with-just-a-few-drops-of-blood/ 2022-07-23T23:20:00+00:00 https://www.oncozine.com/wp-content/uploads/2016/06/Fotolia_127793957_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/07/Alexander-Wyatt.jpg.png https://www.oncozine.com/study-uncovers-the-double-edged-function-of-t-cells-in-colorectal-cancer/ 2022-07-26T00:51:51+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/MAX_AOM-DSS-stack-8-15.jpeg.png https://www.oncozine.com/crispr-genome-editing-may-result-in-loss-of-genetic-material-and-destabilize-the-genome/ 2022-07-26T05:59:19+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/Dr.-Uri-Ben-David-Dr.-Adi-Barzel-Dr.-Asaf-Madi.-e1658813933174.png https://www.oncozine.com/wp-content/uploads/2022/07/Chromsome-degreadation-TAU.png https://www.oncozine.com/hodgkin-lymphoma-survivors-have-a-higher-risk-of-dying-from-cardiovascular-disease-than-from-cancer/ 2022-07-26T06:17:15+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/Fotolia_211674813_Subscription_Monthly_M.jpg https://www.oncozine.com/behav3d/ 2022-07-26T07:41:20+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/Princess-Maxima-Hospital-Utrexch.png https://www.oncozine.com/capp2-trial-and-the-long-term-effects-of-aspirin-and-resistant-starch-on-cancer-incidence/ 2022-07-26T21:54:59+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/Prof-John-Mathers-standard-1.jpg https://www.oncozine.com/wp-content/uploads/2022/07/rofessor-sir_john_burn-Newcastle-University.jpg https://www.oncozine.com/selectively-targeting-drug-resistant-glioma-fighting-cancer-cells-with-dna-modification/ 2022-07-29T21:33:14+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/ModifiBio-Onco-Zine_Chameleon_1536x1025.jpg https://www.oncozine.com/wp-content/uploads/2022/07/Modifi-Bio-Co-founders2-scaled.jpeg https://www.oncozine.com/hospices-have-become-big-business-for-private-equity-firms-raising-concerns-about-end-of-life-care/ 2022-07-30T05:29:04+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/national-cancer-institute-BxXgTQEw1M4-unsplash-scaled.jpg https://www.oncozine.com/wp-content/uploads/2022/07/Joan-M-Teno-MD-Brown-University.jpg https://www.oncozine.com/wp-content/uploads/2022/07/Steve-J-Larkin-e1659134195487.jpg https://www.oncozine.com/wp-content/uploads/2022/07/Robert-Tyler-Braun-Braun.png https://www.oncozine.com/wp-content/uploads/2022/07/Christy-Borchard-Whitney.jpg https://www.oncozine.com/wp-content/uploads/2022/07/Cordt-Kassner-CEO-at-Hospice-Analytics-.jpg https://www.oncozine.com/benefits-of-pre-surgical-immunotherapy-independent-of-race-in-aggressive-breast-cancer/ 2022-07-30T06:16:39+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_193186103_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/07/pusztai1-e1659160337457.jpg https://www.oncozine.com/researchers-finds-association-between-high-insulin-dosage-and-cancer-in-patients-with-t1dm/ 2022-08-01T19:39:59+00:00 https://www.oncozine.com/wp-content/uploads/2022/08/david-moruzzi-mzzo4LrgP4-unsplash-scaled-e1659382572565.jpg https://www.oncozine.com/study-shows-patient-activation-creates-more-equitable-interactions-between-patients-and-physicians/ 2022-08-01T20:28:10+00:00 https://www.oncozine.com/wp-content/uploads/2022/08/cdc-UrsI_qbYvv8-unsplash-scaled-e1659385591595.jpg https://www.oncozine.com/wp-content/uploads/2022/08/Jennifer-J.-Griggs-M.D.-MPH.jpg https://www.oncozine.com/fewer-people-tried-to-quit-smoking-during-the-covid-19-pandemic/ 2022-08-01T22:24:39+00:00 https://www.oncozine.com/wp-content/uploads/2020/02/Fotolia_Smoking_End-e1581547401202.jpg https://www.oncozine.com/researchers-discover-vulnerability-causing-drug-sensitivity-in-leukemia/ 2022-08-01T23:07:49+00:00 https://www.oncozine.com/wp-content/uploads/2022/08/Josep-Carreras-Leukemia-Research1454.jpg https://www.oncozine.com/wp-content/uploads/2022/08/Cells-2.jpg.png https://www.oncozine.com/3d-model-of-glioblastoma-microenvironment-may-help-the-development-of-personalized-treatment/ 2022-08-02T00:28:51+00:00 https://www.oncozine.com/wp-content/uploads/2022/08/Gabriela-Mendes-a-postdoctoral-associate-at-Fralin-Biomedical-Research-Institute-at-VTC--e1659396719769.png https://www.oncozine.com/wp-content/uploads/2022/08/Jennifer-Munson4.jpg.png https://www.oncozine.com/simple-blood-test-could-lead-to-better-detection-of-glioblastoma/ 2022-08-03T06:54:11+00:00 https://www.oncozine.com/wp-content/uploads/2019/08/Fotolia_220350594_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/08/RSI-brain-tumour-blood-test-figure-1.JPG.png https://www.oncozine.com/wp-content/uploads/2022/08/Johanna-Blee-MPhys-PhD.jpg https://www.oncozine.com/scientists-identify-a-molecular-biomarker-for-cancer-venture-off-to-form-distant-tumors/ 2022-08-08T23:36:35+00:00 https://www.oncozine.com/wp-content/uploads/2022/08/blobid0_Johns-Hopkins-e1659998227822.jpg https://www.oncozine.com/wp-content/uploads/2022/08/Andrew-J.-Ewald-Ph.D.jpg https://www.oncozine.com/wp-content/uploads/2022/08/Elaina-PM.png https://www.oncozine.com/tarlatamab-shows-encouraging-anti-tumor-activity-against-sclc-in-phase-1-trial/ 2022-08-09T07:02:53+00:00 https://www.oncozine.com/wp-content/uploads/2022/08/anton-67HnmVYpVo0-unsplash-scaled-e1660028217836.jpg https://www.oncozine.com/wp-content/uploads/2022/08/IASLC-2022-Lung-Cancer.png https://www.oncozine.com/osimertinib-savolitinib-demonstrated-49-orr-in-lung-cancer-patients-with-met-over-expression/ 2022-08-09T20:04:30+00:00 https://www.oncozine.com/wp-content/uploads/2022/08/robina-weermeijer-Pw9aFhc92P8-unsplash-scaled.jpg https://www.oncozine.com/wp-content/uploads/2022/08/IASLC-2022-Lung-Cancer.png https://www.oncozine.com/wp-content/uploads/2022/08/Cristian-Massacesi-MD.jpg https://www.oncozine.com/mount-sinai-researchers-awarded-grant-to-explore-therapeutic-approach-to-kras-mutant-lung-tumors/ 2022-08-09T21:05:01+00:00 https://www.oncozine.com/wp-content/uploads/2019/05/Fotolia_82833114_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/08/1200px-Stand_up_to_Cancer_logo.svg_.png https://www.oncozine.com/right-to-know-the-critical-importance-of-options-and-choices-in-skin-cancer-treatment/ 2022-08-12T02:34:24+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/Fotolia_112737156_Subscription_Monthly_M-1.jpg https://www.oncozine.com/using-bayesian-designs-to-inform-dose-recommendations-in-clinical-trials/ 2022-08-16T22:10:36+00:00 https://www.oncozine.com/wp-content/uploads/2022/08/national-cancer-institute-PP5nO5gcLdA-unsplash-scaled-e1660189087986.jpg https://www.oncozine.com/wp-content/uploads/2022/08/BY_E_Matthews_001.jpg https://www.oncozine.com/hypericin-mediated-photodynamic-therapy-in-cutaneous-t-cell-lymphoma/ 2022-08-18T01:11:39+00:00 https://www.oncozine.com/wp-content/uploads/2022/08/Neck_of_a_woman_suffering_from_mycosis_fungoides_of_the_skin_Wellcome_L0061976-scaled.jpg https://www.oncozine.com/novel-strategies-in-exploring-treatment-resistance-in-pancreatic-cancer/ 2022-08-22T20:50:29+00:00 https://www.oncozine.com/wp-content/uploads/2022/08/PancreaticCancerDingHTAN-600x400-1.jpg https://www.oncozine.com/wp-content/uploads/2022/08/Li-Ding-PhD.jpg https://www.oncozine.com/wp-content/uploads/2022/08/David-G.-DeNardo-PhD.jpg https://www.oncozine.com/wp-content/uploads/2022/08/Fields_Ryan-280x386-1.jpg https://www.oncozine.com/researchers-discover-an-achilles-heel-in-neuroblastoma/ 2022-08-18T04:04:11+00:00 https://www.oncozine.com/wp-content/uploads/2018/06/Fotolia_117609459_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/08/barbieri.jpeg https://www.oncozine.com/biological-rather-than-behavioral-differences-reason-why-men-face-higher-risk-of-cancer-than-women/ 2022-08-18T04:44:41+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_204073525_Subscription_Monthly_M.jpg https://www.oncozine.com/poseida-and-roche-signs-agreement-to-jointly-develop-allogeneic-car-t-cell-therapies/ 2022-08-18T05:38:07+00:00 https://www.oncozine.com/wp-content/uploads/2022/08/196948-Roche-Laboratory-scaled-e1660800653464.jpeg https://www.oncozine.com/researchers-identify-biomarkers-linked-with-patient-response-to-immunotherapy/ 2022-08-18T06:15:08+00:00 https://www.oncozine.com/wp-content/uploads/2022/08/1920_sungyongyoureporttothecommunity08.jpg https://www.oncozine.com/a-new-clinical-practice-guideline-on-immunotherapy-for-the-treatment-of-nonmelanoma-skin-cancer/ 2022-08-18T07:03:49+00:00 https://www.oncozine.com/wp-content/uploads/2022/08/Basal_cell_carcinoma_histopathology_3.jpg https://www.oncozine.com/beyond-docusign-how-to-upgrade-specialty-drug-patients-to-a-first-class-experience/ 2022-08-18T19:43:32+00:00 https://www.oncozine.com/wp-content/uploads/2022/08/kelly-sikkema-_nmfUwTe9nA-unsplash-scaled-e1660845191611.jpg https://www.oncozine.com/esmo-2022-sacituzumab-govitecan-show-pfs-benefits-in-patients-diagnosed-with-hr-her2-mbc/ 2022-09-05T19:51:05+00:00 https://www.oncozine.com/wp-content/uploads/2019/09/ESMO-2019-General-8_o.jpg https://www.oncozine.com/wp-content/uploads/2017/03/981-esmo_logo_medium-300x120.jpg https://www.oncozine.com/fda-approves-durvalumab-chemotherapy-as-immunotherapy-regimen-in-advanced-biliary-tract-cancer/ 2022-09-05T21:16:00+00:00 https://www.oncozine.com/wp-content/uploads/2022/09/Gallbladder_adenocarcinoma_lymphatic_invasion_histopathology.jpg https://www.oncozine.com/wp-content/uploads/2022/09/Stacie-Lindsey-Cholangiocarcinoma.png https://www.oncozine.com/is-finding-a-donor-for-all-in-need-of-allogeneic-hct-possible-new-modeling-says-yes/ 2022-09-05T22:27:35+00:00 https://www.oncozine.com/wp-content/uploads/2019/04/Fotolia_137289643_Subscription_Monthly_M.jpg https://www.oncozine.com/study-shows-how-a-new-delivery-strategy-may-improve-chemotherapy-for-acute-myeloid-leukemia/ 2022-09-20T17:21:37+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/Fotolia_200359299_Subscription_Monthly_M-e1626644890152.jpg https://www.oncozine.com/latest-technology-advances-spinal-fusion-cedars-sinai-neurosurgeons-help-cancer-patient-sail-again/ 2022-09-20T18:39:04+00:00 https://www.oncozine.com/wp-content/uploads/2022/09/cedars-sinai-sailing-patient-scaled-e1663698925989.jpg https://www.oncozine.com/wp-content/uploads/2022/09/tiffany.perry-tg-1280x1280-1.jpeg https://www.oncozine.com/wp-content/uploads/2022/09/jeanneaandbeckypratt.jpg https://www.oncozine.com/active-surveillance-may-be-an-effective-option-for-low-risk-thyroid-cancer/ 2022-09-20T19:30:45+00:00 https://www.oncozine.com/wp-content/uploads/2022/09/Sacks-and-Ho.jpg https://www.oncozine.com/wp-content/uploads/2022/06/theodorescud-cedar-sinai.jpg https://www.oncozine.com/study-shows-nearly-three-quarters-of-patients-prefer-stool-test-to-colonoscopy/ 2022-09-20T21:44:52+00:00 https://www.oncozine.com/wp-content/uploads/2018/03/Fotolia_169254752_Subscription_Monthly_M-1-1.jpg https://www.oncozine.com/wp-content/uploads/2022/09/almario_christopher.almariocv.jpg https://www.oncozine.com/potential-biomarker-may-help-distinguish-between-two-aggressive-types-of-pediatric-brain-tumors/ 2022-09-21T17:45:39+00:00 https://www.oncozine.com/wp-content/uploads/2022/09/Ranjan-Perera--e1663778965992.jpg https://www.oncozine.com/a-new-blood-test-could-detect-liver-cancer-early-increasing-chances-for-remission-and-cure/ 2022-09-22T18:52:00+00:00 https://www.oncozine.com/wp-content/uploads/2022/09/Blood-Test-photo-1581594693702-fbdc51b2763b-e1663712499939.webp https://www.oncozine.com/wp-content/uploads/2022/09/Ju-Dong-Yang-MD.jpg https://www.oncozine.com/wp-content/uploads/2022/06/theodorescud-cedar-sinai.jpg https://www.oncozine.com/research-shows-genetic-variation-may-explain-racial-disparity-in-esophageal-cancer/ 2022-09-22T19:31:02+00:00 https://www.oncozine.com/wp-content/uploads/2022/09/Esophagus_Cancer_01.jpg https://www.oncozine.com/seagen-and-lava-therapeutics-agree-to-jointly-advance-lava-1223-for-egfr-expressing-solid-tumors/ 2022-09-29T00:52:41+00:00 https://www.oncozine.com/wp-content/uploads/2022/09/martin-woortman-plGt4oL6_wI-unsplash-scaled.jpg https://www.oncozine.com/how-dna-signatures-in-stool-samples-can-reduce-colorectal-cancer-deaths/ 2022-09-29T23:30:05+00:00 https://www.oncozine.com/wp-content/uploads/2017/07/Fotolia_135199314_Subscription_Monthly_M.jpg https://www.oncozine.com/new-who-campaign-amplifies-the-lived-experience-of-people-affected-by-cancer/ 2022-10-18T20:36:18+00:00 https://www.oncozine.com/wp-content/uploads/2022/10/WHO-Courtesey-NPR-2021-e1666125475606.jpg https://www.oncozine.com/axicabtagene-ciloleucel-receives-eu-approval-for-the-treatment-of-patients-with-dlbcl-and-hgbl/ 2022-10-19T01:29:50+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/Fotolia_205060840_Subscription_Monthly_M-BBBC-e1658363656793.jpg https://www.oncozine.com/esmo-2022-advances-in-the-treatment-of-cancer/ 2022-10-19T05:29:14+00:00 https://www.oncozine.com/wp-content/uploads/2022/10/ESOM-2022-Paris-France-e1666156728958.jpg https://www.oncozine.com/elaine-1-trial-results-presented-at-4th-congress-of-the-international-society-of-liquid-biopsy/ 2022-10-21T21:24:03+00:00 https://www.oncozine.com/wp-content/uploads/2017/11/Fotolia_169706158_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/10/ISLB-2022.png https://www.oncozine.com/wp-content/uploads/2017/03/343-Massimo_Cristofanilli-294x300.jpg https://www.oncozine.com/project-optimus-how-to-prepare-for-success/ 2022-10-22T06:37:01+00:00 https://www.oncozine.com/wp-content/uploads/2022/10/scott-graham-5fNmWej4tAA-unsplash-scaled.jpg https://www.oncozine.com/men-and-women-and-the-risk-of-brca-positive-breast-cancer/ 2022-10-23T05:19:39+00:00 https://www.oncozine.com/wp-content/uploads/2022/10/male-breast-cancer-cedars-sinai-scaled.jpg https://www.oncozine.com/wp-content/uploads/2022/06/theodorescud-cedar-sinai.jpg https://www.oncozine.com/wp-content/uploads/2022/10/John-E.-Lee-MS-LCGC.jpg https://www.oncozine.com/fourth-ras-initiative-symposium-highlights-preclinical-data-in-solid-tumor-models/ 2022-10-23T17:44:56+00:00 https://www.oncozine.com/wp-content/uploads/2022/10/NCI-Fred-e1666546752754.jpg https://www.oncozine.com/wp-content/uploads/2022/10/Qualigen-UoL-Poster-1.png https://www.oncozine.com/wp-content/uploads/2022/10/Qualigen-UoL-poster-2.png https://www.oncozine.com/jazz-pharmaceuticals-and-zymeworks-agree-to-jointly-develop-and-commercialize-zanidatamab/ 2022-10-24T01:48:00+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/Zymeworks_0930-copy-2-e1655792409382.jpg https://www.oncozine.com/wp-content/uploads/2021/11/TOB-Zymeworks-2021.jpg.png https://www.oncozine.com/wp-content/uploads/2022/10/Ken-G-Zymeworks.png https://www.oncozine.com/the-dictatorship-of-cancer-how-to-topple-it-in-three-not-so-easy-steps/ 2022-10-24T22:42:25+00:00 https://www.oncozine.com/wp-content/uploads/2022/10/diane-serik-YNZW7KW0uqs-unsplash-scaled-e1666416487539.jpg https://www.oncozine.com/wp-content/uploads/2022/10/A_001.png https://www.oncozine.com/wp-content/uploads/2022/10/B_002.png https://www.oncozine.com/wp-content/uploads/2022/10/C_003.png https://www.oncozine.com/wp-content/uploads/2022/10/D_004.png https://www.oncozine.com/the-oncozine-brief-a-novel-approach-to-advancing-breast-cancer-therapy/ 2022-10-27T06:37:59+00:00 https://www.oncozine.com/wp-content/uploads/2016/04/Fotolia_87499980_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/10/Sean-P.-Bohen-President-CEO-Olema-Oncology.jpeg https://www.oncozine.com/despite-katie-courics-advice-experts-say-ultrasound-breast-exams-may-not-really-be-needed/ 2022-11-08T04:12:35+00:00 https://www.oncozine.com/wp-content/uploads/2022/11/angiola-harry-SJCalEw-1LM-unsplash-scaled-e1667880590645.jpg https://www.oncozine.com/wp-content/uploads/2018/09/Founders-SU2C.jpg https://www.oncozine.com/wp-content/uploads/2022/11/Carol-M.-Mangione-M.D.-M.S.P.H..jpg https://www.oncozine.com/wp-content/uploads/2022/11/mass-sharon.jpg https://www.oncozine.com/wp-content/uploads/2022/11/Karla-Kerlikowske-M.D..jpg https://www.oncozine.com/genetic-tests-may-create-both-treatment-opportunities-and-confusion-for-breast-cancer-patients/ 2022-11-08T05:01:31+00:00 https://www.oncozine.com/wp-content/uploads/2022/11/image-rawpixel-id-3338043-genetic-testing.jpg https://www.oncozine.com/wp-content/uploads/2022/11/Mark-E.-Robson-MD-MSKCC.jpg https://www.oncozine.com/wp-content/uploads/2022/11/Eric-R.-Manahan-MD-MBA-FACS_800-400x300-1.jpg https://www.oncozine.com/wp-content/uploads/2022/11/Steven-J.-Katz-M.D.-MPH.jpg https://www.oncozine.com/wp-content/uploads/2022/11/Tuya-Pal-MD.jpg https://www.oncozine.com/wp-content/uploads/2022/11/Allison-W.-Kurian-M.D.-M.Sc_..jpg https://www.oncozine.com/congress-should-increase-access-to-prostate-cancer-care-for-veterans/ 2022-11-12T05:31:02+00:00 https://www.oncozine.com/wp-content/uploads/2022/11/mike-stoll-5-3pb2I4tiE-unsplash-scaled-e1668057899556.jpg https://www.oncozine.com/complete-er-antagonist-op-1250-continues-to-demonstrate-robust-activity-in-phase-1-2-clinical-trial/ 2022-11-15T16:53:59+00:00 https://www.oncozine.com/wp-content/uploads/2022/10/male-breast-cancer-cedars-sinai-scaled.jpg https://www.oncozine.com/wp-content/uploads/2022/11/TOB-Updated-Logo-PM.png https://www.oncozine.com/wp-content/uploads/2022/11/Erica-Hamilton-PM.png https://www.oncozine.com/wp-content/uploads/2022/10/Sean-P.-Bohen-President-CEO-Olema-Oncology.jpeg https://www.oncozine.com/wp-content/uploads/2022/11/Olema-2PM.png https://www.oncozine.com/mirvetuximab-soravtansine-gynx-approved-for-the-treatment-of-fr%ce%b1-platinum-resistant-ovarian-cancer/ 2022-11-16T04:00:14+00:00 https://www.oncozine.com/wp-content/uploads/2019/06/Fotolia_237743640_Subscription_Monthly_M-e1600399749408.jpg https://www.oncozine.com/wp-content/uploads/2022/11/Elahere_TM-Full_Logo-GYNX.jpg https://www.oncozine.com/wp-content/uploads/2022/11/Ursula-A-Matulonis.jpg https://www.oncozine.com/new-prodrug-targets-cancer-cells-appetite-for-glutamine-eliminates-cancer-without-causing-toxicity/ 2022-11-17T00:52:31+00:00 https://www.oncozine.com/wp-content/uploads/2022/11/julia-koblitz-RlOAwXt2fEA-unsplash-scaled.jpg https://www.oncozine.com/wp-content/uploads/2022/11/DRP-104-Johns-Hopkins-scaled.jpg https://www.oncozine.com/data-for-amun-003-a-first-in-class-oncolytic-virus-against-tnbc-to-be-presented-at-sabcs/ 2022-11-24T06:38:53+00:00 https://www.oncozine.com/wp-content/uploads/2021/12/2021-SABCS-001-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo-300x212.jpg https://www.oncozine.com/wp-content/uploads/2022/11/VK_Gadi_Hero.jpg https://www.oncozine.com/sermonix-to-present-four-posters-during-the-2022-san-antonio-breast-cancer-symposium/ 2022-11-24T07:19:34+00:00 https://www.oncozine.com/wp-content/uploads/2022/11/SABCS_TB_04201-2019-2-scaled-e1669274049161.jpeg https://www.oncozine.com/wp-content/uploads/2017/03/859-sabcslogo_2012.gif https://www.oncozine.com/val-083-novel-treatment-may-help-patients-suffering-from-gbm/ 2022-11-24T18:01:31+00:00 https://www.oncozine.com/fda-grants-fast-track-designation-for-val-083-for-the-treatment-of-newly-diagnosed-glioblastoma/ 2022-11-24T18:36:58+00:00 https://www.oncozine.com/wp-content/uploads/2018/01/Fotolia_137025190_Subscription_Monthly_M.jpg https://www.oncozine.com/new-approach-may-improve-treatments-for-patients-diagnosed-with-pancreatic-cancer/ 2022-11-24T20:09:47+00:00 https://www.oncozine.com/wp-content/uploads/2020/02/Pancreatic_Cancer.jpg https://www.oncozine.com/wp-content/uploads/2022/11/UCI-BioSci-Professor-Halbrook-Photo-768x1152-1.jpeg https://www.oncozine.com/a-new-artificial-intelligence-based-blood-testing-technology-successfully-detects-liver-cancer/ 2022-11-24T20:36:58+00:00 https://www.oncozine.com/wp-content/uploads/2022/06/Fotolia_194566205_Subscription_Monthly_M-e1655953870592.jpg https://www.oncozine.com/wp-content/uploads/2022/11/Victor-E.-Velculescu-M.D.-Ph.D..jpeg https://www.oncozine.com/epigenetic-therapy-extends-median-survival-in-hard-to-treat-lung-cancer/ 2022-11-24T20:38:32+00:00 https://www.oncozine.com/oral-health-and-cancer-new-who-report-shows-neglect-affects-nearly-50-of-the-worlds-population/ 2022-11-24T22:24:16+00:00 https://www.oncozine.com/wp-content/uploads/2022/11/ibrahim-boran-zsKFQs2kDpM-unsplash-scaled.jpg https://www.oncozine.com/wp-content/uploads/2022/11/WHO-Global-Oral-Healt-Status-Report-PM.png https://www.oncozine.com/good-oral-health-may-play-a-role-in-good-colon-health/ 2022-11-24T22:29:33+00:00 https://www.oncozine.com/study-shows-that-hiv-positive-patients-with-cancer-may-have-accelerated-biological-aging/ 2022-11-24T23:32:16+00:00 https://www.oncozine.com/wp-content/uploads/2022/11/jon-tyson-FlHdnPO6dlw-unsplash-scaled-e1669332524424.jpg https://www.oncozine.com/wp-content/uploads/2022/11/Coghill_Anna.jpeg https://www.oncozine.com/british-study-show-direct-cancer-linked-epigenetic-effect-of-smoking/ 2022-11-24T23:33:35+00:00 https://www.oncozine.com/machine-learning-gives-insight-in-the-biology-behind-cancer-and-and-predict-effective-response/ 2022-11-25T02:12:21+00:00 https://www.oncozine.com/wp-content/uploads/2022/11/national-cancer-institute-kWAPbD_zaEU-unsplash-scaled-e1669336454350.jpg https://www.oncozine.com/wp-content/uploads/2022/11/Sidhom-John-William-MD-PhD.jpeg https://www.oncozine.com/wp-content/uploads/2022/11/Drew-Mark-Pardoll-M.D.-Ph.D..jpeg https://www.oncozine.com/bristol-myers-squibb-and-lilly-sign-agreement-to-evaluate-nivolumab-in-combination-with-galunisertib-in-advanced-solid-tumors/ 2022-11-25T02:14:50+00:00 https://www.oncozine.com/wp-content/uploads/2008/12/Fotolia_66477636_Subscription_Monthly_M.jpg https://www.oncozine.com/zolbetuximab-meets-primary-endpoint-in-phase-3-spotlight-trial-in-treatment-in-gastric-cancers/ 2022-11-25T03:46:48+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/Fotolia_195507244_Subscription_Monthly_M.jpg https://www.oncozine.com/ponatinib-met-primary-endpoint-in-newly-diagnosed-ph-all-in-phase-3-phallcon-trial/ 2022-11-25T06:04:23+00:00 https://www.oncozine.com/wp-content/uploads/2022/03/Takeda-2020.jpg https://www.oncozine.com/phase-i-trial-demonstrates-ponatinib-acts-against-the-most-resistant-tform-of-chronic-myeloid-leukemia-cml-helps-patients-after-other-treatments-fail/ 2022-11-25T06:16:02+00:00 http://146.66.70.91/~adcrevie/oncozine.com/wp-content/uploads/2017/03/829-Moshe_Talpaz_2_UoM_Trotyman_Professor_of_Leukemia_Research.jpg?width=440 https://www.oncozine.com/positive-top-line-results-from-phase-3-trial-of-dcvax-l-in-treatment-of-glioblastoma/ 2022-11-25T20:05:45+00:00 https://www.oncozine.com/wp-content/uploads/2021/06/Glioblastoma.png https://www.oncozine.com/wp-content/uploads/2022/11/Kinda-F-Powers-e1669400076244.jpeg https://www.oncozine.com/promising-clinical-trial-of-dcvax-for-brain-cancer-resumes-enrollment-of-new-patients/ 2022-11-25T20:10:39+00:00 https://www.oncozine.com/understanding-the-genetic-drivers-of-head-and-neck-cancers/ 2022-11-25T21:37:38+00:00 https://www.oncozine.com/wp-content/uploads/2022/11/loume-visser-O7U51lfjPtY-unsplash-scaled.jpg https://www.oncozine.com/study-high-sugar-consumption-may-increase-risk-of-premature-aging-in-childhood-cancer-survivors/ 2022-11-27T17:41:51+00:00 https://www.oncozine.com/wp-content/uploads/2022/11/alexander-grey-oKay0q7Pa30-unsplash-scaled-e1669444844513.jpg https://www.oncozine.com/wp-content/uploads/2016/04/AACR.jpeg https://www.oncozine.com/wp-content/uploads/2022/11/Park_Yikyung_145x145-1.jpg https://www.oncozine.com/wp-content/uploads/2022/11/Lan_Tuo.jpg https://www.oncozine.com/study-shows-black-women-with-breast-cancer-may-have-worse-outcomes/ 2022-12-06T19:31:22+00:00 https://www.oncozine.com/wp-content/uploads/2019/12/19ASH_TB_01041-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo-300x212.jpg https://www.oncozine.com/wp-content/uploads/2022/12/Abdou_Yara-AACR-SABCS-2022.jpg https://www.oncozine.com/susanna-greer-ph-d-advancing-funding-for-cutting-edge-cancer-research/ 2022-12-02T07:10:37+00:00 https://www.oncozine.com/wp-content/uploads/2022/12/abhishek-chandra-kXJksx1kdJ0-unsplash-scaled.jpg https://www.oncozine.com/wp-content/uploads/2022/12/sgreer.jpg https://www.oncozine.com/sacituzumab-govitecan-demonstrates-clinical-efficacy-across-trop-2-expression-levels-in-hr-her2-metastatic-breast-cancer/ 2022-12-07T06:15:52+00:00 https://www.oncozine.com/wp-content/uploads/2022/12/SABCS_2022_LPtRrkp-X3.jpg https://www.oncozine.com/wp-content/uploads/2017/03/867-sabcs_logo-300x212.jpg https://www.oncozine.com/wp-content/uploads/2022/06/dr-hope-rugo-md-106-320x320-2x.jpg https://www.oncozine.com/racial-disparity-in-tme-in-patients-with-residual-breast-cancer-after-neoadjuvant-therapy/ 2022-12-08T06:31:18+00:00 https://www.oncozine.com/wp-content/uploads/2022/12/SABCS_2022_mbJXvL5-X2-e1670480932881.jpg https://www.oncozine.com/wp-content/uploads/2021/12/SABCS-2021-cluster-logo.png https://www.oncozine.com/wp-content/uploads/2022/12/Oktay_Maja-1_AACR_SABCS.jpg https://www.oncozine.com/updated-data-to-be-presented-at-ash-reinforces-the-strength-of-serviers-hematology-portfolio/ 2022-12-08T18:03:14+00:00 https://www.oncozine.com/wp-content/uploads/2020/12/AH-2018-App-o-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/wp-content/uploads/2021/12/TOB-Servier-ASH-2021-12-10.png https://www.oncozine.com/viale-a-study-showed-venetoclax-azacitidine-reduced-risk-of-death-in-newly-diagnosed-aml/ 2022-12-08T18:18:26+00:00 https://www.oncozine.com/wp-content/uploads/2020/08/AbbVie_6554-scaled-e1726094178386.jpg https://www.oncozine.com/ash-2022-positive-os-data-for-patients-in-r-r-aml-in-phase-1-actimab-a-clag-m-combination-trial/ 2022-12-08T18:22:15+00:00 https://www.oncozine.com/wp-content/uploads/2022/07/national-cancer-institute-BxXgTQEw1M4-unsplash-scaled.jpg https://www.oncozine.com/wp-content/uploads/2017/03/805-ASH_logo.jpg https://www.oncozine.com/wp-content/uploads/2022/11/Actimab-A.png https://www.oncozine.com/wp-content/uploads/2022/11/Abedin-Sameem-MD.jpg https://www.oncozine.com/the-oncozine-brief-radio-show-expands-distribution-to-create-a-realistic-and-constructive-approach-about-cancer-prevention-treatment-and-care/ 2022-12-08T20:29:16+00:00 https://www.oncozine.com/wp-content/uploads/2018/03/KFNX_002-1.jpg https://www.oncozine.com/research-update-how-the-hoxa5-gene-suppresses-formation-of-breast-cancer/ 2022-12-08T22:15:25+00:00 https://www.oncozine.com/wp-content/uploads/2019/01/Fotolia_115598064_Subscription_Monthly_M.jpg https://www.oncozine.com/wp-content/uploads/2022/12/blobid1.jpg https://www.oncozine.com/wp-content/uploads/2022/12/Saraswati-Sukumar-Ph.D..jpg https://www.oncozine.com/capivasertib-plus-fulvestrant-shows-statistically-significant-and-clinical-improvement-in-pfs/ 2022-12-09T03:07:35+00:00 https://www.oncozine.com/wp-content/uploads/2022/12/SABCS-2022i-kR9trrj-X2-e1670554959593.jpg https://www.oncozine.com/wp-content/uploads/2021/12/SABCS-2021-cluster-logo.png https://www.oncozine.com/wp-content/uploads/2022/12/Professor-Nicholas-Turner.jpg https://www.oncozine.com/serena-2-study-show-potential-of-camizestrant-as-a-next-generation-serd-in-endocrine-therapy/ 2022-12-09T05:50:30+00:00 https://www.oncozine.com/wp-content/uploads/2022/12/22SABCS_TB_04606-scaled-e1670564848937.jpg https://www.oncozine.com/wp-content/uploads/2021/12/SABCS-2021-cluster-logo.png https://www.oncozine.com/wp-content/uploads/2022/12/Mafalda_Oliveira.jpg https://www.oncozine.com/wp-content/uploads/2022/08/Cristian-Massacesi-MD.jpg https://www.oncozine.com/updated-interim-analysis-of-phase-3-monarche-trial-abemaciclib-shows-absolute-improvement-in-idfs/ 2022-12-09T05:52:46+00:00 https://www.oncozine.com/wp-content/uploads/2018/12/18SABCS_00261.jpg https://www.oncozine.com/wp-content/uploads/2021/12/SABCS-2021-cluster-logo.png https://www.oncozine.com/wp-content/uploads/2022/12/Screen-Shot-2022-12-07-at-12.49.18-PM.png https://www.oncozine.com/treatment-guided-by-ctc-count-may-improve-long-term-outcomes-in-patients-with-mbc/ 2022-12-10T05:47:35+00:00 https://www.oncozine.com/wp-content/uploads/2022/12/SABCS_2022-i-dpczNDR-X3-e1670651015442.jpg https://www.oncozine.com/wp-content/uploads/2021/12/SABCS-2021-cluster-logo.png https://www.oncozine.com/potential-chemotherapy-free-option-in-her2-hr-mbc-with-zanidatamab-palbociclib-fulvestrant/ 2022-12-10T05:57:00+00:00 https://www.oncozine.com/wp-content/uploads/2022/12/SABCS-2022i-2dvmtCj-X3-e1670644565444.jpg https://www.oncozine.com/wp-content/uploads/2021/12/SABCS-2021-cluster-logo.png https://www.oncozine.com/impact-of-breast-conservation-therapy-on-local-recurrence-in-patients-with-multiple-ipsilateral-bc/ 2022-12-11T01:22:02+00:00 https://www.oncozine.com/wp-content/uploads/2022/12/SABCS-2022i-TFs9zzS-X3-e1670721472140.jpg https://www.oncozine.com/wp-content/uploads/2021/12/SABCS-2021-cluster-logo.png https://www.oncozine.com/wp-content/uploads/2022/12/Boughey_Judy.jpg https://www.oncozine.com/genetic-profiling-may-help-omit-radiation-therapy-after-breast-conserving-surgery/ 2022-12-11T16:50:30+00:00 https://www.oncozine.com/wp-content/uploads/2022/12/SABCS-2022-i-K8F52jx-X3-e1670777083247.jpg https://www.oncozine.com/wp-content/uploads/2021/12/SABCS-2021-cluster-logo.png https://www.oncozine.com/wp-content/uploads/2022/12/Karlsson_Per.jpg